FromID,ToID,Relation_value,Relation_type,Relation_Context_ClinicalPhase,FromType,ToType
3004,25557,phosphodiesterase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
11307,25557,phosphodiesterase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25558,25557,phosphodiesterase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7103,25557,phosphodiesterase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
11214,25557,phosphodiesterase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
13139,25559,benzodiazepine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25560,25559,benzodiazepine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
11307,25561,phosphodiesterase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7103,25561,phosphodiesterase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
12473,25562,tachykinin antagonist,MoA,Preclinical,Gene,Chemical_Compound
6999,25563,glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8086,25563,glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13789,25564,retinoid receptor ligand,MoA,Preclinical,Gene,Chemical_Compound
25565,25566,purinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
2788,25567,histone lysine methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5189,25567,histone lysine methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25549,25568,dopamine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25569,25570,purinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25571,25572,nicotinic receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25573,25574,adrenergic receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
13991,25574,adrenergic receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25575,25574,adrenergic receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
11481,25576,AKT inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12916,25576,AKT inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5770,25576,AKT inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6190,25577,transient receptor potential channel antagonist,MoA,Preclinical,Gene,Chemical_Compound
25578,25579,sodium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
25569,25580,purinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25569,25581,purinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25582,25583,acetylcholine receptor allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
25584,25583,acetylcholine receptor allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
25571,25583,acetylcholine receptor allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
25578,25585,sodium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
6399,25586,diacylglycerol O acyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4180,25587,stearoyl-CoA desaturase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10608,25588,transient receptor potential channel antagonist,MoA,Preclinical,Gene,Chemical_Compound
8041,25589,histamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25590,25589,histamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25591,25589,histamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25592,25589,histamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25593,25589,histamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25594,25589,histamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25595,25589,histamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25548,25589,histamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25551,25589,histamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25552,25589,histamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25554,25589,histamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
7079,25589,histamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25596,25589,histamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25597,25589,histamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25598,25599,GABA receptor positive allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
25600,25599,GABA receptor positive allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
15774,25599,GABA receptor positive allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
25602,25603,metalloproteinase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25604,25605,gonadotropin releasing factor hormone receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
6510,25606,sphingosine kinase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
13040,25612,histamine receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25613,25612,histamine receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25614,25612,histamine receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25615,25616,platelet activating factor receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25617,25618,calcium channel blocker,MoA,Phase 2,Gene,Chemical_Compound
25619,25618,calcium channel blocker,MoA,Phase 2,Gene,Chemical_Compound
25620,25618,calcium channel blocker,MoA,Phase 2,Gene,Chemical_Compound
10319,25621,adenosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25549,25622,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
5075,25623,BCL inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
16033,25623,BCL inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
13520,25623,BCL inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
7762,25624,tubulin polymerization inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25625,25626,estrogen receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
14201,25627,retinoid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
7740,25628,PAR agonist,MoA,Preclinical,Gene,Chemical_Compound
9999,25629,PARP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6481,25630,retinoid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
14201,25630,retinoid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
5185,25631,PDGFR tyrosine kinase receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25632,25631,PDGFR tyrosine kinase receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25633,25631,PDGFR tyrosine kinase receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7392,25631,PDGFR tyrosine kinase receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12302,25631,PDGFR tyrosine kinase receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25634,25635,urotensin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
6809,25638,PI3K inhibitor,MoA,Phase 1,Gene,Chemical_Compound
12097,25638,PI3K inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25655,25659,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25662,25663,polarization inhibitor,MoA,Phase 3,Gene,Chemical_Compound
7333,25688,lipoxygenase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25689,25688,lipoxygenase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
15875,25696,cholesterol inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25697,25696,cholesterol inhibitor,MoA,Phase 3,Gene,Chemical_Compound
2519,25702,gamma glutamyltransferase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25709,25710,orexin receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25711,25710,orexin receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25712,25713,FGFR inhibitor|VEGFR inhibitor,MoA,Phase 1,Gene,Chemical_Compound
15295,25713,FGFR inhibitor|VEGFR inhibitor,MoA,Phase 1,Gene,Chemical_Compound
9570,25714,HDAC inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
9941,25714,HDAC inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
5184,25714,HDAC inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
15499,25714,HDAC inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
11646,25714,HDAC inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
2742,25716,aldose reductase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
2742,25718,TGF beta receptor inhibitor,MoA,Phase 3,Gene,Chemical_Compound
6995,25718,TGF beta receptor inhibitor,MoA,Phase 3,Gene,Chemical_Compound
3828,25718,TGF beta receptor inhibitor,MoA,Phase 3,Gene,Chemical_Compound
5655,25718,TGF beta receptor inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25719,25718,TGF beta receptor inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25720,25721,CC chemokine receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
14201,25722,retinoid receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
6665,25722,retinoid receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25551,25723,serotonin receptor agonist|serotonin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25554,25723,serotonin receptor agonist|serotonin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
9763,25724,protein synthesis stimulant,MoA,Preclinical,Gene,Chemical_Compound
5896,25724,protein synthesis stimulant,MoA,Preclinical,Gene,Chemical_Compound
4603,25724,protein synthesis stimulant,MoA,Preclinical,Gene,Chemical_Compound
7148,25724,protein synthesis stimulant,MoA,Preclinical,Gene,Chemical_Compound
13271,25724,protein synthesis stimulant,MoA,Preclinical,Gene,Chemical_Compound
10260,25724,protein synthesis stimulant,MoA,Preclinical,Gene,Chemical_Compound
4086,25728,adenosine receptor agonist,MoA,Launched,Gene,Chemical_Compound
12778,25728,adenosine receptor agonist,MoA,Launched,Gene,Chemical_Compound
3041,25728,adenosine receptor agonist,MoA,Launched,Gene,Chemical_Compound
4467,25728,adenosine receptor agonist,MoA,Launched,Gene,Chemical_Compound
10319,25728,adenosine receptor agonist,MoA,Launched,Gene,Chemical_Compound
11199,25728,adenosine receptor agonist,MoA,Launched,Gene,Chemical_Compound
25729,25728,adenosine receptor agonist,MoA,Launched,Gene,Chemical_Compound
8891,25728,adenosine receptor agonist,MoA,Launched,Gene,Chemical_Compound
11307,25728,adenosine receptor agonist,MoA,Launched,Gene,Chemical_Compound
7103,25728,adenosine receptor agonist,MoA,Launched,Gene,Chemical_Compound
2676,25728,adenosine receptor agonist,MoA,Launched,Gene,Chemical_Compound
13924,25728,adenosine receptor agonist,MoA,Launched,Gene,Chemical_Compound
7535,25728,adenosine receptor agonist,MoA,Launched,Gene,Chemical_Compound
12634,25728,adenosine receptor agonist,MoA,Launched,Gene,Chemical_Compound
12212,25728,adenosine receptor agonist,MoA,Launched,Gene,Chemical_Compound
10825,25728,adenosine receptor agonist,MoA,Launched,Gene,Chemical_Compound
5594,25730,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25731,25730,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25732,25730,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
14354,25730,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25679,25730,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
2854,25730,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
13204,25730,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
10758,25730,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
12639,25730,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
4086,25730,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
12778,25730,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
3041,25730,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
12119,25730,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
3862,25730,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25733,25730,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
4467,25730,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25734,25730,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25735,25730,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
15130,25730,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
11481,25730,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
11330,25730,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25736,25730,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
3446,25730,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
13259,25730,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25737,25730,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
11401,25730,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
6083,25730,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
12862,25730,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25738,25730,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
10708,25730,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
6963,25730,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
4181,25730,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25739,25730,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25740,25730,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25741,25730,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25742,25730,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25743,25730,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
13924,25730,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25744,25730,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25745,25730,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
14716,25730,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
13773,25730,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
4074,25730,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
10825,25730,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
10978,25730,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25748,25749,solute carrier family member inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14890,25750,adiponectin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
13395,25750,adiponectin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25751,25752,opioid receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25547,25753,dopamine receptor antagonist|serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25551,25753,dopamine receptor antagonist|serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
7333,25755,11-beta hydroxysteroid dehydrogenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25689,25755,11-beta hydroxysteroid dehydrogenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25655,25756,glutamate receptor negative allosteric modulator,MoA,Phase 2,Gene,Chemical_Compound
25655,25757,glutamate receptor modulator,MoA,Preclinical,Gene,Chemical_Compound
12907,25758,EGFR inhibitor|VEGFR inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
13590,25758,EGFR inhibitor|VEGFR inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
11200,25758,EGFR inhibitor|VEGFR inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
25759,25758,EGFR inhibitor|VEGFR inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
25760,25758,EGFR inhibitor|VEGFR inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
25712,25758,EGFR inhibitor|VEGFR inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
25547,25761,dopamine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
11393,25763,estrogen receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25625,25763,estrogen receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25764,25763,estrogen receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
8093,25763,estrogen receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
15425,25763,estrogen receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25765,25763,estrogen receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25766,25763,estrogen receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25767,25763,estrogen receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
3990,25768,sortilin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11627,25769,insulin growth factor receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13754,25770,PARP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12907,25771,EGFR inhibitor|JAK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11600,25771,EGFR inhibitor|JAK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5775,25771,EGFR inhibitor|JAK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8227,25772,tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8748,25773,isocitrate dehydrogenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6693,25774,isocitrate dehydrogenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11461,25775,cell cycle inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25544,25776,nitric oxide synthase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25777,25776,nitric oxide synthase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25778,25776,nitric oxide synthase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25746,25776,nitric oxide synthase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25652,25776,nitric oxide synthase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25681,25776,nitric oxide synthase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
6576,25776,nitric oxide synthase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
6576,25779,imidazoline receptor ligand,MoA,Preclinical,Gene,Chemical_Compound
9967,25780,retinoid receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
14857,25780,retinoid receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25701,25780,retinoid receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
6481,25781,retinoid receptor agonist,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
25785,25786,free fatty acid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
13991,25787,adrenergic receptor ligand,MoA,Preclinical,Gene,Chemical_Compound
25788,25789,prostanoid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25790,25789,prostanoid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
9776,25789,prostanoid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
7320,25789,prostanoid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
2939,25791,core binding factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4074,25792,tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25547,25793,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25548,25793,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25549,25793,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
14923,25794,SIRT inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25795,25796,lipoxygenase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
4449,25797,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8551,25799,apoptosis stimulant|STAT inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25800,25801,serotonin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
15452,25802,gonadotropin releasing factor hormone receptor antagonist,MoA,Launched,Gene,Chemical_Compound
4215,25812,aldehyde dehydrogenase activator,MoA,Preclinical,Gene,Chemical_Compound
12989,25813,topoisomerase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
9732,25816,phosphatidylglycerophosphatase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13343,25828,Aurora kinase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
10608,25831,cytokine production inhibitor,MoA,Phase 2,Gene,Chemical_Compound
6190,25831,cytokine production inhibitor,MoA,Phase 2,Gene,Chemical_Compound
10608,25836,TRPV agonist,MoA,Preclinical,Gene,Chemical_Compound
25709,25838,orexin receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25711,25838,orexin receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
8386,25840,anticancer agent,MoA,Preclinical,Gene,Chemical_Compound
25596,25842,serotonin receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25843,25844,protease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
6599,25847,cytochrome P450 inhibitor|HMGCR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11229,25848,omega 3 fatty acid stimulant,MoA,Phase 3,Gene,Chemical_Compound
12320,25848,omega 3 fatty acid stimulant,MoA,Phase 3,Gene,Chemical_Compound
6423,25848,omega 3 fatty acid stimulant,MoA,Phase 3,Gene,Chemical_Compound
25849,25848,omega 3 fatty acid stimulant,MoA,Phase 3,Gene,Chemical_Compound
25785,25848,omega 3 fatty acid stimulant,MoA,Phase 3,Gene,Chemical_Compound
25665,25848,omega 3 fatty acid stimulant,MoA,Phase 3,Gene,Chemical_Compound
12796,25848,omega 3 fatty acid stimulant,MoA,Phase 3,Gene,Chemical_Compound
6190,25848,omega 3 fatty acid stimulant,MoA,Phase 3,Gene,Chemical_Compound
25614,25850,histamine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25614,25851,histamine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25553,25852,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25853,25852,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25854,25852,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25554,25852,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
7079,25852,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25555,25852,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25855,25852,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25598,25856,benzodiazepine receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
2742,25863,aldose reductase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25554,25864,serotonin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25584,25865,nicotinic receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25866,25865,nicotinic receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25712,25867,MET inhibitor|VEGFR inhibitor,MoA,Phase 1,Gene,Chemical_Compound
10745,25867,MET inhibitor|VEGFR inhibitor,MoA,Phase 1,Gene,Chemical_Compound
15295,25867,MET inhibitor|VEGFR inhibitor,MoA,Phase 1,Gene,Chemical_Compound
4229,25870,HSP inhibitor,MoA,Phase 2,Gene,Chemical_Compound
15298,25874,CDK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
8227,25874,CDK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
5659,25874,CDK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
6044,25874,CDK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
3305,25874,CDK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
5178,25874,CDK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
13950,25874,CDK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11699,25874,CDK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
12907,25874,CDK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25719,25874,CDK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11061,25875,glycine transporter inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25876,25877,cannabinoid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25878,25877,cannabinoid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25795,25879,lipoxygenase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25876,25880,cannabinoid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25881,25880,cannabinoid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25882,25880,cannabinoid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25876,25883,cannabinoid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25878,25883,cannabinoid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25882,25883,cannabinoid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25876,25884,cyclooxygenase inhibitor|FAAH inhibitor|TRPV antagonist,MoA,Preclinical,Gene,Chemical_Compound
25878,25884,cyclooxygenase inhibitor|FAAH inhibitor|TRPV antagonist,MoA,Preclinical,Gene,Chemical_Compound
25885,25884,cyclooxygenase inhibitor|FAAH inhibitor|TRPV antagonist,MoA,Preclinical,Gene,Chemical_Compound
6190,25884,cyclooxygenase inhibitor|FAAH inhibitor|TRPV antagonist,MoA,Preclinical,Gene,Chemical_Compound
6481,25886,retinoid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25876,25887,cannabinoid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25878,25887,cannabinoid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25652,25888,potassium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
25894,25895,CC chemokine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25720,25896,CC chemokine receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25894,25896,CC chemokine receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25832,25899,xanthine oxidase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
15715,25900,PERK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10745,25901,tyrosine kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
9986,25902,MDM inhibitor,MoA,Phase 2,Gene,Chemical_Compound
12097,25903,PI3K inhibitor,MoA,Phase 2,Gene,Chemical_Compound
10745,25904,MET inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25905,25906,CC chemokine receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
6190,25907,TRPV antagonist,MoA,Phase 1,Gene,Chemical_Compound
25908,25909,MAP kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
15947,25909,MAP kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
6608,25909,MAP kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
4449,25909,MAP kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25849,25910,free fatty acid receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
5659,25911,CDK inhibitor|FLT3 inhibitor,MoA,Phase 1,Gene,Chemical_Compound
3305,25911,CDK inhibitor|FLT3 inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25632,25911,CDK inhibitor|FLT3 inhibitor,MoA,Phase 1,Gene,Chemical_Compound
6190,25912,TRPV antagonist,MoA,Preclinical,Gene,Chemical_Compound
12097,25913,PI3K inhibitor,MoA,Phase 2,Gene,Chemical_Compound
10745,25914,MET inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13343,25915,Aurora kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
8285,25915,Aurora kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25916,25915,Aurora kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
10034,25917,protein arginine N-methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25918,25919,adrenergic receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
7020,25920,monoamine oxidase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25921,25920,monoamine oxidase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25921,25934,dopamine receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
25800,25934,dopamine receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
2742,25941,nitric oxide synthase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25942,25941,nitric oxide synthase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
5826,25941,nitric oxide synthase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25942,25943,nitric oxide synthase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10895,25946,dihydrofolate reductase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
9813,25946,dihydrofolate reductase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
15298,25947,CDK inhibitor|tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8227,25947,CDK inhibitor|tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6044,25947,CDK inhibitor|tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25727,25950,inosine monophosphate dehydrogenase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
13152,25950,inosine monophosphate dehydrogenase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25942,25951,cyclin D inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25921,25957,serotonin transporter (SERT) inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25958,25957,serotonin transporter (SERT) inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25800,25957,serotonin transporter (SERT) inhibitor,MoA,Phase 3,Gene,Chemical_Compound
2676,25979,Pim kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25980,25981,glutamate receptor modulator,MoA,Preclinical,Gene,Chemical_Compound
12989,25983,topoisomerase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
8077,25983,topoisomerase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25652,25989,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25990,25991,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25652,25991,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25992,25993,glutamate receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25990,25993,glutamate receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
15548,25993,glutamate receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25994,25993,glutamate receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25613,26001,histamine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25633,26003,FLT3 inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|RAD51 inhibitor|RET tyrosine kinase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
10745,26003,FLT3 inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|RAD51 inhibitor|RET tyrosine kinase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
12018,26004,caspase activator,MoA,Phase 2,Gene,Chemical_Compound
26005,26006,cannabinoid receptor agonist|lipoxygenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25876,26006,cannabinoid receptor agonist|lipoxygenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25878,26006,cannabinoid receptor agonist|lipoxygenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6074,26007,tropomyosin receptor kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26008,26009,cholesteryl ester transfer protein inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26012,26013,growth hormone secretagogue receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25617,26014,cannabinoid receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25619,26014,cannabinoid receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25620,26014,cannabinoid receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25876,26014,cannabinoid receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25878,26014,cannabinoid receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
6354,26014,cannabinoid receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25881,26014,cannabinoid receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25882,26014,cannabinoid receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
26015,26014,cannabinoid receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
8372,26014,cannabinoid receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
26016,26014,cannabinoid receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
26017,26014,cannabinoid receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
6190,26014,cannabinoid receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
7292,26019,androgen receptor modulator,MoA,Phase 1,Gene,Chemical_Compound
26020,26021,tumor necrosis factor production inhibitor,MoA,Phase 2,Gene,Chemical_Compound
6026,26021,tumor necrosis factor production inhibitor,MoA,Phase 2,Gene,Chemical_Compound
13922,26021,tumor necrosis factor production inhibitor,MoA,Phase 2,Gene,Chemical_Compound
3377,26021,tumor necrosis factor production inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25998,26021,tumor necrosis factor production inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26022,26023,protein synthesis inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25547,26024,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
25992,26024,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
25990,26024,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
15548,26024,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
25994,26024,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
25554,26024,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
25573,26026,lipid peroxidase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26027,26028,DNA synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26029,26028,DNA synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8606,26028,DNA synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3621,26028,DNA synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8763,26028,DNA synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3556,26028,DNA synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14918,26028,DNA synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9372,26028,DNA synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4103,26028,DNA synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9528,26028,DNA synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3239,26028,DNA synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9058,26028,DNA synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9292,26028,DNA synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25712,26030,PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Launched,Gene,Chemical_Compound
12302,26030,PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Launched,Gene,Chemical_Compound
25552,26031,serotonin receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25726,26032,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
9097,26033,neuropeptide receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
26034,26035,corticotropin releasing factor receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
3033,26037,CDC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11686,26038,ATP synthase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10608,26039,transient receptor potential channel antagonist,MoA,Preclinical,Gene,Chemical_Compound
14000,26040,apolipoprotein expression enhancer,MoA,Phase 3,Gene,Chemical_Compound
25615,26041,platelet activating factor receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
4588,26042,RET tyrosine kinase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25712,26042,RET tyrosine kinase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25633,26042,RET tyrosine kinase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
4171,26042,RET tyrosine kinase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
7292,26043,androgen receptor antagonist|anti-inflammatory agent,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
25633,26044,KIT inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8551,26044,KIT inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26045,26046,glucose dependent insulinotropic receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
26045,26047,glucose dependent insulinotropic receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
14233,26048,sigma receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
11481,26049,AKT inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3613,26049,AKT inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12367,26049,AKT inhibitor,MoA,Preclinical,Gene,Chemical_Compound
2742,26050,casein kinase inhibitor|cell proliferation inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7292,26050,casein kinase inhibitor|cell proliferation inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3305,26050,casein kinase inhibitor|cell proliferation inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26051,26050,casein kinase inhibitor|cell proliferation inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25940,26050,casein kinase inhibitor|cell proliferation inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3148,26050,casein kinase inhibitor|cell proliferation inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3557,26050,casein kinase inhibitor|cell proliferation inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5253,26053,NADPH oxidase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7382,26054,carboxylesterase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7230,26054,carboxylesterase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8546,26055,p53 activator,MoA,Phase 3,Gene,Chemical_Compound
5898,26057,matrix metalloprotease inhibitor|tumor necrosis factor production inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26058,26057,matrix metalloprotease inhibitor|tumor necrosis factor production inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26059,26057,matrix metalloprotease inhibitor|tumor necrosis factor production inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25602,26057,matrix metalloprotease inhibitor|tumor necrosis factor production inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25652,26063,glutamate receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
11107,26064,kr√ºppel-like factor expression enhancer,MoA,Phase 1,Gene,Chemical_Compound
6202,26065,serine/threonine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26066,26067,phosphoinositide dependent kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26068,26067,phosphoinositide dependent kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9909,26067,phosphoinositide dependent kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11330,26070,ALK tyrosine kinase receptor inhibitor,MoA,Phase 2,Gene,Chemical_Compound
12907,26070,ALK tyrosine kinase receptor inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25593,26071,acetylcholine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
8086,26072,glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7323,26073,monocarboxylate transporter inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4208,26073,monocarboxylate transporter inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5297,26074,phosphoinositide dependent kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
9570,26075,HDAC inhibitor,MoA,Phase 1,Gene,Chemical_Compound
10885,26076,cytochrome P450 inhibitor,MoA,Phase 1,Gene,Chemical_Compound
26077,26076,cytochrome P450 inhibitor,MoA,Phase 1,Gene,Chemical_Compound
26078,26076,cytochrome P450 inhibitor,MoA,Phase 1,Gene,Chemical_Compound
26079,26076,cytochrome P450 inhibitor,MoA,Phase 1,Gene,Chemical_Compound
8368,26076,cytochrome P450 inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25767,26076,cytochrome P450 inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7829,26076,cytochrome P450 inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7510,26076,cytochrome P450 inhibitor,MoA,Phase 1,Gene,Chemical_Compound
26080,26076,cytochrome P450 inhibitor,MoA,Phase 1,Gene,Chemical_Compound
26082,26083,melanin inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
25541,26084,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25543,26084,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25544,26084,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
5026,26085,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14717,26085,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14804,26086,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5659,26086,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5819,26087,thrombin inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25593,26088,acetylcholine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25592,26089,acetylcholine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25593,26089,acetylcholine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25594,26089,acetylcholine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25595,26089,acetylcholine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25592,26090,acetylcholine receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25593,26090,acetylcholine receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25594,26090,acetylcholine receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25595,26090,acetylcholine receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
3325,26093,farnesyltransferase inhibitor,MoA,Launched,Gene,Chemical_Compound
13922,26093,farnesyltransferase inhibitor,MoA,Launched,Gene,Chemical_Compound
3004,26095,phosphodiesterase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
3613,26097,AKT inhibitor,MoA,Phase 1,Gene,Chemical_Compound
15188,26098,kinesin-like spindle protein inhibitor,MoA,Phase 1,Gene,Chemical_Compound
13590,26099,EGFR inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
25665,26106,astrocyte modulating agent,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
26107,26106,astrocyte modulating agent,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
15528,26108,bromodomain inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26045,26109,glucose dependent insulinotropic receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
13626,26110,rho associated kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26111,26112,SHIP2 phosphatase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25849,26113,free fatty acid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
12199,26114,interleukin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25846,26115,PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9637,26116,PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25846,26116,PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14717,26117,MEK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
15643,26117,MEK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26118,26119,potassium channel blocker,MoA,Phase 1,Gene,Chemical_Compound
26120,26119,potassium channel blocker,MoA,Phase 1,Gene,Chemical_Compound
13006,26119,potassium channel blocker,MoA,Phase 1,Gene,Chemical_Compound
25665,26121,cyclooxygenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7292,26122,androgen receptor enhancer,MoA,Phase 2,Gene,Chemical_Compound
14171,26123,calcineurin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25719,26127,apoptosis stimulant,MoA,Preclinical,Gene,Chemical_Compound
25872,26128,opioid receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
11061,26129,glycine transporter inhibitor,MoA,Phase 1,Gene,Chemical_Compound
11330,26134,ALK tyrosine kinase receptor inhibitor,MoA,Phase 1,Gene,Chemical_Compound
12907,26135,EGFR inhibitor,MoA,Phase 1,Gene,Chemical_Compound
13590,26135,EGFR inhibitor,MoA,Phase 1,Gene,Chemical_Compound
13040,26136,histamine receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
5402,26136,histamine receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25955,26136,histamine receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25942,26137,nitric oxide synthase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
26138,26137,nitric oxide synthase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25554,26139,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
15298,26140,CDK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
8227,26140,CDK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
5659,26140,CDK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
6044,26140,CDK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
3305,26140,CDK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11699,26140,CDK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
13343,26141,Aurora kinase inhibitor|JAK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
8285,26141,Aurora kinase inhibitor|JAK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11600,26141,Aurora kinase inhibitor|JAK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
5775,26141,Aurora kinase inhibitor|JAK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
12535,26141,Aurora kinase inhibitor|JAK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
13288,26141,Aurora kinase inhibitor|JAK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
9776,26143,cyclooxygenase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11600,26146,JAK inhibitor|STAT inhibitor,MoA,Phase 2,Gene,Chemical_Compound
8551,26146,JAK inhibitor|STAT inhibitor,MoA,Phase 2,Gene,Chemical_Compound
3004,26147,phosphodiesterase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11307,26147,phosphodiesterase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25558,26147,phosphodiesterase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7103,26147,phosphodiesterase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
8497,26148,integrin antagonist,MoA,Phase 2,Gene,Chemical_Compound
6567,26148,integrin antagonist,MoA,Phase 2,Gene,Chemical_Compound
15105,26148,integrin antagonist,MoA,Phase 2,Gene,Chemical_Compound
13890,26148,integrin antagonist,MoA,Phase 2,Gene,Chemical_Compound
8327,26155,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
5173,26156,endothelin receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25592,26158,acetylcholine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25593,26158,acetylcholine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25594,26158,acetylcholine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25595,26158,acetylcholine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
9280,26158,acetylcholine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
11481,26159,protein kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
3613,26159,protein kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
12367,26159,protein kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
13626,26159,protein kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
9902,26159,protein kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
3328,26159,protein kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
4229,26160,HSP inhibitor,MoA,Phase 2,Gene,Chemical_Compound
3613,26161,AKT inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8086,26161,AKT inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12916,26161,AKT inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5770,26161,AKT inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13343,26163,Aurora kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15178,26165,autotaxin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12907,26166,protein tyrosine kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
13590,26166,protein tyrosine kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
12473,26167,tachykinin antagonist,MoA,Phase 2,Gene,Chemical_Compound
8514,26168,gamma secretase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7230,26170,ACAT inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26173,26174,angiotensin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25636,26175,Bruton's tyrosine kinase (BTK) inhibitor,MoA,Phase 2,Gene,Chemical_Compound
6491,26175,Bruton's tyrosine kinase (BTK) inhibitor,MoA,Phase 2,Gene,Chemical_Compound
13152,26176,inosine monophosphate dehydrogenase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11666,26176,inosine monophosphate dehydrogenase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
12018,26181,caspase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25569,26182,purinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26183,26184,hedgehog pathway inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9018,26185,RAF inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5450,26185,RAF inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13040,26187,histamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
10635,26188,purine antagonist,MoA,Preclinical,Gene,Chemical_Compound
25665,26190,cyclooxygenase inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
6999,26195,glycogen synthase kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
8086,26195,glycogen synthase kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
2676,26196,Pim kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
26197,26196,Pim kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
3068,26196,Pim kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
4071,26198,purinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25584,26199,acetylcholine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25866,26199,acetylcholine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
3105,26200,JAK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
11600,26200,JAK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
5775,26200,JAK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
26201,26202,CRTH receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
7640,26203,mTOR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
8086,26204,glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8456,26205,IKK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11330,26206,ALK tyrosine kinase receptor inhibitor|insulin growth factor receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11627,26206,ALK tyrosine kinase receptor inhibitor|insulin growth factor receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7292,26207,androgen receptor modulator,MoA,Phase 1,Gene,Chemical_Compound
12907,26208,EGFR inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
6908,26209,beta-secretase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7323,26210,monocarboxylate transporter inhibitor,MoA,Phase 1,Gene,Chemical_Compound
6399,26211,diacylglycerol kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26212,26213,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
26214,26213,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
4400,26213,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
26215,26213,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
26216,26213,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
8980,26213,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
26217,26213,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
6268,26213,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
15618,26213,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
26218,26213,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
6354,26213,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
3070,26213,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
26219,26213,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
7731,26213,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
26220,26213,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
26221,26213,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
14530,26213,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
26222,26213,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25881,26213,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
26223,26213,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25652,26213,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
11142,26213,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
4203,26213,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
14160,26213,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
14968,26213,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25654,26213,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
4647,26213,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
9814,26213,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
6708,26213,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
26224,26213,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
26225,26213,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
8124,26213,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
26226,26213,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
11061,26213,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
5212,26227,FGFR inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
25759,26227,FGFR inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
25760,26227,FGFR inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
26228,26227,FGFR inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
11627,26227,FGFR inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
25712,26227,FGFR inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
26229,26230,CC chemokine receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
11481,26231,AKT inhibitor,MoA,Phase 3,Gene,Chemical_Compound
3613,26231,AKT inhibitor,MoA,Phase 3,Gene,Chemical_Compound
12367,26231,AKT inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25955,26232,CDK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
4198,26233,XIAP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26234,26233,XIAP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8344,26233,XIAP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9637,26235,PI3K inhibitor,MoA,Phase 1,Gene,Chemical_Compound
6809,26235,PI3K inhibitor,MoA,Phase 1,Gene,Chemical_Compound
12097,26235,PI3K inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25846,26235,PI3K inhibitor,MoA,Phase 1,Gene,Chemical_Compound
15816,26236,ATR kinase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25652,26237,glutamate receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
3724,26238,pyruvate dehydrogenase kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
6399,26239,diacylglycerol O acyltransferase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7517,26240,CHK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
8332,26240,CHK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7640,26241,mTOR inhibitor,MoA,Phase 1,Gene,Chemical_Compound
6809,26242,PI3K inhibitor,MoA,Phase 1,Gene,Chemical_Compound
12097,26242,PI3K inhibitor,MoA,Phase 1,Gene,Chemical_Compound
13225,26243,MEK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
9637,26244,PI3K inhibitor,MoA,Phase 1,Gene,Chemical_Compound
12097,26244,PI3K inhibitor,MoA,Phase 1,Gene,Chemical_Compound
12907,26245,EGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
13590,26245,EGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26246,26245,EGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25655,26247,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
11393,26248,estrogen receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
26249,26250,elastase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26255,26256,RAGE receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
26120,26261,potassium channel blocker,MoA,Phase 3,Gene,Chemical_Compound
15786,26264,SRC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13005,26266,DYRK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15816,26267,ATR kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7640,26267,ATR kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8682,26268,histone lysine methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12907,26269,EGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11600,26270,JAK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11173,26271,polynucleotide kinase/phosphatase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26272,26273,ICAM1 expression inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25670,26273,ICAM1 expression inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25573,26274,adrenergic receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
9637,26275,PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25569,26276,purinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25545,26277,dopamine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
6399,26278,diacylglycerol O acyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10141,26282,PPAR receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
10758,26283,Bcr-Abl kinase inhibitor|LYN tyrosine kinase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
5820,26283,Bcr-Abl kinase inhibitor|LYN tyrosine kinase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
13780,26283,Bcr-Abl kinase inhibitor|LYN tyrosine kinase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25846,26284,phosphoinositide dependent kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25795,26285,lipoxygenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6843,26285,lipoxygenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7432,26285,lipoxygenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26286,26285,lipoxygenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25671,26285,lipoxygenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25998,26285,lipoxygenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25832,26285,lipoxygenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7902,26288,DNA polymerase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
10141,26289,insulin sensitizer|PPAR receptor partial agonist,MoA,Phase 3,Gene,Chemical_Compound
5877,26290,cathepsin inhibitor,MoA,Phase 2,Gene,Chemical_Compound
9474,26293,BAX activator,MoA,Preclinical,Gene,Chemical_Compound
26294,26295,nociceptin/orphanin FQ receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
12989,26296,topoisomerase inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
13343,26297,Aurora kinase inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
8285,26297,Aurora kinase inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
8285,26298,Aurora kinase inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
25942,26299,nuclear factor erythroid derived|like (NRF2) activator,MoA,Phase 1,Gene,Chemical_Compound
10141,26299,nuclear factor erythroid derived|like (NRF2) activator,MoA,Phase 1,Gene,Chemical_Compound
10141,26300,nuclear factor erythroid derived|like (NRF2) activator,MoA,Phase 3,Gene,Chemical_Compound
8551,26300,nuclear factor erythroid derived|like (NRF2) activator,MoA,Phase 3,Gene,Chemical_Compound
25655,26302,glutamate receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
26303,26304,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
12088,26304,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25684,26304,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
6064,26304,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
3521,26304,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26305,26304,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25614,26306,histamine receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
9474,26307,cytochrome C release inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15539,26308,L-type calcium channel activator,MoA,Preclinical,Gene,Chemical_Compound
3844,26309,NFkB pathway inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10968,26310,NFkB pathway inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26311,26312,guanylyl cyclase activator,MoA,Preclinical,Gene,Chemical_Compound
26313,26312,guanylyl cyclase activator,MoA,Preclinical,Gene,Chemical_Compound
8041,26314,adenosine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25726,26314,adenosine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
9810,26314,adenosine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25727,26314,adenosine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26315,26316,phosphodiesterase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26317,26318,SYK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7902,26319,hypoxia inducible factor inhibitor,MoA,Phase 1,Gene,Chemical_Compound
14052,26321,bromodomain inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9106,26322,urokinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6190,26323,TRPV antagonist,MoA,Preclinical,Gene,Chemical_Compound
3589,26324,complement inhibitor|serine protease inhibitor,MoA,Phase 1,Gene,Chemical_Compound
14233,26325,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
14233,26326,sigma receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25573,26327,adrenergic receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
8514,26331,gamma secretase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25596,26337,serotonin receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
26192,26337,serotonin receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
14645,26338,AMPK inhibitor,MoA,Launched,Gene,Chemical_Compound
6599,26343,gluconeogenesis inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25926,26357,sodium channel blocker,MoA,Phase 2,Gene,Chemical_Compound
25928,26357,sodium channel blocker,MoA,Phase 2,Gene,Chemical_Compound
25929,26357,sodium channel blocker,MoA,Phase 2,Gene,Chemical_Compound
25930,26357,sodium channel blocker,MoA,Phase 2,Gene,Chemical_Compound
25931,26357,sodium channel blocker,MoA,Phase 2,Gene,Chemical_Compound
25932,26357,sodium channel blocker,MoA,Phase 2,Gene,Chemical_Compound
12796,26357,sodium channel blocker,MoA,Phase 2,Gene,Chemical_Compound
25746,26366,cholinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26367,26368,CCK receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
26369,26368,CCK receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
11834,26376,LDL receptor activator,MoA,Launched,Gene,Chemical_Compound
26020,26377,interleukin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25998,26377,interleukin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7625,26378,beta amyloid synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25598,26379,benzodiazepine receptor ligand,MoA,Launched,Gene,Chemical_Compound
25648,26379,benzodiazepine receptor ligand,MoA,Launched,Gene,Chemical_Compound
3521,26380,apoptosis stimulant,MoA,Launched,Gene,Chemical_Compound
25602,26380,apoptosis stimulant,MoA,Launched,Gene,Chemical_Compound
25751,26381,opioid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25872,26381,opioid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25873,26381,opioid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
7640,26382,protein synthesis stimulant,MoA,Launched,Gene,Chemical_Compound
15946,26384,topoisomerase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26393,26394,GLP receptor positive allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
26396,26397,apoptosis stimulant|NFkB pathway inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
7640,26400,PI3K inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
9637,26400,PI3K inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
6809,26400,PI3K inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
25846,26400,PI3K inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
26401,26402,ATPase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26403,26404,ribosomal protein inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8439,26404,ribosomal protein inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15329,26404,ribosomal protein inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12535,26404,ribosomal protein inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15528,26405,PLK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
14636,26405,PLK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26406,26405,PLK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
15336,26405,PLK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
9097,26407,JNK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13343,26408,Aurora kinase inhibitor|MEK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
8285,26408,Aurora kinase inhibitor|MEK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25916,26408,Aurora kinase inhibitor|MEK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
14717,26408,Aurora kinase inhibitor|MEK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
15643,26408,Aurora kinase inhibitor|MEK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
26409,26410,calcitonin antagonist,MoA,Phase 2,Gene,Chemical_Compound
3725,26410,calcitonin antagonist,MoA,Phase 2,Gene,Chemical_Compound
15447,26410,calcitonin antagonist,MoA,Phase 2,Gene,Chemical_Compound
26411,26412,telomerase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12907,26413,EGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12907,26414,EGFR inhibitor,MoA,Phase 1,Gene,Chemical_Compound
13590,26414,EGFR inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25598,26416,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25640,26416,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25641,26416,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25600,26416,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25642,26416,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25643,26416,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26417,26416,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
4229,26420,HSP inhibitor,MoA,Phase 2,Gene,Chemical_Compound
6354,26422,GABA receptor modulator,MoA,Preclinical,Gene,Chemical_Compound
3070,26422,GABA receptor modulator,MoA,Preclinical,Gene,Chemical_Compound
7731,26422,GABA receptor modulator,MoA,Preclinical,Gene,Chemical_Compound
25596,26422,GABA receptor modulator,MoA,Preclinical,Gene,Chemical_Compound
26192,26422,GABA receptor modulator,MoA,Preclinical,Gene,Chemical_Compound
25855,26424,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26425,26426,glutamate receptor positive allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
4266,26427,NFkB pathway inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26428,26427,NFkB pathway inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26429,26427,NFkB pathway inhibitor,MoA,Phase 2,Gene,Chemical_Compound
12477,26431,integrin antagonist,MoA,Phase 2,Gene,Chemical_Compound
15105,26431,integrin antagonist,MoA,Phase 2,Gene,Chemical_Compound
12477,26432,integrin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15105,26432,integrin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12616,26433,vitamin B,MoA,Launched,Gene,Chemical_Compound
9763,26433,vitamin B,MoA,Launched,Gene,Chemical_Compound
11977,26433,vitamin B,MoA,Launched,Gene,Chemical_Compound
11211,26433,vitamin B,MoA,Launched,Gene,Chemical_Compound
11374,26433,vitamin B,MoA,Launched,Gene,Chemical_Compound
3845,26433,vitamin B,MoA,Launched,Gene,Chemical_Compound
12963,26433,vitamin B,MoA,Launched,Gene,Chemical_Compound
13047,26433,vitamin B,MoA,Launched,Gene,Chemical_Compound
5413,26433,vitamin B,MoA,Launched,Gene,Chemical_Compound
7863,26434,dipeptidyl peptidase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
4198,26436,XIAP inhibitor,MoA,Phase 2,Gene,Chemical_Compound
8344,26436,XIAP inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26272,26437,lymphocyte function-associated antigen negative modulator,MoA,Preclinical,Gene,Chemical_Compound
4909,26438,tyrosine phosphatase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11481,26439,PKC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8086,26439,PKC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26440,26439,PKC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15365,26439,PKC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25908,26439,PKC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15947,26439,PKC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4449,26439,PKC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9097,26439,PKC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7247,26439,PKC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13626,26439,PKC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8554,26439,PKC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10315,26439,PKC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7292,26444,synthetic estrogen,MoA,Phase 1,Gene,Chemical_Compound
11393,26444,synthetic estrogen,MoA,Phase 1,Gene,Chemical_Compound
25625,26444,synthetic estrogen,MoA,Phase 1,Gene,Chemical_Compound
25764,26444,synthetic estrogen,MoA,Phase 1,Gene,Chemical_Compound
10141,26444,synthetic estrogen,MoA,Phase 1,Gene,Chemical_Compound
11393,26445,autotaxin inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25625,26445,autotaxin inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
13264,26445,autotaxin inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
26226,26446,glycine transporter inhibitor,MoA,Phase 3,Gene,Chemical_Compound
11061,26446,glycine transporter inhibitor,MoA,Phase 3,Gene,Chemical_Compound
2788,26448,histone lysine methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5189,26448,histone lysine methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12748,26449,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12748,26450,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15491,26450,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7003,26451,ATPase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26452,26451,ATPase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26228,26454,FGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25878,26455,cannabinoid receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
26456,26457,CC chemokine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
5173,26458,endothelin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
14707,26459,potassium channel activator,MoA,Preclinical,Gene,Chemical_Compound
15298,26460,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8227,26460,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4155,26461,fatty acid binding protein inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5026,26462,IKK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8456,26462,IKK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8227,26463,CDK inhibitor|cell cycle inhibitor|MCL1 inhibitor,MoA,Phase 1,Gene,Chemical_Compound
5178,26463,CDK inhibitor|cell cycle inhibitor|MCL1 inhibitor,MoA,Phase 1,Gene,Chemical_Compound
11699,26463,CDK inhibitor|cell cycle inhibitor|MCL1 inhibitor,MoA,Phase 1,Gene,Chemical_Compound
10651,26464,melanocortin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
11481,26465,IGF-1 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26466,26465,IGF-1 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8227,26465,IGF-1 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25808,26465,IGF-1 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13590,26465,IGF-1 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11627,26465,IGF-1 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25712,26465,IGF-1 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26440,26465,IGF-1 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15365,26465,IGF-1 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10745,26465,IGF-1 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7392,26465,IGF-1 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12302,26465,IGF-1 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13152,26467,inosine monophosphate dehydrogenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11666,26467,inosine monophosphate dehydrogenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26468,26469,integrin antagonist,MoA,Phase 2,Gene,Chemical_Compound
26470,26469,integrin antagonist,MoA,Phase 2,Gene,Chemical_Compound
12907,26471,EGFR inhibitor|protein tyrosine kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
13590,26471,EGFR inhibitor|protein tyrosine kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
11200,26471,EGFR inhibitor|protein tyrosine kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
9967,26472,retinoid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26272,26473,ICAM1 antagonist|leukocyte function-associated antigen receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
12907,26474,EGFR inhibitor|VEGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
13590,26474,EGFR inhibitor|VEGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25632,26474,EGFR inhibitor|VEGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25712,26474,EGFR inhibitor|VEGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11481,26475,IGF-1 inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11627,26475,IGF-1 inhibitor,MoA,Phase 2,Gene,Chemical_Compound
4293,26476,AXL kinase inhibitor|c-Met inhibitor|FLT3 inhibitor|hepatocyte growth factor receptor inhibitor|macrophage migration inhibiting factor inhibitor|tyrosine kinase inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
26477,26476,AXL kinase inhibitor|c-Met inhibitor|FLT3 inhibitor|hepatocyte growth factor receptor inhibitor|macrophage migration inhibiting factor inhibitor|tyrosine kinase inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
10745,26476,AXL kinase inhibitor|c-Met inhibitor|FLT3 inhibitor|hepatocyte growth factor receptor inhibitor|macrophage migration inhibiting factor inhibitor|tyrosine kinase inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
26478,26476,AXL kinase inhibitor|c-Met inhibitor|FLT3 inhibitor|hepatocyte growth factor receptor inhibitor|macrophage migration inhibiting factor inhibitor|tyrosine kinase inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
9785,26476,AXL kinase inhibitor|c-Met inhibitor|FLT3 inhibitor|hepatocyte growth factor receptor inhibitor|macrophage migration inhibiting factor inhibitor|tyrosine kinase inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
25712,26479,c-Met inhibitor|VEGFR inhibitor,MoA,Phase 1,Gene,Chemical_Compound
10745,26479,c-Met inhibitor|VEGFR inhibitor,MoA,Phase 1,Gene,Chemical_Compound
10922,26480,smoothened receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
7038,26481,CDC inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
2676,26481,CDC inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
6078,26482,lysophosphatidic acid receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25551,26483,sigma receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
9852,26484,IP1 prostacyclin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25573,26485,adrenergic receptor antagonist|serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
13991,26485,adrenergic receptor antagonist|serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25575,26485,adrenergic receptor antagonist|serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25551,26485,adrenergic receptor antagonist|serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25751,26486,opioid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25872,26486,opioid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25873,26486,opioid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25551,26496,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25573,26497,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25575,26497,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25541,26497,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25546,26497,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25547,26497,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25548,26497,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25549,26497,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25551,26497,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
7079,26497,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
5173,26498,endothelin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
6150,26499,endothelin receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
12161,26500,Ras GTPase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12295,26500,Ras GTPase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5189,26501,histone lysine methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26403,26502,ribosomal protein inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8439,26502,ribosomal protein inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15329,26502,ribosomal protein inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15188,26503,kinesin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8688,26504,protein synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14870,26504,protein synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
2942,26510,dihydroorotate dehydrogenase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25598,26511,GABA benzodiazepine site receptor partial agonist,MoA,Phase 2,Gene,Chemical_Compound
25640,26511,GABA benzodiazepine site receptor partial agonist,MoA,Phase 2,Gene,Chemical_Compound
25641,26511,GABA benzodiazepine site receptor partial agonist,MoA,Phase 2,Gene,Chemical_Compound
25600,26511,GABA benzodiazepine site receptor partial agonist,MoA,Phase 2,Gene,Chemical_Compound
25642,26511,GABA benzodiazepine site receptor partial agonist,MoA,Phase 2,Gene,Chemical_Compound
25643,26511,GABA benzodiazepine site receptor partial agonist,MoA,Phase 2,Gene,Chemical_Compound
14804,26514,cyclin D inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25808,26519,FGFR inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
5212,26519,FGFR inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26178,26519,FGFR inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25955,26519,FGFR inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25712,26519,FGFR inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25760,26520,FGFR inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25551,26521,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25552,26521,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25553,26521,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25853,26521,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25854,26521,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25554,26521,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
7079,26521,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25555,26521,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25962,26521,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
7449,26522,cholesterol inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25660,26523,adrenergic receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25804,26523,adrenergic receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25918,26523,adrenergic receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25541,26524,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25543,26524,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25544,26524,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
4153,26525,phosphodiesterase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8147,26525,phosphodiesterase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25872,26526,opioid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25853,26527,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25854,26527,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
7829,26529,cyclooxygenase inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25665,26529,cyclooxygenase inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25804,26534,adrenergic receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25592,26535,glycine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25593,26535,glycine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25594,26535,glycine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25595,26535,glycine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
9280,26535,glycine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
5178,26536,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26537,26538,ATPase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13691,26539,mitotic kinesin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25921,26540,dopamine reuptake inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25958,26540,dopamine reuptake inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25800,26540,dopamine reuptake inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
13139,26541,GABA receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
15694,26542,integrin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15105,26542,integrin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7020,26543,imidazoline receptor ligand,MoA,Preclinical,Gene,Chemical_Compound
7633,26543,imidazoline receptor ligand,MoA,Preclinical,Gene,Chemical_Compound
26333,26548,cyclooxygenase inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
15499,26548,cyclooxygenase inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
9637,26554,PI3K inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25846,26554,PI3K inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25660,26556,adrenergic receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
13953,26561,tripeptidyl peptidase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25546,26562,dopamine receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25547,26562,dopamine receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25548,26562,dopamine receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25549,26562,dopamine receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25550,26562,dopamine receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25551,26562,dopamine receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25554,26562,dopamine receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
7591,26564,EGFR inhibitor|SRC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7658,26566,glutathione transferase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25676,26567,carbonic anhydrase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
3557,26569,11-beta hydroxysteroid dehydrogenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4909,26570,tyrosine phosphatase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6921,26570,tyrosine phosphatase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5751,26570,tyrosine phosphatase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25795,26571,lipoxygenase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25795,26572,lipoxygenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25751,26573,opioid receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25873,26573,opioid receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25751,26574,opioid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
7020,26575,monoamine oxidase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25554,26576,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
7079,26576,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25555,26576,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
8227,26577,IKK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7517,26577,IKK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8086,26577,IKK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25712,26577,IKK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3724,26577,IKK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5297,26577,IKK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8227,26578,pyruvate dehydrogenase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7517,26578,pyruvate dehydrogenase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8086,26578,pyruvate dehydrogenase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25712,26578,pyruvate dehydrogenase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3724,26578,pyruvate dehydrogenase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5297,26578,pyruvate dehydrogenase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13754,26579,PARP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26580,26581,CC chemokine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
7247,26582,protein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26594,26595,calcium-activated chloride channel inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25795,26596,HIV integrase inhibitor|lipoxygenase inhibitor|nitric oxide production inhibitor|tumor necrosis factor production inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10043,26596,HIV integrase inhibitor|lipoxygenase inhibitor|nitric oxide production inhibitor|tumor necrosis factor production inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3844,26597,HIV integrase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26611,26612,calcium sensing receptor negative allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
26262,26613,motilin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
11481,26614,calcium/calmodulin dependent protein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14776,26614,calcium/calmodulin dependent protein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12895,26614,calcium/calmodulin dependent protein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6322,26614,calcium/calmodulin dependent protein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6190,26617,TRPV activator,MoA,Phase 1,Gene,Chemical_Compound
15946,26618,topoisomerase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
11481,26622,EGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
12907,26622,EGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
13590,26622,EGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
11200,26622,EGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
12016,26623,mineralocorticoid receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
8041,26624,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
6190,26627,TRPV agonist,MoA,Preclinical,Gene,Chemical_Compound
6139,26627,TRPV agonist,MoA,Preclinical,Gene,Chemical_Compound
7850,26629,ribonucleotide reductase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26662,26663,calcium channel blocker,MoA,Phase 3,Gene,Chemical_Compound
5948,26664,angiotensin antagonist,MoA,Phase 1,Gene,Chemical_Compound
3188,26665,WNT signaling inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13040,26666,histamine receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
15168,26669,NADPH quinone oxidoreductase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11988,26670,sodium/hydrogen exchanger inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25804,26673,adrenergic receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25547,26674,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
7020,26676,monoamine oxidase inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
7633,26676,monoamine oxidase inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
2512,26683,GTPase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3928,26684,glucosidase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
4689,26684,glucosidase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
2744,26685,cathepsin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4497,26685,cathepsin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26686,26685,cathepsin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25846,26687,PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7292,26688,androgen receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
11104,26689,valosin-containing protein inhibitor,MoA,Phase 1,Gene,Chemical_Compound
10125,26690,glutaminase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26425,26691,glutamate receptor positive allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
25795,26692,lipoxygenase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7640,26693,DNA protein kinase inhibitor|mTOR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7640,26694,mTOR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
9097,26695,JNK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7661,26696,apoptosis stimulant,MoA,Preclinical,Gene,Chemical_Compound
12487,26696,apoptosis stimulant,MoA,Preclinical,Gene,Chemical_Compound
12463,26697,G protein signaling inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26698,26697,G protein signaling inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12463,26699,G protein signaling inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12463,26700,G protein signaling inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25571,26701,acetylcholine receptor allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
3188,26702,WNT signaling inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4229,26703,HSP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4111,26703,HSP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13343,26704,Aurora kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8285,26704,Aurora kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25916,26704,Aurora kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13343,26705,Aurora kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8285,26705,Aurora kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25916,26705,Aurora kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25866,26706,nicotinic receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
6665,26707,retinoid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
6665,26708,retinoid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
15298,26709,CDK inhibitor|glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6044,26709,CDK inhibitor|glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8086,26709,CDK inhibitor|glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11699,26710,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25655,26711,glutamate receptor positive allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
26294,26712,opioid receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25873,26712,opioid receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
5185,26713,KIT inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26178,26713,KIT inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25632,26713,KIT inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26179,26713,KIT inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25712,26713,KIT inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25633,26713,KIT inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
7392,26713,KIT inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
12302,26713,KIT inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
9018,26723,RAF inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
5450,26723,RAF inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
11600,26724,JAK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11330,26725,ALK tyrosine kinase receptor inhibitor,MoA,Phase 1,Gene,Chemical_Compound
26367,26729,CCK receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
8337,26730,ACAT inhibitor|cholesterol inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26731,26732,triacylglycerol lipase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
7762,26737,microtubule stimulant|tubulin polymerization inhibitor,MoA,Phase 1,Gene,Chemical_Compound
26738,26739,rap guanine nucleotide exchange factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26051,26740,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
8041,26741,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25726,26741,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
9810,26741,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25727,26741,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
8041,26742,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
9810,26742,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25727,26742,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
12946,26743,ATM kinase inhibitor|ATR kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15816,26743,ATM kinase inhibitor|ATR kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9986,26744,MDM inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25660,26745,adrenergic receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25804,26745,adrenergic receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25918,26745,adrenergic receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
13139,26746,GABA receptor modulator,MoA,Preclinical,Gene,Chemical_Compound
25660,26747,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25918,26747,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
12796,26748,mitochondrial Na+/Ca2+ exchanger antagonist|sodium/calcium exchange inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11142,26749,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
4203,26749,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
14160,26749,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
14968,26749,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
12907,26750,EGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12907,26751,EGFR inhibitor|PKC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26752,26751,EGFR inhibitor|PKC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13139,26753,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25560,26753,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
10388,26753,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
2657,26753,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26281,26753,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
13139,26754,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25560,26754,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
10388,26754,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
2657,26754,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26281,26754,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
8285,26755,MAP kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26440,26755,MAP kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3103,26755,MAP kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4881,26755,MAP kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4757,26755,MAP kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15298,26756,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8227,26756,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26757,26758,neuropeptide receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
15298,26759,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13139,26760,GABA receptor modulator,MoA,Preclinical,Gene,Chemical_Compound
8041,26761,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25726,26761,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
9810,26761,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25727,26761,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25598,26762,benzodiazepine receptor agonist|GABA benzodiazepine site receptor partial agonist,MoA,Phase 1,Gene,Chemical_Compound
25640,26762,benzodiazepine receptor agonist|GABA benzodiazepine site receptor partial agonist,MoA,Phase 1,Gene,Chemical_Compound
25641,26762,benzodiazepine receptor agonist|GABA benzodiazepine site receptor partial agonist,MoA,Phase 1,Gene,Chemical_Compound
25600,26762,benzodiazepine receptor agonist|GABA benzodiazepine site receptor partial agonist,MoA,Phase 1,Gene,Chemical_Compound
25642,26762,benzodiazepine receptor agonist|GABA benzodiazepine site receptor partial agonist,MoA,Phase 1,Gene,Chemical_Compound
25643,26762,benzodiazepine receptor agonist|GABA benzodiazepine site receptor partial agonist,MoA,Phase 1,Gene,Chemical_Compound
8041,26763,adenosine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25726,26763,adenosine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
9810,26763,adenosine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25727,26763,adenosine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25598,26764,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25645,26764,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25648,26764,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
5212,26765,fibroblast growth factor inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25759,26765,fibroblast growth factor inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25760,26765,fibroblast growth factor inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7323,26766,monocarboxylate transporter inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8514,26769,gamma secretase modulator,MoA,Phase 2,Gene,Chemical_Compound
10043,26770,glutamate inhibitor|macrophage migration inhibiting factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7517,26772,CHK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6999,26773,glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8086,26773,glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15298,26774,glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6999,26774,glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8086,26774,glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15365,26774,glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25746,26776,acetylcholine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25598,26778,GABA receptor modulator,MoA,Withdrawn,Gene,Chemical_Compound
6859,26795,acetylcholinesterase inhibitor,MoA,Launched,Gene,Chemical_Compound
6859,26805,acetylcholine precursor,MoA,Phase 3,Gene,Chemical_Compound
7382,26805,acetylcholine precursor,MoA,Phase 3,Gene,Chemical_Compound
25691,26805,acetylcholine precursor,MoA,Phase 3,Gene,Chemical_Compound
2628,26805,acetylcholine precursor,MoA,Phase 3,Gene,Chemical_Compound
26806,26805,acetylcholine precursor,MoA,Phase 3,Gene,Chemical_Compound
26807,26805,acetylcholine precursor,MoA,Phase 3,Gene,Chemical_Compound
8093,26805,acetylcholine precursor,MoA,Phase 3,Gene,Chemical_Compound
3540,26805,acetylcholine precursor,MoA,Phase 3,Gene,Chemical_Compound
25655,26808,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26809,26810,serine/threonine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
2742,26811,breast cancer resistance protein inhibitor,MoA,Phase 1,Gene,Chemical_Compound
3305,26811,breast cancer resistance protein inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25940,26811,breast cancer resistance protein inhibitor,MoA,Phase 1,Gene,Chemical_Compound
3148,26811,breast cancer resistance protein inhibitor,MoA,Phase 1,Gene,Chemical_Compound
12907,26812,EGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7640,26812,EGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6024,26813,aryl hydrocarbon receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
7640,26814,PI3K inhibitor,MoA,Phase 1,Gene,Chemical_Compound
9637,26814,PI3K inhibitor,MoA,Phase 1,Gene,Chemical_Compound
6809,26814,PI3K inhibitor,MoA,Phase 1,Gene,Chemical_Compound
12097,26814,PI3K inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25846,26814,PI3K inhibitor,MoA,Phase 1,Gene,Chemical_Compound
6481,26815,retinoid receptor binder,MoA,Preclinical,Gene,Chemical_Compound
14201,26815,retinoid receptor binder,MoA,Preclinical,Gene,Chemical_Compound
26816,26817,GAT inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7512,26818,ACAT inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7230,26818,ACAT inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7829,26819,fatty acid synthase inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
7829,26822,cyclooxygenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25665,26822,cyclooxygenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25882,26823,G protein-coupled receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
6958,26824,protein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26551,26825,G protein-coupled receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
5719,26826,MAP kinase phosphatase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10141,26827,PPAR receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
26828,26829,dehydropeptidase inhibitor,MoA,Launched,Gene,Chemical_Compound
6567,26831,integrin antagonist,MoA,Phase 3,Gene,Chemical_Compound
13890,26831,integrin antagonist,MoA,Phase 3,Gene,Chemical_Compound
3004,26833,phosphodiesterase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
11307,26833,phosphodiesterase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
7103,26833,phosphodiesterase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
12418,26834,phosphodiesterase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12939,26834,phosphodiesterase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9069,26836,transient receptor potential channel agonist,MoA,Preclinical,Gene,Chemical_Compound
25660,26837,adrenergic receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25804,26837,adrenergic receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25918,26837,adrenergic receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26311,26843,guanylate cyclase activator,MoA,Phase 2,Gene,Chemical_Compound
26313,26843,guanylate cyclase activator,MoA,Phase 2,Gene,Chemical_Compound
26844,26845,leukotriene receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25554,26846,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26848,26849,P glycoprotein inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10608,26850,aldose reductase inhibitor|TRPV agonist,MoA,Preclinical,Gene,Chemical_Compound
26768,26851,CAR antagonist,MoA,Preclinical,Gene,Chemical_Compound
26852,26851,CAR antagonist,MoA,Preclinical,Gene,Chemical_Compound
10141,26851,CAR antagonist,MoA,Preclinical,Gene,Chemical_Compound
5898,26853,metalloproteinase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26058,26853,metalloproteinase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26059,26853,metalloproteinase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
3521,26853,metalloproteinase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
11446,26853,metalloproteinase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26305,26853,metalloproteinase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25602,26853,metalloproteinase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25541,26856,histamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25544,26856,histamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25614,26856,histamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25961,26856,histamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25596,26856,histamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
14160,26857,glutamate receptor potentiator,MoA,Preclinical,Gene,Chemical_Compound
14968,26857,glutamate receptor potentiator,MoA,Preclinical,Gene,Chemical_Compound
25573,26858,adrenergic receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26425,26860,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26861,26860,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26862,26860,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25980,26860,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26863,26860,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26138,26864,nitric oxide stimulant,MoA,Phase 1,Gene,Chemical_Compound
25554,26865,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25554,26866,serotonin receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
25596,26866,serotonin receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
25855,26866,serotonin receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
25955,26866,serotonin receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
26852,26870,constitutive androstane receptor (CAR) agonist,MoA,Preclinical,Gene,Chemical_Compound
2742,26873,coagulation factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14671,26873,coagulation factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4603,26873,coagulation factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26874,26873,coagulation factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26875,26873,coagulation factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25677,26873,coagulation factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26876,26873,coagulation factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4546,26873,coagulation factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13223,26873,coagulation factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26222,26873,coagulation factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11012,26873,coagulation factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12759,26873,coagulation factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26877,26873,coagulation factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3032,26873,coagulation factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14897,26873,coagulation factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8994,26873,coagulation factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10043,26873,coagulation factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11214,26873,coagulation factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25928,26873,coagulation factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6099,26873,coagulation factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26878,26873,coagulation factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26879,26873,coagulation factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15786,26873,coagulation factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11622,26873,coagulation factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5392,26873,coagulation factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25855,26880,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
13758,26881,actin related protein inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10115,26881,actin related protein inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9000,26881,actin related protein inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8752,26881,actin related protein inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15017,26881,actin related protein inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8759,26881,actin related protein inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5396,26881,actin related protein inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11600,26882,NFkB pathway inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7355,26882,NFkB pathway inhibitor,MoA,Phase 1,Gene,Chemical_Compound
14325,26883,casein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25598,26884,benzodiazepine receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25640,26884,benzodiazepine receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25641,26884,benzodiazepine receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25642,26884,benzodiazepine receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25645,26884,benzodiazepine receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25648,26884,benzodiazepine receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25872,26894,chelating agent,MoA,Withdrawn,Gene,Chemical_Compound
13040,26895,histamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25613,26895,histamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25614,26895,histamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25961,26895,histamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26120,26905,potassium channel blocker,MoA,Phase 2,Gene,Chemical_Compound
5402,26905,potassium channel blocker,MoA,Phase 2,Gene,Chemical_Compound
7020,26915,monoamine oxidase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26079,26920,potassium channel activator,MoA,Preclinical,Gene,Chemical_Compound
25918,26922,adrenergic receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
26923,26922,adrenergic receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
14357,26922,adrenergic receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
26924,26922,adrenergic receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25604,26925,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4449,26925,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25992,26926,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25990,26926,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
15548,26926,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25994,26926,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
12907,26927,EGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25636,26928,Bruton's tyrosine kinase (BTK) inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4203,26929,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25824,26930,sodium channel blocker,MoA,Phase 1,Gene,Chemical_Compound
25826,26930,sodium channel blocker,MoA,Phase 1,Gene,Chemical_Compound
15921,26963,adenylyl cyclase activator,MoA,Phase 2,Gene,Chemical_Compound
12009,26963,adenylyl cyclase activator,MoA,Phase 2,Gene,Chemical_Compound
6908,26964,beta-secretase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7640,26965,DNA dependent protein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7453,26965,DNA dependent protein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25878,26969,cannabinoid receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
7333,26970,PKC inhibitor|protein tyrosine kinase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
4909,26970,PKC inhibitor|protein tyrosine kinase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7333,26971,mineralocorticoid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
15076,26971,mineralocorticoid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
12016,26971,mineralocorticoid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
7292,26974,androgen receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
13234,26975,MAPK-interacting kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13234,26976,MAPK-interacting kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12212,26979,glycogen phosphorylase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26118,26980,potassium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
26034,26981,corticotropin releasing factor receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
26058,26982,matrix metalloprotease inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26059,26982,matrix metalloprotease inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3521,26982,matrix metalloprotease inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11446,26982,matrix metalloprotease inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25602,26982,matrix metalloprotease inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26008,26983,cholesteryl ester transfer protein inhibitor,MoA,Phase 1,Gene,Chemical_Compound
12616,26984,acetyl-CoA carboxylase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9763,26984,acetyl-CoA carboxylase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25633,26985,PDGFR tyrosine kinase receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7392,26985,PDGFR tyrosine kinase receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12302,26985,PDGFR tyrosine kinase receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13590,26986,EGFR inhibitor|protein tyrosine kinase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
8337,26987,PPAR receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
12212,26988,glycogen phosphorylase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25551,26989,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25552,26990,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25876,26991,cannabinoid receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
12473,26992,tachykinin antagonist,MoA,Phase 2,Gene,Chemical_Compound
26993,26994,carboxypeptidase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26995,26994,carboxypeptidase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26996,26997,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
15528,26998,bromodomain inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25998,26999,tumor necrosis factor release inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11100,27000,histone lysine methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15528,27001,bromodomain inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11100,27002,histone lysine methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13824,27003,pyruvate dehydrogenase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25652,27004,glutamate receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
11142,27004,glutamate receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
4203,27004,glutamate receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
14160,27004,glutamate receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
14968,27004,glutamate receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
10043,27005,macrophage migration inhibiting factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5185,27010,PDGFR tyrosine kinase receptor inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25632,27010,PDGFR tyrosine kinase receptor inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25633,27010,PDGFR tyrosine kinase receptor inhibitor,MoA,Phase 3,Gene,Chemical_Compound
7392,27010,PDGFR tyrosine kinase receptor inhibitor,MoA,Phase 3,Gene,Chemical_Compound
12302,27010,PDGFR tyrosine kinase receptor inhibitor,MoA,Phase 3,Gene,Chemical_Compound
12683,27014,MTH1 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8551,27018,acetylcholinesterase inhibitor|STAT inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9645,27019,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25958,27020,dopamine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25729,27021,fructose biphosphate inhibitor,MoA,Phase 2,Gene,Chemical_Compound
12477,27022,integrin antagonist,MoA,Phase 2,Gene,Chemical_Compound
25655,27023,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26058,27024,metalloproteinase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26059,27024,metalloproteinase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
3521,27024,metalloproteinase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11446,27024,metalloproteinase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25602,27024,metalloproteinase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
6908,27025,beta-secretase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
8859,27026,toll-like receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27027,27028,toll-like receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
27029,27028,toll-like receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
12907,27030,EGFR inhibitor,MoA,Phase 1,Gene,Chemical_Compound
13590,27030,EGFR inhibitor,MoA,Phase 1,Gene,Chemical_Compound
8344,27031,apoptosis inhibitor,MoA,Phase 1,Gene,Chemical_Compound
9941,27032,PI3K inhibitor,MoA,Phase 2,Gene,Chemical_Compound
5177,27032,PI3K inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26183,27033,smoothened receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
27034,27033,smoothened receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
10922,27033,smoothened receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
7625,27035,cyclooxygenase inhibitor|histone acetyltransferase inhibitor|lipoxygenase inhibitor|NFkB pathway inhibitor,MoA,Launched,Gene,Chemical_Compound
10748,27035,cyclooxygenase inhibitor|histone acetyltransferase inhibitor|lipoxygenase inhibitor|NFkB pathway inhibitor,MoA,Launched,Gene,Chemical_Compound
7555,27035,cyclooxygenase inhibitor|histone acetyltransferase inhibitor|lipoxygenase inhibitor|NFkB pathway inhibitor,MoA,Launched,Gene,Chemical_Compound
25675,27035,cyclooxygenase inhibitor|histone acetyltransferase inhibitor|lipoxygenase inhibitor|NFkB pathway inhibitor,MoA,Launched,Gene,Chemical_Compound
25676,27035,cyclooxygenase inhibitor|histone acetyltransferase inhibitor|lipoxygenase inhibitor|NFkB pathway inhibitor,MoA,Launched,Gene,Chemical_Compound
25677,27035,cyclooxygenase inhibitor|histone acetyltransferase inhibitor|lipoxygenase inhibitor|NFkB pathway inhibitor,MoA,Launched,Gene,Chemical_Compound
26681,27035,cyclooxygenase inhibitor|histone acetyltransferase inhibitor|lipoxygenase inhibitor|NFkB pathway inhibitor,MoA,Launched,Gene,Chemical_Compound
26682,27035,cyclooxygenase inhibitor|histone acetyltransferase inhibitor|lipoxygenase inhibitor|NFkB pathway inhibitor,MoA,Launched,Gene,Chemical_Compound
25594,27035,cyclooxygenase inhibitor|histone acetyltransferase inhibitor|lipoxygenase inhibitor|NFkB pathway inhibitor,MoA,Launched,Gene,Chemical_Compound
25808,27035,cyclooxygenase inhibitor|histone acetyltransferase inhibitor|lipoxygenase inhibitor|NFkB pathway inhibitor,MoA,Launched,Gene,Chemical_Compound
11040,27035,cyclooxygenase inhibitor|histone acetyltransferase inhibitor|lipoxygenase inhibitor|NFkB pathway inhibitor,MoA,Launched,Gene,Chemical_Compound
9531,27035,cyclooxygenase inhibitor|histone acetyltransferase inhibitor|lipoxygenase inhibitor|NFkB pathway inhibitor,MoA,Launched,Gene,Chemical_Compound
26059,27035,cyclooxygenase inhibitor|histone acetyltransferase inhibitor|lipoxygenase inhibitor|NFkB pathway inhibitor,MoA,Launched,Gene,Chemical_Compound
25602,27035,cyclooxygenase inhibitor|histone acetyltransferase inhibitor|lipoxygenase inhibitor|NFkB pathway inhibitor,MoA,Launched,Gene,Chemical_Compound
25942,27035,cyclooxygenase inhibitor|histone acetyltransferase inhibitor|lipoxygenase inhibitor|NFkB pathway inhibitor,MoA,Launched,Gene,Chemical_Compound
7829,27035,cyclooxygenase inhibitor|histone acetyltransferase inhibitor|lipoxygenase inhibitor|NFkB pathway inhibitor,MoA,Launched,Gene,Chemical_Compound
25665,27035,cyclooxygenase inhibitor|histone acetyltransferase inhibitor|lipoxygenase inhibitor|NFkB pathway inhibitor,MoA,Launched,Gene,Chemical_Compound
25832,27035,cyclooxygenase inhibitor|histone acetyltransferase inhibitor|lipoxygenase inhibitor|NFkB pathway inhibitor,MoA,Launched,Gene,Chemical_Compound
3105,27036,JAK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
11600,27036,JAK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
5775,27036,JAK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
14233,27037,sigma receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25726,27038,adenosine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
4215,27039,aldehyde dehydrogenase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
5770,27040,PKA activator,MoA,Preclinical,Gene,Chemical_Compound
11536,27041,casein kinase inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
6700,27041,casein kinase inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
3594,27041,casein kinase inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
2826,27041,casein kinase inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
25660,27045,adrenergic receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25551,27045,adrenergic receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25553,27045,adrenergic receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
9528,27051,protein synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26401,27056,ATPase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13343,27065,Aurora kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
8285,27065,Aurora kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25712,27065,Aurora kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
27066,27067,sphingosine 1-phosphate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
27066,27068,sphingosine 1-phosphate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
27069,27070,neuropeptide receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
27071,27072,sphingosine 1-phosphate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
6723,27073,sphingosine 1-phosphate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
12316,27074,sphingosine 1-phosphate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
7762,27080,tubulin polymerization inhibitor,MoA,Phase 2,Gene,Chemical_Compound
8974,27085,microtubule inhibitor,MoA,Phase 2,Gene,Chemical_Compound
3105,27086,JAK inhibitor,MoA,Phase 3,Gene,Chemical_Compound
11600,27086,JAK inhibitor,MoA,Phase 3,Gene,Chemical_Compound
5775,27086,JAK inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25545,27087,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
4204,27088,leucine rich repeat kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25846,27089,PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14448,27094,toll-like receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9531,27095,histone acetyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27097,27098,enkephalinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27099,27098,enkephalinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25697,27098,enkephalinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6354,27100,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
25652,27100,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
11142,27100,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
4203,27100,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
14160,27100,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
14968,27100,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
27101,27100,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
8901,27102,TGF beta receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10658,27102,TGF beta receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7264,27102,TGF beta receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7762,27103,microtubule inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9535,27104,benzodiazepine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
9570,27110,HDAC inhibitor,MoA,Phase 1,Gene,Chemical_Compound
9941,27110,HDAC inhibitor,MoA,Phase 1,Gene,Chemical_Compound
5184,27110,HDAC inhibitor,MoA,Phase 1,Gene,Chemical_Compound
11348,27110,HDAC inhibitor,MoA,Phase 1,Gene,Chemical_Compound
11002,27110,HDAC inhibitor,MoA,Phase 1,Gene,Chemical_Compound
15499,27110,HDAC inhibitor,MoA,Phase 1,Gene,Chemical_Compound
26335,27110,HDAC inhibitor,MoA,Phase 1,Gene,Chemical_Compound
11646,27110,HDAC inhibitor,MoA,Phase 1,Gene,Chemical_Compound
3799,27110,HDAC inhibitor,MoA,Phase 1,Gene,Chemical_Compound
12907,27111,EGFR inhibitor,MoA,Launched,Gene,Chemical_Compound
13590,27111,EGFR inhibitor,MoA,Launched,Gene,Chemical_Compound
11200,27111,EGFR inhibitor,MoA,Launched,Gene,Chemical_Compound
2833,27113,estrogen receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
27114,27113,estrogen receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25764,27113,estrogen receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
26792,27113,estrogen receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
4215,27115,antioxidant,MoA,Phase 1,Gene,Chemical_Compound
25873,27116,opioid receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
26008,27118,cholesteryl ester transfer protein inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26913,27142,thromboxane receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
12416,27143,KDM2A inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15241,27143,KDM2A inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11184,27143,KDM2A inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26229,27146,CC chemokine receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
13343,27148,Aurora kinase inhibitor|growth factor receptor inhibitor,MoA,Phase 2,Gene,Chemical_Compound
8285,27148,Aurora kinase inhibitor|growth factor receptor inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25916,27148,Aurora kinase inhibitor|growth factor receptor inhibitor,MoA,Phase 2,Gene,Chemical_Compound
5212,27148,Aurora kinase inhibitor|growth factor receptor inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25966,27148,Aurora kinase inhibitor|growth factor receptor inhibitor,MoA,Phase 2,Gene,Chemical_Compound
4171,27148,Aurora kinase inhibitor|growth factor receptor inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7841,27148,Aurora kinase inhibitor|growth factor receptor inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25808,27151,non-nucleoside reverse transcriptase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
3308,27151,non-nucleoside reverse transcriptase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
15280,27153,hypoxia inducible factor inhibitor,MoA,Phase 3,Gene,Chemical_Compound
27155,27156,phospholipase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
10141,27157,PPAR receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
5173,27161,endothelin receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25594,27167,acetylcholine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
15890,27169,thromboxane synthase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
15890,27170,thromboxane synthase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
12018,27171,ATPase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7351,27172,dipeptidyl peptidase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25849,27173,free fatty acid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25633,27174,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7392,27174,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor,MoA,Phase 1,Gene,Chemical_Compound
27175,27176,potassium channel activator,MoA,Preclinical,Gene,Chemical_Compound
27177,27176,potassium channel activator,MoA,Preclinical,Gene,Chemical_Compound
13006,27176,potassium channel activator,MoA,Preclinical,Gene,Chemical_Compound
26872,27178,chloride channel blocker|gap junction modulator|glutamate inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5998,27179,discoidin domain receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12793,27179,discoidin domain receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5775,27182,JAK inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
9052,27184,focal adhesion kinase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7640,27189,mTOR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
6859,27191,acetylcholinesterase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26487,27195,proteasome inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
25843,27195,proteasome inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
25808,27195,proteasome inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
26249,27195,proteasome inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
6843,27199,membrane permeability inhibitor,MoA,Phase 2,Gene,Chemical_Compound
6599,27200,HMGCR inhibitor,MoA,Phase 1,Gene,Chemical_Compound
5261,27201,phosphodiesterase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12016,27204,progestogen hormone,MoA,Preclinical,Gene,Chemical_Compound
25573,27205,adrenergic receptor agonist|dopamine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25546,27205,adrenergic receptor agonist|dopamine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25547,27205,adrenergic receptor agonist|dopamine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
13040,27206,histamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25555,27217,acetylcholine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
14109,27223,mineralocorticoid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
12016,27223,mineralocorticoid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
6859,27224,acetylcholinesterase inhibitor|monoamine oxidase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
26051,27229,membrane integrity inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27230,27229,membrane integrity inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26862,27229,membrane integrity inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25980,27229,membrane integrity inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26863,27229,membrane integrity inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10849,27229,membrane integrity inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5297,27229,membrane integrity inhibitor,MoA,Preclinical,Gene,Chemical_Compound
2676,27229,membrane integrity inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5770,27229,membrane integrity inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25766,27229,membrane integrity inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12212,27229,membrane integrity inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25719,27229,membrane integrity inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27231,27229,membrane integrity inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27232,27229,membrane integrity inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27101,27229,membrane integrity inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13891,27229,membrane integrity inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14320,27229,membrane integrity inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26367,27235,CCK receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25727,27237,calmodulin antagonist,MoA,Phase 2,Gene,Chemical_Compound
25655,27243,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
12385,27244,PPAR receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
25784,27245,melatonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25741,27247,adenosine kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25742,27247,adenosine kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25625,27248,estrogen receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25546,27254,dopamine reuptake inhibitor,MoA,Phase 3,Gene,Chemical_Compound
7020,27254,dopamine reuptake inhibitor,MoA,Phase 3,Gene,Chemical_Compound
7633,27254,dopamine reuptake inhibitor,MoA,Phase 3,Gene,Chemical_Compound
11393,27262,estrogen receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
25625,27262,estrogen receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
27114,27262,estrogen receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
25764,27262,estrogen receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
10693,27266,ATPase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7829,27269,prostanoid receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25665,27269,prostanoid receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25546,27270,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25547,27270,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25548,27270,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25549,27270,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25550,27270,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
26996,27274,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25655,27274,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25613,27278,histamine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25614,27278,histamine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25961,27278,histamine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
13040,27282,acetylcholine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25924,27285,angiotensin converting enzyme activator,MoA,Phase 3,Gene,Chemical_Compound
9157,27285,angiotensin converting enzyme activator,MoA,Phase 3,Gene,Chemical_Compound
26615,27285,angiotensin converting enzyme activator,MoA,Phase 3,Gene,Chemical_Compound
15298,27287,CDK inhibitor,MoA,Phase 3,Gene,Chemical_Compound
8227,27287,CDK inhibitor,MoA,Phase 3,Gene,Chemical_Compound
6044,27287,CDK inhibitor,MoA,Phase 3,Gene,Chemical_Compound
11699,27287,CDK inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25858,27289,prostanoid receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
3489,27289,prostanoid receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
25860,27289,prostanoid receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
25861,27289,prostanoid receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
25788,27289,prostanoid receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
26201,27289,prostanoid receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
25790,27289,prostanoid receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
9776,27289,prostanoid receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
7320,27289,prostanoid receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
25862,27289,prostanoid receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
6297,27289,prostanoid receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
26913,27289,prostanoid receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
25905,27290,apoptosis stimulant,MoA,Preclinical,Gene,Chemical_Compound
25942,27296,nitric oxide synthase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26138,27296,nitric oxide synthase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25655,27298,glutamate receptor negative allosteric modulator,MoA,Phase 2,Gene,Chemical_Compound
25551,27299,dopamine reuptake inhibitor|serotonin reuptake inhibitor,MoA,Launched,Gene,Chemical_Compound
25554,27299,dopamine reuptake inhibitor|serotonin reuptake inhibitor,MoA,Launched,Gene,Chemical_Compound
25555,27299,dopamine reuptake inhibitor|serotonin reuptake inhibitor,MoA,Launched,Gene,Chemical_Compound
10748,27308,immunostimulant,MoA,Phase 3,Gene,Chemical_Compound
25676,27308,immunostimulant,MoA,Phase 3,Gene,Chemical_Compound
25677,27308,immunostimulant,MoA,Phase 3,Gene,Chemical_Compound
25652,27309,sigma receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
11142,27309,sigma receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
4203,27309,sigma receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
14233,27309,sigma receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25652,27310,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
11142,27310,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
4203,27310,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
14160,27310,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
14968,27310,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25571,27311,adrenergic receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25655,27312,glutamate receptor modulator,MoA,Preclinical,Gene,Chemical_Compound
12119,27313,ALK tyrosine kinase receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25712,27314,VEGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26718,27315,elastase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25992,27316,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25990,27316,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
8327,27316,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25652,27316,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
11142,27316,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
4203,27316,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25795,27318,lipoxygenase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25849,27320,PPAR receptor agonist,MoA,Launched,Gene,Chemical_Compound
7829,27320,PPAR receptor agonist,MoA,Launched,Gene,Chemical_Compound
25665,27320,PPAR receptor agonist,MoA,Launched,Gene,Chemical_Compound
25731,27324,MRP inhibitor|P glycoprotein inhibitor,MoA,Phase 3,Gene,Chemical_Compound
5402,27325,potassium channel blocker,MoA,Withdrawn,Gene,Chemical_Compound
25955,27325,potassium channel blocker,MoA,Withdrawn,Gene,Chemical_Compound
9812,27325,potassium channel blocker,MoA,Withdrawn,Gene,Chemical_Compound
8368,27325,potassium channel blocker,MoA,Withdrawn,Gene,Chemical_Compound
7762,27327,tubulin polymerization inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25551,27331,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25552,27331,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25553,27331,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25853,27331,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25854,27331,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25554,27331,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25556,27331,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25962,27331,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25908,27333,p38 MAPK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
15947,27333,p38 MAPK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
6608,27333,p38 MAPK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
4449,27333,p38 MAPK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
12119,27335,AMPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
2805,27335,AMPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7729,27335,AMPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27164,27335,AMPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14171,27335,AMPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26178,27335,AMPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25632,27335,AMPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25712,27335,AMPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26440,27335,AMPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3103,27335,AMPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13924,27335,AMPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26403,27335,AMPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15786,27335,AMPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5185,27338,EGFR inhibitor|FGFR inhibitor|FLT3 inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
12907,27338,EGFR inhibitor|FGFR inhibitor|FLT3 inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
5212,27338,EGFR inhibitor|FGFR inhibitor|FLT3 inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25759,27338,EGFR inhibitor|FGFR inhibitor|FLT3 inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25760,27338,EGFR inhibitor|FGFR inhibitor|FLT3 inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26178,27338,EGFR inhibitor|FGFR inhibitor|FLT3 inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25632,27338,EGFR inhibitor|FGFR inhibitor|FLT3 inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26179,27338,EGFR inhibitor|FGFR inhibitor|FLT3 inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
6218,27338,EGFR inhibitor|FGFR inhibitor|FLT3 inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25712,27338,EGFR inhibitor|FGFR inhibitor|FLT3 inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25633,27338,EGFR inhibitor|FGFR inhibitor|FLT3 inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
7392,27338,EGFR inhibitor|FGFR inhibitor|FLT3 inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
12302,27338,EGFR inhibitor|FGFR inhibitor|FLT3 inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
8041,27347,adenosine receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25726,27347,adenosine receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
9810,27347,adenosine receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25727,27347,adenosine receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25804,27348,sodium channel activator,MoA,Phase 2,Gene,Chemical_Compound
26120,27349,potassium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
25731,27350,histamine receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
13040,27350,histamine receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
14160,27351,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
14968,27351,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
13754,27352,PARP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5938,27352,PARP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25963,27353,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
8901,27354,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11393,27355,selective estrogen receptor modulator (SERM),MoA,Phase 3,Gene,Chemical_Compound
15499,27363,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11646,27363,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27321,27364,toll-like receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
27365,27366,structural glycoprotein antagonist,MoA,Phase 1,Gene,Chemical_Compound
13890,27366,structural glycoprotein antagonist,MoA,Phase 1,Gene,Chemical_Compound
25665,27368,cyclooxygenase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
9637,27370,PI3K inhibitor,MoA,Launched,Gene,Chemical_Compound
6809,27370,PI3K inhibitor,MoA,Launched,Gene,Chemical_Compound
12097,27370,PI3K inhibitor,MoA,Launched,Gene,Chemical_Compound
25846,27370,PI3K inhibitor,MoA,Launched,Gene,Chemical_Compound
10933,27373,dynamin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9751,27373,dynamin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9441,27373,dynamin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10933,27374,dynamin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27114,27376,estrogen-related receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25764,27376,estrogen-related receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
4684,27377,gamma secretase modulator,MoA,Phase 1,Gene,Chemical_Compound
9297,27377,gamma secretase modulator,MoA,Phase 1,Gene,Chemical_Compound
12083,27377,gamma secretase modulator,MoA,Phase 1,Gene,Chemical_Compound
5402,27378,potassium channel blocker,MoA,Phase 1,Gene,Chemical_Compound
25955,27378,potassium channel blocker,MoA,Phase 1,Gene,Chemical_Compound
5876,27379,calpain inhibitor|cysteine protease inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27380,27381,calcium-activated chloride channel inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13754,27382,PARP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
2742,27384,aldose reductase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25613,27385,histamine receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
27386,27387,cyclooxygenase inhibitor|glutathione peroxidase agonist|H+/K+-ATPase inhibitor|nitric oxide synthase inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
4229,27388,HSP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4111,27388,HSP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6481,27389,retinoid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
14201,27389,retinoid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
6665,27389,retinoid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
10141,27395,PPAR receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
6427,27399,polycomb protein inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27400,27401,hemoglobin oxygen release stimulant,MoA,Phase 3,Gene,Chemical_Compound
27303,27401,hemoglobin oxygen release stimulant,MoA,Phase 3,Gene,Chemical_Compound
25726,27402,adrenergic receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
10141,27403,PPAR receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
12907,27407,EGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26425,27408,glutamate receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
26861,27408,glutamate receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
26862,27408,glutamate receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
26863,27408,glutamate receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
12186,27409,neuropilin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
8975,27410,Ras GTPase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27411,27410,Ras GTPase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25541,27412,sodium/hydrogen exchanger inhibitor|transient receptor potential polycystic inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25926,27412,sodium/hydrogen exchanger inhibitor|transient receptor potential polycystic inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25928,27412,sodium/hydrogen exchanger inhibitor|transient receptor potential polycystic inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25942,27413,nitric oxide synthase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26138,27413,nitric oxide synthase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11100,27414,histone lysine methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25731,27415,P glycoprotein inhibitor,MoA,Phase 1,Gene,Chemical_Compound
6777,27416,exportin antagonist,MoA,Phase 1,Gene,Chemical_Compound
14769,27417,antineoplastic agent,MoA,Phase 3,Gene,Chemical_Compound
8337,27418,PPAR receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
12385,27418,PPAR receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
10141,27418,PPAR receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25604,27419,gonadotropin releasing factor hormone receptor antagonist,MoA,Launched,Gene,Chemical_Compound
6126,27420,bone formation stimulant,MoA,Phase 3,Gene,Chemical_Compound
13141,27421,oxidative stress inducer,MoA,Phase 3,Gene,Chemical_Compound
4071,27424,purinergic receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25652,27425,glutamate receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
4203,27425,glutamate receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
10748,27426,glutathione transferase inhibitor|non-nucleoside reverse transcriptase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7555,27426,glutathione transferase inhibitor|non-nucleoside reverse transcriptase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25675,27426,glutathione transferase inhibitor|non-nucleoside reverse transcriptase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25676,27426,glutathione transferase inhibitor|non-nucleoside reverse transcriptase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
10749,27426,glutathione transferase inhibitor|non-nucleoside reverse transcriptase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25677,27426,glutathione transferase inhibitor|non-nucleoside reverse transcriptase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26518,27426,glutathione transferase inhibitor|non-nucleoside reverse transcriptase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
13433,27426,glutathione transferase inhibitor|non-nucleoside reverse transcriptase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26681,27426,glutathione transferase inhibitor|non-nucleoside reverse transcriptase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25678,27426,glutathione transferase inhibitor|non-nucleoside reverse transcriptase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26682,27426,glutathione transferase inhibitor|non-nucleoside reverse transcriptase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11536,27426,glutathione transferase inhibitor|non-nucleoside reverse transcriptase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
8086,27426,glutathione transferase inhibitor|non-nucleoside reverse transcriptase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
5770,27426,glutathione transferase inhibitor|non-nucleoside reverse transcriptase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7247,27426,glutathione transferase inhibitor|non-nucleoside reverse transcriptase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26752,27426,glutathione transferase inhibitor|non-nucleoside reverse transcriptase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
12173,27426,glutathione transferase inhibitor|non-nucleoside reverse transcriptase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26317,27426,glutathione transferase inhibitor|non-nucleoside reverse transcriptase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
6455,27427,bradykinin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25598,27428,GABA receptor positive allosteric modulator,MoA,Phase 3,Gene,Chemical_Compound
25640,27428,GABA receptor positive allosteric modulator,MoA,Phase 3,Gene,Chemical_Compound
25641,27428,GABA receptor positive allosteric modulator,MoA,Phase 3,Gene,Chemical_Compound
25600,27428,GABA receptor positive allosteric modulator,MoA,Phase 3,Gene,Chemical_Compound
25642,27428,GABA receptor positive allosteric modulator,MoA,Phase 3,Gene,Chemical_Compound
25643,27428,GABA receptor positive allosteric modulator,MoA,Phase 3,Gene,Chemical_Compound
25645,27428,GABA receptor positive allosteric modulator,MoA,Phase 3,Gene,Chemical_Compound
25648,27428,GABA receptor positive allosteric modulator,MoA,Phase 3,Gene,Chemical_Compound
25551,27429,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25552,27429,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
8344,27432,HCV inhibitor|XIAP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10745,27433,hepatocyte growth factor receptor inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25962,27434,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
27435,27436,phosphodiesterase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
5948,27437,angiotensin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
9319,27439,protein synthesis inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11536,27440,11-beta hydroxysteroid dehydrogenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4815,27442,caspase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
12018,27442,caspase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
12936,27442,caspase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25598,27446,GABA receptor modulator,MoA,Phase 3,Gene,Chemical_Compound
7800,27448,PARP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11431,27448,PARP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11393,27449,estrogen receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
2583,27453,dihydropyrimidine dehydrogenase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
11857,27453,dihydropyrimidine dehydrogenase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25832,27453,dihydropyrimidine dehydrogenase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
13343,27454,Aurora kinase inhibitor|FLT3 inhibitor|VEGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25632,27454,Aurora kinase inhibitor|FLT3 inhibitor|VEGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25712,27454,Aurora kinase inhibitor|FLT3 inhibitor|VEGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7392,27454,Aurora kinase inhibitor|FLT3 inhibitor|VEGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
9052,27454,Aurora kinase inhibitor|FLT3 inhibitor|VEGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
15786,27454,Aurora kinase inhibitor|FLT3 inhibitor|VEGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
8041,27459,phosphodiesterase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25726,27459,phosphodiesterase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
9810,27459,phosphodiesterase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25727,27459,phosphodiesterase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
3004,27459,phosphodiesterase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
11307,27459,phosphodiesterase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
9570,27461,HDAC inhibitor,MoA,Phase 3,Gene,Chemical_Compound
9941,27461,HDAC inhibitor,MoA,Phase 3,Gene,Chemical_Compound
5184,27461,HDAC inhibitor,MoA,Phase 3,Gene,Chemical_Compound
3799,27461,HDAC inhibitor,MoA,Phase 3,Gene,Chemical_Compound
11481,27465,PKC inhibitor,MoA,Phase 3,Gene,Chemical_Compound
8086,27465,PKC inhibitor,MoA,Phase 3,Gene,Chemical_Compound
7247,27465,PKC inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26752,27465,PKC inhibitor,MoA,Phase 3,Gene,Chemical_Compound
15425,27465,PKC inhibitor,MoA,Phase 3,Gene,Chemical_Compound
27466,27465,PKC inhibitor,MoA,Phase 3,Gene,Chemical_Compound
15397,27467,endoplasmic reticulum oxidation inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25908,27468,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4449,27468,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27469,27470,"indoleamine 2,3-dioxygenase inhibitor",MoA,Phase 3,Gene,Chemical_Compound
13973,27476,steroid,MoA,Preclinical,Gene,Chemical_Compound
6908,27477,bacterial DNA gyrase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
4277,27477,bacterial DNA gyrase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26249,27478,bacterial DNA gyrase inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
9531,27478,bacterial DNA gyrase inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
4277,27478,bacterial DNA gyrase inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
4710,27478,bacterial DNA gyrase inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
3464,27478,bacterial DNA gyrase inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
3521,27478,bacterial DNA gyrase inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
7762,27488,microtubule stabilizing agent|tubulin polymerization inhibitor,MoA,Phase 3,Gene,Chemical_Compound
7762,27489,microtubule stabilizing agent|tubulin polymerization inhibitor,MoA,Phase 2,Gene,Chemical_Compound
27490,27491,trace amine associated receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
11705,27493,amyloid protein inhibitor|antiamyloidogenic agent,MoA,Phase 3,Gene,Chemical_Compound
4882,27496,histone lysine methyltransferase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
4882,27497,histone lysine methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11100,27498,histone lysine methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11100,27499,histone lysine methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6929,27500,protein arginine N-methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10552,27501,protein arginine N-methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3557,27502,estrogen receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
11393,27503,estrogen receptor agonist,MoA,Launched,Gene,Chemical_Compound
25625,27503,estrogen receptor agonist,MoA,Launched,Gene,Chemical_Compound
26317,27504,mediator release inhibitor|SYK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6481,27505,retinoid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
5610,27506,ion channel antagonist,MoA,Preclinical,Gene,Chemical_Compound
12907,27507,EGFR inhibitor|tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6126,27508,vitamin D receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
5212,27509,FGFR inhibitor,MoA,Launched,Gene,Chemical_Compound
25759,27509,FGFR inhibitor,MoA,Launched,Gene,Chemical_Compound
25760,27509,FGFR inhibitor,MoA,Launched,Gene,Chemical_Compound
26228,27509,FGFR inhibitor,MoA,Launched,Gene,Chemical_Compound
15491,27513,MAP kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11393,27515,estrogen receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25625,27515,estrogen receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25751,27521,acetylcholinesterase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25873,27521,acetylcholinesterase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26738,27522,EPAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14283,27522,EPAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11393,27526,selective estrogen receptor modulator (SERM),MoA,Phase 3,Gene,Chemical_Compound
11393,27529,contraceptive agent,MoA,Preclinical,Gene,Chemical_Compound
15774,27538,phosphodiesterase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
3004,27538,phosphodiesterase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
4919,27539,beta catenin inhibitor|porcupine inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25547,27548,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25548,27548,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25549,27548,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25548,27552,dopamine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
8215,27560,carnitine palmitoyltransferase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
9637,27565,PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6809,27565,PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12097,27565,PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25846,27565,PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6481,27567,protein synthesis inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25701,27567,protein synthesis inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
7625,27570,catalase stimulant,MoA,Preclinical,Gene,Chemical_Compound
16048,27570,catalase stimulant,MoA,Preclinical,Gene,Chemical_Compound
26008,27571,cholesteryl ester transfer protein inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25992,27572,glutamate receptor negative allosteric modulator,MoA,Launched,Gene,Chemical_Compound
4909,27572,glutamate receptor negative allosteric modulator,MoA,Launched,Gene,Chemical_Compound
9776,27573,prostaglandin inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25862,27573,prostaglandin inhibitor,MoA,Phase 2,Gene,Chemical_Compound
6190,27575,ATPase inhibitor|TRPV agonist,MoA,Preclinical,Gene,Chemical_Compound
25571,27576,acetylcholine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
3862,27577,TGF beta receptor inhibitor,MoA,Phase 2,Gene,Chemical_Compound
2774,27577,TGF beta receptor inhibitor,MoA,Phase 2,Gene,Chemical_Compound
10315,27578,SIRT inhibitor,MoA,Phase 2,Gene,Chemical_Compound
27579,27580,growth hormone releasing factor agonist,MoA,Phase 2,Gene,Chemical_Compound
26012,27580,growth hormone releasing factor agonist,MoA,Phase 2,Gene,Chemical_Compound
15946,27581,topoisomerase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
5074,27584,cadherin antagonist,MoA,Phase 2,Gene,Chemical_Compound
26082,27585,nootropic agent,MoA,Withdrawn,Gene,Chemical_Compound
11214,27586,phosphodiesterase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
7800,27587,WNT signaling inhibitor negative control,MoA,Preclinical,Gene,Chemical_Compound
14627,27588,glutathione transferase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
3287,27591,utrophin enhancer,MoA,Phase 2,Gene,Chemical_Compound
13754,27592,PARP inhibitor,MoA,Phase 2,Gene,Chemical_Compound
9999,27592,PARP inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7800,27592,PARP inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11431,27592,PARP inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25551,27593,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
5932,27595,glucosidase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25554,27598,dopamine receptor antagonist|serotonin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
7848,27599,Ras GTPase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7829,27605,cyclooxygenase inhibitor,MoA,Launched,Gene,Chemical_Compound
25665,27605,cyclooxygenase inhibitor,MoA,Launched,Gene,Chemical_Compound
27362,27609,tryptophan hydroxylase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27610,27609,tryptophan hydroxylase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27611,27609,tryptophan hydroxylase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7079,27612,calcium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
25655,27614,glutamate receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25804,27622,adrenergic receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
6481,27624,apoptosis stimulant|retinoid receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
13590,27626,EGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10748,27627,antioxidant,MoA,Phase 2,Gene,Chemical_Compound
7555,27627,antioxidant,MoA,Phase 2,Gene,Chemical_Compound
25675,27627,antioxidant,MoA,Phase 2,Gene,Chemical_Compound
25676,27627,antioxidant,MoA,Phase 2,Gene,Chemical_Compound
25677,27627,antioxidant,MoA,Phase 2,Gene,Chemical_Compound
26681,27627,antioxidant,MoA,Phase 2,Gene,Chemical_Compound
26682,27627,antioxidant,MoA,Phase 2,Gene,Chemical_Compound
26768,27629,FXR agonist,MoA,Preclinical,Gene,Chemical_Compound
15280,27631,hypoxia inducible factor prolyl hydroxylase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
13964,27631,hypoxia inducible factor prolyl hydroxylase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7902,27631,hypoxia inducible factor prolyl hydroxylase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
15280,27632,hypoxia inducible factor prolyl hydroxylase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
13964,27632,hypoxia inducible factor prolyl hydroxylase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
7545,27632,hypoxia inducible factor prolyl hydroxylase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
9535,27633,inositol monophosphatase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9535,27634,benzodiazepine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
12385,27635,PPAR receptor antagonist|WNT signaling inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10141,27635,PPAR receptor antagonist|WNT signaling inhibitor,MoA,Preclinical,Gene,Chemical_Compound
2742,27636,aldose reductase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
15188,27637,kinesin inhibitor|kinesin-like spindle protein inhibitor,MoA,Phase 3,Gene,Chemical_Compound
3105,27638,JAK inhibitor,MoA,Phase 3,Gene,Chemical_Compound
11600,27638,JAK inhibitor,MoA,Phase 3,Gene,Chemical_Compound
5775,27638,JAK inhibitor,MoA,Phase 3,Gene,Chemical_Compound
10662,27638,JAK inhibitor,MoA,Phase 3,Gene,Chemical_Compound
8093,27643,phospholipase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3540,27643,phospholipase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12477,27644,integrin antagonist,MoA,Phase 2,Gene,Chemical_Compound
3305,27646,Aurora kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4277,27646,Aurora kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25751,27647,opioid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25873,27648,opioid receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25665,27649,cyclooxygenase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
13063,27650,niacinamide phosphoribosyltransferase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
12473,27651,tachykinin antagonist,MoA,Phase 2,Gene,Chemical_Compound
25597,27651,tachykinin antagonist,MoA,Phase 2,Gene,Chemical_Compound
14707,27658,potassium channel agonist,MoA,Phase 3,Gene,Chemical_Compound
13006,27658,potassium channel agonist,MoA,Phase 3,Gene,Chemical_Compound
25965,27658,potassium channel agonist,MoA,Phase 3,Gene,Chemical_Compound
26374,27658,potassium channel agonist,MoA,Phase 3,Gene,Chemical_Compound
5524,27658,potassium channel agonist,MoA,Phase 3,Gene,Chemical_Compound
2789,27669,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
27380,27669,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
7292,27669,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
8143,27669,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
26636,27669,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
26637,27669,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
26638,27669,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
26639,27669,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
26640,27669,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
9579,27669,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
26641,27669,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
26642,27669,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
26643,27669,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
26644,27669,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
26645,27669,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
26646,27669,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
26647,27669,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
5740,27669,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
26648,27669,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
26649,27669,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
26650,27669,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
26651,27669,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
26652,27669,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
26653,27669,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
10624,27669,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
26654,27669,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
26655,27669,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
25928,27669,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
7829,27669,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
25665,27669,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
26792,27669,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
26080,27669,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
27670,27669,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
10758,27671,Bcr-Abl kinase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
12302,27671,Bcr-Abl kinase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25551,27687,serotonin receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25552,27687,serotonin receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
9297,27689,gamma secretase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
6908,27689,gamma secretase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
7027,27689,gamma secretase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
8514,27689,gamma secretase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
15929,27689,gamma secretase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
7829,27689,gamma secretase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25665,27689,gamma secretase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26178,27701,VEGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26179,27701,VEGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25712,27701,VEGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
10745,27701,VEGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26800,27703,alcohol dehydrogenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26620,27703,alcohol dehydrogenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25615,27706,platelet activating factor receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
15921,27707,adenylyl cyclase activator,MoA,Launched,Gene,Chemical_Compound
12009,27707,adenylyl cyclase activator,MoA,Launched,Gene,Chemical_Compound
4308,27707,adenylyl cyclase activator,MoA,Launched,Gene,Chemical_Compound
27709,27710,tubulin polymerization inhibitor|VE-cadherin antagonist,MoA,Phase 3,Gene,Chemical_Compound
5460,27717,WNT5a peptide mimetic,MoA,Phase 2,Gene,Chemical_Compound
15539,27718,calcium channel activator,MoA,Preclinical,Gene,Chemical_Compound
25973,27718,calcium channel activator,MoA,Preclinical,Gene,Chemical_Compound
26255,27719,RAGE receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
5173,27720,endothelin receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
15365,27721,MAP kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5719,27721,MAP kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7178,27722,serine/threonine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7386,27722,serine/threonine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8342,27722,serine/threonine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3944,27722,serine/threonine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27091,27723,elastase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26249,27723,elastase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10034,27731,protein arginine N-methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15890,27732,thromboxane synthase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7264,27734,TGF beta receptor inhibitor,MoA,Phase 2,Gene,Chemical_Compound
6859,27735,acetylcholinesterase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5193,27736,G protein-coupled receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
5193,27737,estrogen receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25598,27751,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25640,27751,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25641,27751,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25600,27751,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25642,27751,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25643,27751,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25648,27751,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25598,27754,benzodiazepine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25640,27754,benzodiazepine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25641,27754,benzodiazepine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25600,27754,benzodiazepine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25642,27754,benzodiazepine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25643,27754,benzodiazepine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25646,27754,benzodiazepine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
27755,27754,benzodiazepine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
27756,27754,benzodiazepine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
27757,27754,benzodiazepine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
7292,27766,androgen receptor modulator,MoA,Phase 3,Gene,Chemical_Compound
25610,27766,androgen receptor modulator,MoA,Phase 3,Gene,Chemical_Compound
10748,27768,beta amyloid protein neurotoxicity inhibitor|PPAR receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
7555,27768,beta amyloid protein neurotoxicity inhibitor|PPAR receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25675,27768,beta amyloid protein neurotoxicity inhibitor|PPAR receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25676,27768,beta amyloid protein neurotoxicity inhibitor|PPAR receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25677,27768,beta amyloid protein neurotoxicity inhibitor|PPAR receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26681,27768,beta amyloid protein neurotoxicity inhibitor|PPAR receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26682,27768,beta amyloid protein neurotoxicity inhibitor|PPAR receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25671,27768,beta amyloid protein neurotoxicity inhibitor|PPAR receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
5075,27770,caspase activator,MoA,Phase 2,Gene,Chemical_Compound
13139,27771,benzodiazepine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25560,27771,benzodiazepine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25598,27771,benzodiazepine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25640,27771,benzodiazepine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25641,27771,benzodiazepine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25642,27771,benzodiazepine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25645,27771,benzodiazepine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25648,27771,benzodiazepine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26217,27771,benzodiazepine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
10388,27771,benzodiazepine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
2657,27771,benzodiazepine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26281,27771,benzodiazepine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26816,27771,benzodiazepine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
7829,27772,cyclooxygenase inhibitor|prostanoid receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25665,27772,cyclooxygenase inhibitor|prostanoid receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25598,27773,GABA receptor modulator,MoA,Phase 3,Gene,Chemical_Compound
25640,27773,GABA receptor modulator,MoA,Phase 3,Gene,Chemical_Compound
25641,27773,GABA receptor modulator,MoA,Phase 3,Gene,Chemical_Compound
25600,27773,GABA receptor modulator,MoA,Phase 3,Gene,Chemical_Compound
25642,27773,GABA receptor modulator,MoA,Phase 3,Gene,Chemical_Compound
25643,27773,GABA receptor modulator,MoA,Phase 3,Gene,Chemical_Compound
4229,27774,HSP inhibitor,MoA,Phase 3,Gene,Chemical_Compound
27775,27776,GLI antagonist,MoA,Preclinical,Gene,Chemical_Compound
27775,27777,GLI antagonist,MoA,Preclinical,Gene,Chemical_Compound
14195,27777,GLI antagonist,MoA,Preclinical,Gene,Chemical_Compound
7731,27779,glutamate receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25652,27779,glutamate receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
11142,27779,glutamate receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
4203,27779,glutamate receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
14160,27779,glutamate receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
14968,27779,glutamate receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25653,27779,glutamate receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25654,27779,glutamate receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
5948,27780,dopamine reuptake inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25958,27780,dopamine reuptake inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25958,27781,dopamine reuptake inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11481,27782,AKT inhibitor,MoA,Phase 3,Gene,Chemical_Compound
3613,27782,AKT inhibitor,MoA,Phase 3,Gene,Chemical_Compound
12367,27782,AKT inhibitor,MoA,Phase 3,Gene,Chemical_Compound
8196,27782,AKT inhibitor,MoA,Phase 3,Gene,Chemical_Compound
4198,27783,XIAP inhibitor,MoA,Phase 1,Gene,Chemical_Compound
26234,27783,XIAP inhibitor,MoA,Phase 1,Gene,Chemical_Compound
27784,27783,XIAP inhibitor,MoA,Phase 1,Gene,Chemical_Compound
8344,27783,XIAP inhibitor,MoA,Phase 1,Gene,Chemical_Compound
9637,27785,Pim kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
11393,27786,selective estrogen receptor destabilizer,MoA,Phase 2,Gene,Chemical_Compound
25636,27787,Bruton's tyrosine kinase (BTK) inhibitor,MoA,Phase 1,Gene,Chemical_Compound
9018,27788,RAF inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9637,27789,PI3K inhibitor,MoA,Phase 2,Gene,Chemical_Compound
6809,27789,PI3K inhibitor,MoA,Phase 2,Gene,Chemical_Compound
12097,27789,PI3K inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25846,27789,PI3K inhibitor,MoA,Phase 2,Gene,Chemical_Compound
27165,27790,mTOR inhibitor|PI3K inhibitor,MoA,Phase 2,Gene,Chemical_Compound
27791,27790,mTOR inhibitor|PI3K inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7640,27790,mTOR inhibitor|PI3K inhibitor,MoA,Phase 2,Gene,Chemical_Compound
9637,27790,mTOR inhibitor|PI3K inhibitor,MoA,Phase 2,Gene,Chemical_Compound
6809,27790,mTOR inhibitor|PI3K inhibitor,MoA,Phase 2,Gene,Chemical_Compound
12097,27790,mTOR inhibitor|PI3K inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25846,27790,mTOR inhibitor|PI3K inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26317,27790,mTOR inhibitor|PI3K inhibitor,MoA,Phase 2,Gene,Chemical_Compound
15365,27792,MAP kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
5719,27792,MAP kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
4229,27793,HSP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4229,27795,HSP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13437,27797,apoptosis inhibitor|DNA synthesis inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7850,27797,apoptosis inhibitor|DNA synthesis inhibitor,MoA,Phase 1,Gene,Chemical_Compound
14652,27797,apoptosis inhibitor|DNA synthesis inhibitor,MoA,Phase 1,Gene,Chemical_Compound
26393,27800,GLP receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26051,27801,tyrosine kinase inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
11393,27801,tyrosine kinase inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
25625,27801,tyrosine kinase inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
2833,27801,tyrosine kinase inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
27114,27801,tyrosine kinase inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
25764,27801,tyrosine kinase inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
15076,27801,tyrosine kinase inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
13677,27801,tyrosine kinase inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
10141,27801,tyrosine kinase inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
14351,27801,tyrosine kinase inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
12989,27801,tyrosine kinase inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
26792,27801,tyrosine kinase inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
4203,27803,glutamate receptor downregulator,MoA,Phase 3,Gene,Chemical_Compound
7471,27804,glucosylceramidase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15946,27805,topoisomerase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
5297,27807,PKC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
2676,27807,PKC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15374,27807,PKC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25767,27807,PKC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27808,27809,gamma glutamyltransferase Inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4992,27810,GGTase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25632,27811,FLT3 inhibitor,MoA,Launched,Gene,Chemical_Compound
6354,27813,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
7731,27813,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
6354,27814,platelet activating factor receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
3070,27814,platelet activating factor receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
26219,27814,platelet activating factor receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
7731,27814,platelet activating factor receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25596,27814,platelet activating factor receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
26192,27814,platelet activating factor receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25665,27815,NFkB pathway inhibitor|nitric oxide synthase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25955,27816,angiogenesis inhibitor|apoptosis stimulant,MoA,Launched,Gene,Chemical_Compound
9570,27817,HDAC inhibitor,MoA,Phase 3,Gene,Chemical_Compound
9941,27817,HDAC inhibitor,MoA,Phase 3,Gene,Chemical_Compound
5184,27817,HDAC inhibitor,MoA,Phase 3,Gene,Chemical_Compound
11348,27817,HDAC inhibitor,MoA,Phase 3,Gene,Chemical_Compound
11002,27817,HDAC inhibitor,MoA,Phase 3,Gene,Chemical_Compound
15499,27817,HDAC inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26335,27817,HDAC inhibitor,MoA,Phase 3,Gene,Chemical_Compound
11646,27817,HDAC inhibitor,MoA,Phase 3,Gene,Chemical_Compound
3799,27817,HDAC inhibitor,MoA,Phase 3,Gene,Chemical_Compound
27818,27819,glucokinase activator,MoA,Preclinical,Gene,Chemical_Compound
27820,27821,NADPH oxidase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
5253,27821,NADPH oxidase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
15913,27822,transglutaminase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26051,27823,DeltaF508-CFTR Correctors,MoA,Withdrawn,Gene,Chemical_Compound
7292,27828,androgen receptor modulator,MoA,Phase 1,Gene,Chemical_Compound
7292,27829,androgen receptor modulator,MoA,Phase 1,Gene,Chemical_Compound
9241,27833,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
27808,27833,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
6843,27833,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
12486,27833,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
14335,27833,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
27834,27833,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
27835,27833,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
14689,27833,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
4626,27833,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
27836,27833,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
27837,27833,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
3688,27833,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
3768,27833,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
6054,27833,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
4647,27833,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
27838,27833,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
27839,27833,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
27840,27833,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
6007,27833,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
27841,27833,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
11693,27833,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
27842,27833,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
10079,27833,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
7041,27833,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
27843,27833,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
27844,27833,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
4803,27833,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
9719,27833,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
14627,27833,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
27845,27833,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
13320,27833,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
7562,27833,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
27846,27833,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
27847,27833,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
15709,27833,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
8107,27833,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
9595,27833,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
6294,27833,antioxidant,MoA,Phase 3,Gene,Chemical_Compound
25998,27849,tumor necrosis factor release inhibitor,MoA,Phase 3,Gene,Chemical_Compound
14171,27851,immunophilin ligand,MoA,Preclinical,Gene,Chemical_Compound
13063,27852,NAMPT inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
10758,27853,Bcr-Abl kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5820,27853,Bcr-Abl kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10758,27854,Bcr-Abl kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5820,27854,Bcr-Abl kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25966,27855,growth factor receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6074,27855,growth factor receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27463,27855,growth factor receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27818,27856,glucokinase inhibitor|protein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4074,27856,glucokinase inhibitor|protein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25872,27857,opioid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25873,27857,opioid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
7247,27858,protein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26752,27858,protein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15425,27858,protein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27466,27858,protein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25767,27858,protein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9117,27859,ARF inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25712,27860,VEGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
10745,27860,VEGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
5075,27863,BCL inhibitor|MCL1 inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26396,27864,G protein-coupled receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
14171,27865,FKBP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13063,27866,NAMPT inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25785,27867,G protein-coupled receptor modulator,MoA,Preclinical,Gene,Chemical_Compound
25878,27868,cannabinoid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25878,27869,cannabinoid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25548,27870,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25855,27871,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25551,27872,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25552,27872,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25553,27872,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25853,27872,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25854,27872,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25554,27872,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
7079,27872,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25555,27872,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25962,27872,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
27365,27873,integrin antagonist,MoA,Preclinical,Gene,Chemical_Compound
13890,27873,integrin antagonist,MoA,Preclinical,Gene,Chemical_Compound
27874,27875,tachykinin antagonist,MoA,Preclinical,Gene,Chemical_Compound
25597,27875,tachykinin antagonist,MoA,Preclinical,Gene,Chemical_Compound
26768,27876,estrogen receptor agonist|FXR antagonist|progesterone receptor agonist,MoA,Launched,Gene,Chemical_Compound
8041,27877,adenosine receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25726,27877,adenosine receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25855,27882,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25553,27883,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
8203,27884,ubiquitin ligase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10968,27884,ubiquitin ligase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13139,27885,GABA receptor modulator,MoA,Preclinical,Gene,Chemical_Compound
8041,27886,adenosine receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25726,27886,adenosine receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
9810,27886,adenosine receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25727,27886,adenosine receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
27321,27887,toll-like receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
26317,27888,SYK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
6474,27889,histone demethylase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27890,27891,histone lysine demethylase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6474,27891,histone lysine demethylase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9885,27892,histone lysine demethylase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6999,27893,glycogen synthase kinase inhibitor|lipoxygenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8086,27893,glycogen synthase kinase inhibitor|lipoxygenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12385,27894,PPAR receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25846,27895,PI3K inhibitor,MoA,Phase 1,Gene,Chemical_Compound
13343,27896,Aurora kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
8285,27896,Aurora kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25916,27896,Aurora kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
26848,27896,Aurora kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25808,27896,Aurora kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
27897,27898,glucose dependent insulinotropic receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25634,27899,urotensin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25551,27900,serotonin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25552,27900,serotonin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25553,27900,serotonin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
11330,27901,insulin growth factor receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11627,27901,insulin growth factor receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6218,27901,insulin growth factor receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26403,27901,insulin growth factor receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11627,27902,IGF-1 inhibitor|insulin growth factor receptor inhibitor|insulin receptor ligand,MoA,Preclinical,Gene,Chemical_Compound
6218,27902,IGF-1 inhibitor|insulin growth factor receptor inhibitor|insulin receptor ligand,MoA,Preclinical,Gene,Chemical_Compound
11481,27903,AKT inhibitor,MoA,Phase 2,Gene,Chemical_Compound
3613,27903,AKT inhibitor,MoA,Phase 2,Gene,Chemical_Compound
12367,27903,AKT inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7640,27904,mTOR inhibitor|PI3K inhibitor,MoA,Phase 1,Gene,Chemical_Compound
9637,27904,mTOR inhibitor|PI3K inhibitor,MoA,Phase 1,Gene,Chemical_Compound
6809,27904,mTOR inhibitor|PI3K inhibitor,MoA,Phase 1,Gene,Chemical_Compound
12097,27904,mTOR inhibitor|PI3K inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25846,27904,mTOR inhibitor|PI3K inhibitor,MoA,Phase 1,Gene,Chemical_Compound
26005,27905,lipoxygenase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
6139,27906,transient receptor potential channel antagonist,MoA,Preclinical,Gene,Chemical_Compound
4277,27907,fatty acid synthase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12168,27908,epoxide hydolase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
27909,27910,bile acid transporter inhibitor,MoA,Phase 2,Gene,Chemical_Compound
13343,27911,phosphoinositide dependent kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8285,27911,phosphoinositide dependent kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5297,27911,phosphoinositide dependent kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3004,27912,phosphodiesterase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
4204,27913,leucine rich repeat kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8717,27914,protein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27915,27914,protein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6809,27916,PI3K inhibitor,MoA,Phase 2,Gene,Chemical_Compound
13626,27917,rho associated kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9902,27917,rho associated kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11459,27918,bromodomain inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7691,27918,bromodomain inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11100,27919,histone lysine methyltransferase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
10469,27920,protein phosphatase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9139,27921,lactate dehydrogenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9885,27922,histone lysine demethylase inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
25785,27923,free fatty acid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
12385,27924,PPAR receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
13626,27925,rho associated kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14636,27926,PLK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
11100,27927,histone lysine methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4757,27928,serum/glucocorticoid regulated kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14431,27928,serum/glucocorticoid regulated kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11481,27929,AKT inhibitor,MoA,Phase 1,Gene,Chemical_Compound
3613,27929,AKT inhibitor,MoA,Phase 1,Gene,Chemical_Compound
12367,27929,AKT inhibitor,MoA,Phase 1,Gene,Chemical_Compound
3944,27929,AKT inhibitor,MoA,Phase 1,Gene,Chemical_Compound
2906,27929,AKT inhibitor,MoA,Phase 1,Gene,Chemical_Compound
27930,27929,AKT inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25766,27929,AKT inhibitor,MoA,Phase 1,Gene,Chemical_Compound
8196,27929,AKT inhibitor,MoA,Phase 1,Gene,Chemical_Compound
5832,27929,AKT inhibitor,MoA,Phase 1,Gene,Chemical_Compound
14109,27931,glucocorticoid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
8838,27932,centromere associated protein inhibitor,MoA,Phase 1,Gene,Chemical_Compound
5185,27933,FLT3 inhibitor|tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25632,27933,FLT3 inhibitor|tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25633,27933,FLT3 inhibitor|tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12302,27933,FLT3 inhibitor|tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25571,27934,cholinergic receptor agonist,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
25942,27940,nitric oxide synthase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
27007,27941,creatine kinase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
27943,27944,oxoeicosanoid receptor modulator,MoA,Preclinical,Gene,Chemical_Compound
26816,27945,GABA uptake inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27946,27945,GABA uptake inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27947,27945,GABA uptake inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27948,27945,GABA uptake inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12385,27949,PPAR receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25849,27950,G protein-coupled receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
10141,27951,PPAR receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
5185,27952,cFMS kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26249,27953,elastase inhibitor|leukocyte elastase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
9476,27954,LXR agonist,MoA,Preclinical,Gene,Chemical_Compound
11708,27954,LXR agonist,MoA,Preclinical,Gene,Chemical_Compound
25878,27955,cannabinoid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26768,27956,FXR agonist,MoA,Preclinical,Gene,Chemical_Compound
26757,27957,neuropeptide receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25966,27958,growth factor receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8337,27959,PPAR receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
12385,27959,PPAR receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25966,27960,leucine rich repeat kinase inhibitor|RAF inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
5450,27960,leucine rich repeat kinase inhibitor|RAF inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
26417,27961,calcium channel activator,MoA,Preclinical,Gene,Chemical_Compound
12907,27962,EGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13590,27962,EGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25862,27963,prostanoid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
8337,27964,PPAR receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
8337,27965,PPAR receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26440,27966,ALK tyrosine kinase receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4449,27966,ALK tyrosine kinase receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
2774,27966,ALK tyrosine kinase receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25955,27967,melanin inhibitor,MoA,Phase 1,Gene,Chemical_Compound
27968,27967,melanin inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25878,27969,cannabinoid receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
14636,27970,PLK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15336,27970,PLK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25849,27971,free fatty acid receptor agonist|G protein-coupled receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25785,27971,free fatty acid receptor agonist|G protein-coupled receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
13677,27972,PPAR receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
10141,27972,PPAR receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
9967,27972,PPAR receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25992,27973,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25990,27973,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
15548,27973,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25994,27973,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
10758,27974,Bcr-Abl kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5820,27974,Bcr-Abl kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7800,27975,tankyrase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11431,27975,tankyrase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26809,27976,PKA inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12916,27976,PKA inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5770,27976,PKA inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15178,27977,autotaxin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25992,27978,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25992,27979,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
8093,27984,phospholipase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
3540,27984,phospholipase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7020,27990,monoamine oxidase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7633,27990,monoamine oxidase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5075,27991,BCL inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10608,27992,TRPA1 channel blocker,MoA,Phase 1,Gene,Chemical_Compound
6139,27993,transient receptor potential channel antagonist,MoA,Preclinical,Gene,Chemical_Compound
4585,27994,ubiquitin ligase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7592,27994,ubiquitin ligase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5574,27994,ubiquitin ligase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8041,27995,adenosine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25726,27995,adenosine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
9810,27995,adenosine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25727,27995,adenosine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
8285,27997,Aurora kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6399,27998,ACAT inhibitor,MoA,Launched,Gene,Chemical_Compound
27999,27998,ACAT inhibitor,MoA,Launched,Gene,Chemical_Compound
8363,27998,ACAT inhibitor,MoA,Launched,Gene,Chemical_Compound
28000,27998,ACAT inhibitor,MoA,Launched,Gene,Chemical_Compound
8285,28001,flavanone glycoside,MoA,Launched,Gene,Chemical_Compound
25778,28001,flavanone glycoside,MoA,Launched,Gene,Chemical_Compound
25691,28003,cholinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25582,28003,cholinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25584,28003,cholinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
27083,28003,cholinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
11481,28004,AKT inhibitor|differentiation inducer|NFKB pathway inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25804,28011,adrenergic receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
14283,28013,GTPase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12907,28014,EGFR inhibitor,MoA,Phase 1,Gene,Chemical_Compound
6929,28015,protein arginine N-methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14636,28016,PLK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25652,28021,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
11142,28021,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
4203,28021,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
14160,28021,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
14968,28021,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25795,28022,AKT inhibitor,MoA,Phase 3,Gene,Chemical_Compound
7829,28022,AKT inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25665,28022,AKT inhibitor,MoA,Phase 3,Gene,Chemical_Compound
7533,28023,protein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25961,28024,histamine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
6859,28025,acetylcholinesterase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
12916,28041,rho associated kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5770,28041,rho associated kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13626,28041,rho associated kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25835,28043,progesterone receptor agonist,MoA,Launched,Gene,Chemical_Compound
6859,28044,cholinesterase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7020,28047,monoamine oxidase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7633,28047,monoamine oxidase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7591,28049,aldose reductase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
2742,28049,aldose reductase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8456,28050,IKK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
26020,28050,IKK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25998,28050,IKK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
10635,28051,PARP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6078,28052,lysophosphatidic acid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
28053,28052,lysophosphatidic acid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
5999,28054,bromodomain inhibitor,MoA,Phase 2,Gene,Chemical_Compound
14000,28054,bromodomain inhibitor,MoA,Phase 2,Gene,Chemical_Compound
15528,28054,bromodomain inhibitor,MoA,Phase 2,Gene,Chemical_Compound
5999,28055,bromodomain inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14000,28055,bromodomain inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15528,28055,bromodomain inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15636,28056,bromodomain inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12752,28057,bromodomain inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9531,28057,bromodomain inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8041,28058,adenosine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25726,28058,adenosine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
9810,28058,adenosine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25727,28058,adenosine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25697,28060,hydroxycarboxylic acid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
8041,28061,phosphodiesterase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26315,28061,phosphodiesterase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12939,28061,phosphodiesterase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7103,28061,phosphodiesterase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11214,28061,phosphodiesterase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27301,28061,phosphodiesterase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4153,28061,phosphodiesterase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26606,28061,phosphodiesterase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26607,28061,phosphodiesterase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25652,28062,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
7449,28063,lipoprotein lipase activator,MoA,Phase 2,Gene,Chemical_Compound
14979,28070,growth hormone secretagogue receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
26012,28070,growth hormone secretagogue receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25965,28072,voltage-gated potassium channel activator,MoA,Preclinical,Gene,Chemical_Compound
2757,28072,voltage-gated potassium channel activator,MoA,Preclinical,Gene,Chemical_Compound
25965,28073,voltage-gated potassium channel activator,MoA,Preclinical,Gene,Chemical_Compound
25821,28074,sodium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
25823,28074,sodium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
11214,28075,phosphodiesterase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
11214,28076,PPAR receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
3188,28078,beta-catenin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25804,28079,adrenergic receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25918,28079,adrenergic receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25613,28080,histamine receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
26913,28081,thromboxane receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
26848,28082,opioid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25751,28082,opioid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25872,28082,opioid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25873,28082,opioid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25634,28082,opioid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25918,28083,adrenergic receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25660,28084,adrenergic receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25804,28084,adrenergic receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
10608,28085,TRPV agonist,MoA,Phase 1,Gene,Chemical_Compound
26017,28085,TRPV agonist,MoA,Phase 1,Gene,Chemical_Compound
28086,28087,mucin production enhancer,MoA,Phase 3,Gene,Chemical_Compound
3188,28091,beta catenin inhibitor|WNT signaling inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15679,28091,beta catenin inhibitor|WNT signaling inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8901,28092,casein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10658,28092,casein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10045,28092,casein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14325,28092,casein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
28093,28094,insulin sensitizer,MoA,Phase 1,Gene,Chemical_Compound
25962,28095,serotonin receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
9986,28097,MDM inhibitor,MoA,Phase 3,Gene,Chemical_Compound
8546,28097,MDM inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25541,28098,adrenergic receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25665,28098,adrenergic receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
27469,28100,"indoleamine 2,3-dioxygenase inhibitor",MoA,Preclinical,Gene,Chemical_Compound
25992,28101,glutamate receptor positive allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
25990,28101,glutamate receptor positive allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
15548,28101,glutamate receptor positive allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
25994,28101,glutamate receptor positive allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
7304,28102,XIAP inhibitor,MoA,Phase 3,Gene,Chemical_Compound
14020,28102,XIAP inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25990,28103,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25992,28104,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
4203,28105,adrenergic receptor antagonist|glutamate receptor antagonist,MoA,Launched,Gene,Chemical_Compound
14233,28107,sigma receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
8456,28109,IKK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8456,28110,IKK inhibitor|SYK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8456,28111,IKK inhibitor|NFkB pathway inhibitor,MoA,Phase 1,Gene,Chemical_Compound
28112,28113,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26303,28113,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26058,28113,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25684,28113,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26059,28113,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
3464,28113,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
3521,28113,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
11446,28113,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26305,28113,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25602,28113,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25614,28117,histamine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25961,28117,histamine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25541,28120,adrenergic receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25543,28120,adrenergic receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25614,28124,histamine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25961,28124,histamine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25614,28125,histamine receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25614,28126,histamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
10745,28127,c-Met inhibitor,MoA,Phase 3,Gene,Chemical_Compound
6495,28128,calcineurin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26456,28129,CC chemokine receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25800,28131,selective serotonin reuptake inhibitor (SSRI),MoA,Withdrawn,Gene,Chemical_Compound
7020,28133,norepinephrine transporter inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7633,28133,norepinephrine transporter inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15076,28134,PPAR receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
8337,28134,PPAR receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
12385,28134,PPAR receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
10141,28134,PPAR receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25598,28136,benzodiazepine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
15298,28137,CDK inhibitor|glycogen synthase kinase inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
6044,28137,CDK inhibitor|glycogen synthase kinase inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
6999,28137,CDK inhibitor|glycogen synthase kinase inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
15298,28138,CDK inhibitor|glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8227,28138,CDK inhibitor|glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6044,28138,CDK inhibitor|glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
28139,28138,CDK inhibitor|glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8086,28138,CDK inhibitor|glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10748,28140,CDK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7555,28140,CDK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25675,28140,CDK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25676,28140,CDK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26681,28140,CDK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25678,28140,CDK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26682,28140,CDK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
6024,28143,"aryl hydrocarbon receptor agonist|indoleamine 2,3-dioxygenase inhibitor",MoA,Phase 2/Phase 3,Gene,Chemical_Compound
28145,28146,cyclooxygenase inhibitor|prostanoid receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
26229,28146,cyclooxygenase inhibitor|prostanoid receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
7829,28146,cyclooxygenase inhibitor|prostanoid receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25665,28146,cyclooxygenase inhibitor|prostanoid receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
27469,28148,"indoleamine 2,3-dioxygenase inhibitor",MoA,Phase 2,Gene,Chemical_Compound
9407,28151,Hec1 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13754,28152,PARP inhibitor,MoA,Phase 3,Gene,Chemical_Compound
13754,28153,neurotrophic agent,MoA,Launched,Gene,Chemical_Compound
10635,28153,neurotrophic agent,MoA,Launched,Gene,Chemical_Compound
26396,28155,FXR agonist,MoA,Phase 1,Gene,Chemical_Compound
6567,28156,integrin antagonist,MoA,Phase 1,Gene,Chemical_Compound
28157,28156,integrin antagonist,MoA,Phase 1,Gene,Chemical_Compound
25614,28159,histamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25961,28159,histamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26051,28160,CFTR channel antagonist,MoA,Phase 2,Gene,Chemical_Compound
15280,28161,histone demethylase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4020,28161,histone demethylase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7816,28161,histone demethylase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6474,28161,histone demethylase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15280,28162,hypoxia inducible factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12416,28162,hypoxia inducible factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7290,28162,hypoxia inducible factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7178,28163,p21 activated kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6859,28164,acetylcholinesterase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
7020,28167,monoamine oxidase inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
7633,28167,monoamine oxidase inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25551,28168,serotonin receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
6150,28171,endothelin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25676,28172,steroid sulfatase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
8338,28172,steroid sulfatase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25551,28174,adrenergic receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25552,28174,adrenergic receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25808,28175,cytochrome P450 inhibitor,MoA,Phase 3,Gene,Chemical_Compound
10043,28176,macrophage migration inhibiting factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
28177,28178,gene expression stimulant,MoA,Phase 2,Gene,Chemical_Compound
28179,28178,gene expression stimulant,MoA,Phase 2,Gene,Chemical_Compound
25598,28185,benzodiazepine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25640,28185,benzodiazepine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25641,28185,benzodiazepine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25600,28185,benzodiazepine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25642,28185,benzodiazepine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25643,28185,benzodiazepine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
27755,28185,benzodiazepine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
27756,28185,benzodiazepine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
27757,28185,benzodiazepine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
13139,28186,guanylate cyclase activator,MoA,Preclinical,Gene,Chemical_Compound
7829,28194,cyclooxygenase inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25665,28194,cyclooxygenase inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
15188,28196,kinesin inhibitor,MoA,Phase 2,Gene,Chemical_Compound
4968,28198,eukaryotic translation initiation factor inhibitor|PERK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8717,28198,eukaryotic translation initiation factor inhibitor|PERK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10693,28199,ATPase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
28201,28202,neural stem cell inducer,MoA,Preclinical,Gene,Chemical_Compound
3105,28203,JAK inhibitor,MoA,Phase 3,Gene,Chemical_Compound
28204,28205,TGF beta receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6024,28206,aryl hydrocarbon receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
12646,28207,phosphodiesterase inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
8419,28209,GEF inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25894,28210,CC chemokine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
8301,28211,ubiquitin C-terminal hydrolase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4919,28219,porcupine inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5775,28221,JAK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25872,28222,opioid receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25958,28223,dopamine reuptake inhibitor,MoA,Preclinical,Gene,Chemical_Compound
28224,28225,histone lysine demethylase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8514,28226,gamma secretase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25961,28227,histamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25709,28228,orexin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25711,28228,orexin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26996,28229,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25885,28230,FAAH inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6190,28231,TRPV antagonist,MoA,Preclinical,Gene,Chemical_Compound
9570,28232,HDAC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26333,28232,HDAC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26334,28232,HDAC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
9941,28232,HDAC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
5184,28232,HDAC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11348,28232,HDAC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11002,28232,HDAC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
15499,28232,HDAC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26335,28232,HDAC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11646,28232,HDAC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
3799,28232,HDAC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
9986,28232,HDAC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26456,28233,CC chemokine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25547,28234,dopamine receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
10745,28235,tyrosine kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
26425,28236,glutamate receptor positive allosteric modulator,MoA,Phase 2,Gene,Chemical_Compound
2969,28237,hypoxia inducible factor prolyl hydroxylase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25885,28238,FAAH inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25569,28239,purinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
28240,28241,G protein-coupled receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
13343,28242,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8285,28242,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15298,28242,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8227,28242,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25961,28243,histamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
15528,28244,bromodomain inhibitor,MoA,Preclinical,Gene,Chemical_Compound
28245,28244,bromodomain inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26294,28246,opioid receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
28247,28248,lysophospholipid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
6723,28248,lysophospholipid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
28249,28250,cytokine production inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26020,28250,cytokine production inhibitor,MoA,Phase 2,Gene,Chemical_Compound
6026,28250,cytokine production inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25998,28250,cytokine production inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25878,28251,cannabinoid receptor inverse agonist,MoA,Phase 1,Gene,Chemical_Compound
7800,28252,tankyrase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11431,28252,tankyrase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14681,28253,monoacylglycerol lipase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6350,28254,WNT pathway inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8267,28254,WNT pathway inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8086,28254,WNT pathway inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7800,28255,tankyrase inhibitor|WNT signaling inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11431,28255,tankyrase inhibitor|WNT signaling inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4449,28256,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14681,28257,monoacylglucerol lipase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25885,28258,FAAH inhibitor|monoacylglycerol lipase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14681,28258,FAAH inhibitor|monoacylglycerol lipase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5261,28259,K-Ras inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10693,28260,ATPase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
15188,28261,kinesin-like spindle protein inhibitor,MoA,Preclinical,Gene,Chemical_Compound
2742,28262,bone resorption inhibitor|estrogen-related receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
28263,28262,bone resorption inhibitor|estrogen-related receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
25795,28262,bone resorption inhibitor|estrogen-related receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
7292,28262,bone resorption inhibitor|estrogen-related receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
3148,28262,bone resorption inhibitor|estrogen-related receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
6843,28262,bone resorption inhibitor|estrogen-related receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
3557,28262,bone resorption inhibitor|estrogen-related receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
28264,28262,bone resorption inhibitor|estrogen-related receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
25992,28265,kainate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
8327,28265,kainate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
11784,28265,kainate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
28266,28265,kainate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
28267,28265,kainate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
28268,28265,kainate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
15946,28269,topoisomerase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
5849,28270,chondrocyte differentiation stimulator,MoA,Preclinical,Gene,Chemical_Compound
12796,28271,sodium/calcium exchange inhibitor,MoA,Preclinical,Gene,Chemical_Compound
28272,28271,sodium/calcium exchange inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26792,28271,sodium/calcium exchange inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7510,28271,sodium/calcium exchange inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15786,28273,SRC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15883,28274,neprilysin inhibitor,MoA,Phase 2,Gene,Chemical_Compound
12616,28275,ACAT inhibitor,MoA,Phase 2,Gene,Chemical_Compound
9763,28275,ACAT inhibitor,MoA,Phase 2,Gene,Chemical_Compound
9902,28276,rho associated kinase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
8870,28277,CDK inhibitor|glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15298,28277,CDK inhibitor|glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6044,28277,CDK inhibitor|glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8086,28277,CDK inhibitor|glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25671,28284,P selectin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9018,28285,RAF inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25632,28285,RAF inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25633,28285,RAF inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12302,28285,RAF inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3181,28286,CDC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8529,28286,CDC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8328,28286,CDC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
28287,28288,hexokinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3213,28289,neural stem cell inducer,MoA,Preclinical,Gene,Chemical_Compound
6078,28290,lysophosphatidic acid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
28053,28290,lysophosphatidic acid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
5185,28291,c-Fms inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25712,28291,c-Fms inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25633,28291,c-Fms inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12302,28291,c-Fms inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25712,28292,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3823,28293,mannosidase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
9932,28293,mannosidase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25935,28294,lipoprotein antagonist,MoA,Preclinical,Gene,Chemical_Compound
6138,28295,proteasome inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10945,28295,proteasome inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14681,28296,monoacylglucerol lipase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11481,28297,calcium/calmodulin dependent protein kinase inhibitor|purinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
14776,28297,calcium/calmodulin dependent protein kinase inhibitor|purinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
7517,28297,calcium/calmodulin dependent protein kinase inhibitor|purinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26440,28297,calcium/calmodulin dependent protein kinase inhibitor|purinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
15365,28297,calcium/calmodulin dependent protein kinase inhibitor|purinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25908,28297,calcium/calmodulin dependent protein kinase inhibitor|purinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
15947,28297,calcium/calmodulin dependent protein kinase inhibitor|purinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
4449,28297,calcium/calmodulin dependent protein kinase inhibitor|purinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
9097,28297,calcium/calmodulin dependent protein kinase inhibitor|purinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25569,28297,calcium/calmodulin dependent protein kinase inhibitor|purinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
7247,28297,calcium/calmodulin dependent protein kinase inhibitor|purinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
13626,28297,calcium/calmodulin dependent protein kinase inhibitor|purinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
8554,28297,calcium/calmodulin dependent protein kinase inhibitor|purinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
4757,28297,calcium/calmodulin dependent protein kinase inhibitor|purinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
14776,28298,calcium/calmodulin dependent protein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25731,28299,BCRP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10012,28299,BCRP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6777,28300,exportin antagonist,MoA,Preclinical,Gene,Chemical_Compound
6777,28301,exportin antagonist,MoA,Preclinical,Gene,Chemical_Compound
11330,28302,ALK inihibitor,MoA,Preclinical,Gene,Chemical_Compound
26178,28303,VEGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26179,28303,VEGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25712,28303,VEGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27063,28304,BCRP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7640,28305,mTOR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12946,28306,ATM kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7453,28306,ATM kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12946,28307,ATM kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
28308,28309,ribosyl cyclase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10758,28310,Abl kinase inhibitor|Aurora kinase inhibitor|FLT3 inhibitor,MoA,Phase 1,Gene,Chemical_Compound
13343,28310,Abl kinase inhibitor|Aurora kinase inhibitor|FLT3 inhibitor,MoA,Phase 1,Gene,Chemical_Compound
8285,28310,Abl kinase inhibitor|Aurora kinase inhibitor|FLT3 inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25632,28310,Abl kinase inhibitor|Aurora kinase inhibitor|FLT3 inhibitor,MoA,Phase 1,Gene,Chemical_Compound
8041,28311,adenosine receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25726,28311,adenosine receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
9810,28311,adenosine receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25727,28311,adenosine receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
15786,28312,SRC inhibitor|tubulin polymerization inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26551,28313,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25652,28313,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
11142,28313,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
4203,28313,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
8468,28314,WNT pathway inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11792,28315,bone morphogenic protein inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6510,28316,sphingosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10880,28327,metallic radical formation stimulant,MoA,Launched,Gene,Chemical_Compound
28328,28327,metallic radical formation stimulant,MoA,Launched,Gene,Chemical_Compound
13125,28327,metallic radical formation stimulant,MoA,Launched,Gene,Chemical_Compound
28329,28327,metallic radical formation stimulant,MoA,Launched,Gene,Chemical_Compound
11401,28327,metallic radical formation stimulant,MoA,Launched,Gene,Chemical_Compound
28330,28327,metallic radical formation stimulant,MoA,Launched,Gene,Chemical_Compound
5008,28327,metallic radical formation stimulant,MoA,Launched,Gene,Chemical_Compound
28325,28327,metallic radical formation stimulant,MoA,Launched,Gene,Chemical_Compound
6083,28327,metallic radical formation stimulant,MoA,Launched,Gene,Chemical_Compound
12291,28327,metallic radical formation stimulant,MoA,Launched,Gene,Chemical_Compound
12475,28327,metallic radical formation stimulant,MoA,Launched,Gene,Chemical_Compound
5394,28327,metallic radical formation stimulant,MoA,Launched,Gene,Chemical_Compound
13075,28327,metallic radical formation stimulant,MoA,Launched,Gene,Chemical_Compound
14016,28327,metallic radical formation stimulant,MoA,Launched,Gene,Chemical_Compound
25652,28327,metallic radical formation stimulant,MoA,Launched,Gene,Chemical_Compound
11142,28327,metallic radical formation stimulant,MoA,Launched,Gene,Chemical_Compound
4203,28327,metallic radical formation stimulant,MoA,Launched,Gene,Chemical_Compound
14160,28327,metallic radical formation stimulant,MoA,Launched,Gene,Chemical_Compound
14968,28327,metallic radical formation stimulant,MoA,Launched,Gene,Chemical_Compound
26100,28327,metallic radical formation stimulant,MoA,Launched,Gene,Chemical_Compound
9924,28327,metallic radical formation stimulant,MoA,Launched,Gene,Chemical_Compound
26878,28327,metallic radical formation stimulant,MoA,Launched,Gene,Chemical_Compound
3815,28327,metallic radical formation stimulant,MoA,Launched,Gene,Chemical_Compound
10120,28327,metallic radical formation stimulant,MoA,Launched,Gene,Chemical_Compound
7790,28327,metallic radical formation stimulant,MoA,Launched,Gene,Chemical_Compound
26996,28341,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25655,28341,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
6054,28341,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
28342,28341,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
14014,28341,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
14374,28341,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
28345,28346,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
6861,28346,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
2925,28346,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
10326,28346,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
11401,28346,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
7521,28346,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
4898,28346,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
28347,28346,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
2589,28346,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
8536,28346,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
28348,28346,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
8684,28346,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
28349,28346,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
2782,28346,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
28350,28346,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
28351,28346,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
28352,28346,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
9646,28346,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
13611,28346,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
7658,28346,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
15155,28346,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
10125,28346,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
28353,28346,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
11430,28346,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
26950,28346,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
13753,28346,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
12570,28346,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
13075,28346,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
14016,28346,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
28319,28346,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
5063,28346,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
25992,28346,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
25990,28346,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
15548,28346,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
25994,28346,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
15187,28346,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
28354,28346,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
8327,28346,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
11784,28346,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
28266,28346,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
28267,28346,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
28268,28346,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
25652,28346,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
11142,28346,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
4203,28346,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
14160,28346,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
14968,28346,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
25653,28346,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
25654,28346,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
26996,28346,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
26425,28346,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
26861,28346,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
27230,28346,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
26862,28346,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
25980,28346,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
26863,28346,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
28355,28346,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
14532,28346,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
28356,28346,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
28357,28346,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
2954,28346,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
28358,28346,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
9072,28346,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
3815,28346,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
26872,28346,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
6594,28346,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
28359,28346,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
28360,28346,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
15919,28346,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
28361,28346,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
25693,28346,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
28362,28346,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
26223,28366,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
3528,28366,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
8505,28366,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
28367,28366,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
28322,28366,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
28323,28366,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
27307,28369,dopamine beta hydroxylase inhibitor|eukaryotic translation initiation factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9361,28369,dopamine beta hydroxylase inhibitor|eukaryotic translation initiation factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26441,28370,nitric oxide synthase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25942,28370,nitric oxide synthase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26138,28371,nitric oxide synthase inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
26441,28372,nitric oxide synthase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25942,28372,nitric oxide synthase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26138,28372,nitric oxide synthase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8684,28373,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
10639,28373,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
14975,28373,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
8094,28373,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
7185,28373,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
6651,28373,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
7415,28373,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
28374,28373,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
14905,28373,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
7916,28373,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
2649,28373,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
5611,28373,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
4036,28373,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
15632,28373,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
28375,28373,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
28376,28373,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
26961,28373,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
8687,28373,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
28377,28373,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
28378,28373,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
28379,28373,glutamate receptor agonist,MoA,Launched,Gene,Chemical_Compound
28349,28380,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25990,28380,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
8327,28380,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
11784,28380,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26996,28380,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26425,28380,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26861,28380,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25655,28380,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25980,28380,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26863,28380,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26757,28382,neuropeptide receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25862,28383,prostanoid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
12385,28384,PPAR receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
28385,28386,glucagon receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26367,28387,CCK receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
26369,28387,CCK receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
27138,28387,CCK receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25590,28388,oxytocin receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
26153,28388,oxytocin receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
26154,28388,oxytocin receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25598,28389,GABA receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
25640,28389,GABA receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
25641,28389,GABA receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
25642,28389,GABA receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
25648,28389,GABA receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
7153,28390,thromboxane receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25652,28391,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
11142,28391,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
4203,28391,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
14160,28391,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
14968,28391,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
7457,28392,inositol monophosphatase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25547,28393,sigma receptor agonist|sigma receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
14233,28393,sigma receptor agonist|sigma receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25551,28394,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25552,28394,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25553,28394,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25652,28395,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25652,28396,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
11142,28396,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
4203,28396,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
14160,28396,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
14968,28396,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
12473,28397,tachykinin antagonist,MoA,Preclinical,Gene,Chemical_Compound
25597,28397,tachykinin antagonist,MoA,Preclinical,Gene,Chemical_Compound
12473,28398,tachykinin antagonist,MoA,Preclinical,Gene,Chemical_Compound
25548,28399,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25549,28399,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25821,28399,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25823,28399,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25546,28400,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25547,28400,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25548,28400,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25549,28400,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25551,28400,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25554,28400,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25962,28400,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25963,28400,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25660,28401,adrenergic receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25804,28401,adrenergic receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25918,28401,adrenergic receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
12473,28402,tachykinin antagonist,MoA,Preclinical,Gene,Chemical_Compound
3325,28403,farnesyltransferase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
9265,28403,farnesyltransferase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
10206,28403,farnesyltransferase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7320,28404,prostanoid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25598,28405,GABA receptor partial agonist,MoA,Preclinical,Gene,Chemical_Compound
25640,28405,GABA receptor partial agonist,MoA,Preclinical,Gene,Chemical_Compound
25641,28405,GABA receptor partial agonist,MoA,Preclinical,Gene,Chemical_Compound
25642,28405,GABA receptor partial agonist,MoA,Preclinical,Gene,Chemical_Compound
28414,28415,immunosuppressant,MoA,Phase 3,Gene,Chemical_Compound
25966,28417,tropomyosin receptor kinase inhibitor,MoA,Launched,Gene,Chemical_Compound
6074,28417,tropomyosin receptor kinase inhibitor,MoA,Launched,Gene,Chemical_Compound
27463,28417,tropomyosin receptor kinase inhibitor,MoA,Launched,Gene,Chemical_Compound
13040,28420,glutamate receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25962,28420,glutamate receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
28421,28422,actin polymerization inhibitor,MoA,Phase 1,Gene,Chemical_Compound
28423,28422,actin polymerization inhibitor,MoA,Phase 1,Gene,Chemical_Compound
3535,28422,actin polymerization inhibitor,MoA,Phase 1,Gene,Chemical_Compound
28424,28425,bacterial permeability inducer,MoA,Phase 3,Gene,Chemical_Compound
28426,28425,bacterial permeability inducer,MoA,Phase 3,Gene,Chemical_Compound
26145,28425,bacterial permeability inducer,MoA,Phase 3,Gene,Chemical_Compound
11407,28425,bacterial permeability inducer,MoA,Phase 3,Gene,Chemical_Compound
27252,28425,bacterial permeability inducer,MoA,Phase 3,Gene,Chemical_Compound
14448,28425,bacterial permeability inducer,MoA,Phase 3,Gene,Chemical_Compound
7633,28427,monoamine oxidase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
4198,28428,XIAP inhibitor,MoA,Phase 2,Gene,Chemical_Compound
8344,28428,XIAP inhibitor,MoA,Phase 2,Gene,Chemical_Compound
6399,28429,diacylglycerol O acyltransferase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
4293,28430,protein tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26477,28430,protein tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9785,28430,protein tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26809,28431,haspin kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10758,28432,bone morphogenic protein inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12119,28432,bone morphogenic protein inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4774,28432,bone morphogenic protein inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15913,28433,tissue transglutaminase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12119,28434,bone morphogenic protein inhibitor,MoA,Preclinical,Gene,Chemical_Compound
2805,28434,bone morphogenic protein inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14201,28435,retinoid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25709,28437,orexin receptor antagonist,MoA,Launched,Gene,Chemical_Compound
25711,28437,orexin receptor antagonist,MoA,Launched,Gene,Chemical_Compound
25596,28441,serotonin receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25632,28444,FLT3 inhibitor|growth factor receptor inhibitor|JAK inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25966,28444,FLT3 inhibitor|growth factor receptor inhibitor|JAK inhibitor,MoA,Phase 3,Gene,Chemical_Compound
14648,28446,nitric oxide production inhibitor|tau aggregation inhibitor,MoA,Phase 3,Gene,Chemical_Compound
12456,28450,acetylcholine receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
27137,28451,potassium channel activator,MoA,Phase 3,Gene,Chemical_Compound
25592,28454,acetylcholine receptor antagonist,MoA,Launched,Gene,Chemical_Compound
13040,28468,histamine receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25636,28474,Bruton's tyrosine kinase (BTK) inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4919,28475,porcupine inhibitor,MoA,Phase 2,Gene,Chemical_Compound
10658,28476,casein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25940,28477,cytochrome P450 inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
28478,28477,cytochrome P450 inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
25662,28479,voltage-gated sodium channel blocker,MoA,Phase 3,Gene,Chemical_Compound
4909,28480,topoisomerase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25795,28481,cyclooxygenase inhibitor|lipoxygenase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25949,28481,cyclooxygenase inhibitor|lipoxygenase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25665,28481,cyclooxygenase inhibitor|lipoxygenase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25998,28484,tumor necrosis factor production inhibitor,MoA,Preclinical,Gene,Chemical_Compound
2722,28486,LIM kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12844,28492,PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
5185,28492,PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26178,28492,PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25632,28492,PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26179,28492,PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25712,28492,PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25633,28492,PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
12302,28492,PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
4171,28492,PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
15295,28492,PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
4155,28493,oxidative stress inducer,MoA,Phase 3,Gene,Chemical_Compound
25849,28493,oxidative stress inducer,MoA,Phase 3,Gene,Chemical_Compound
25785,28493,oxidative stress inducer,MoA,Phase 3,Gene,Chemical_Compound
28426,28493,oxidative stress inducer,MoA,Phase 3,Gene,Chemical_Compound
12087,28493,oxidative stress inducer,MoA,Phase 3,Gene,Chemical_Compound
10141,28493,oxidative stress inducer,MoA,Phase 3,Gene,Chemical_Compound
26017,28493,oxidative stress inducer,MoA,Phase 3,Gene,Chemical_Compound
25965,28494,potassium channel blocker,MoA,Phase 3,Gene,Chemical_Compound
2757,28494,potassium channel blocker,MoA,Phase 3,Gene,Chemical_Compound
26374,28494,potassium channel blocker,MoA,Phase 3,Gene,Chemical_Compound
5524,28494,potassium channel blocker,MoA,Phase 3,Gene,Chemical_Compound
11627,28495,IGF-1 inhibitor,MoA,Phase 3,Gene,Chemical_Compound
6218,28495,IGF-1 inhibitor,MoA,Phase 3,Gene,Chemical_Compound
28496,28495,IGF-1 inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26396,28503,FXR antagonist|vitamin D receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26768,28503,FXR antagonist|vitamin D receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26919,28503,FXR antagonist|vitamin D receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
6126,28503,FXR antagonist|vitamin D receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
15188,28504,kinesin-like spindle protein inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26153,28505,vasopressin receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
6074,28506,tropomyosin receptor kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15753,28507,survival motor neuron protein modulator,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
11348,28508,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11002,28508,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
28509,28510,neurotrophic agent,MoA,Phase 1,Gene,Chemical_Compound
4522,28513,O6-alkylguanine-DNA alkyltransferase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11542,28515,glycinamide ribonucleotide formyltransferase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
3325,28517,farnesyltransferase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
7848,28517,farnesyltransferase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
5261,28517,farnesyltransferase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
14746,28517,farnesyltransferase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
27818,28518,glucokinase inhibitor,MoA,Launched,Gene,Chemical_Compound
25645,28522,benzodiazepine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
15774,28522,benzodiazepine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25598,28523,GABA receptor modulator,MoA,Phase 2,Gene,Chemical_Compound
26367,28524,CCK receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
26369,28524,CCK receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
4449,28528,p38 MAPK inhibitor,MoA,Phase 3,Gene,Chemical_Compound
2744,28532,cysteine peptidase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
28534,28535,lysophosphatidic acid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
4204,28536,leucine rich repeat kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25655,28537,glutamate receptor positive allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
28538,28539,leukocyte activator,MoA,Phase 2,Gene,Chemical_Compound
28086,28539,leukocyte activator,MoA,Phase 2,Gene,Chemical_Compound
25726,28540,adenosine receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
7896,28542,endonuclease inhibitor,MoA,Phase 2,Gene,Chemical_Compound
15946,28542,endonuclease inhibitor,MoA,Phase 2,Gene,Chemical_Compound
12989,28542,endonuclease inhibitor,MoA,Phase 2,Gene,Chemical_Compound
5212,28543,FGFR inhibitor|VEGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26178,28543,FGFR inhibitor|VEGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25712,28543,FGFR inhibitor|VEGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25633,28543,FGFR inhibitor|VEGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7392,28543,FGFR inhibitor|VEGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
12302,28543,FGFR inhibitor|VEGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
4171,28543,FGFR inhibitor|VEGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25726,28544,adenosine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
9810,28544,adenosine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25547,28546,dopamine receptor modulator|serotonin receptor antagonist,MoA,Launched,Gene,Chemical_Compound
25554,28546,dopamine receptor modulator|serotonin receptor antagonist,MoA,Launched,Gene,Chemical_Compound
7829,28548,cyclooxygenase inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25665,28548,cyclooxygenase inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
28093,28549,sodium channel blocker,MoA,Phase 1,Gene,Chemical_Compound
15946,28551,glucosidase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25783,28552,melatonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25784,28552,melatonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
7292,28553,LXR agonist,MoA,Phase 1,Gene,Chemical_Compound
9476,28553,LXR agonist,MoA,Phase 1,Gene,Chemical_Compound
11708,28553,LXR agonist,MoA,Phase 1,Gene,Chemical_Compound
26919,28553,LXR agonist,MoA,Phase 1,Gene,Chemical_Compound
14109,28553,LXR agonist,MoA,Phase 1,Gene,Chemical_Compound
27610,28554,tryptophan hydroxylase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7284,28555,LIM kinase inhibitor|rho associated kinase inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
13626,28555,LIM kinase inhibitor|rho associated kinase inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
9902,28555,LIM kinase inhibitor|rho associated kinase inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
25876,28556,cannabinoid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
8086,28558,glycogen synthase kinase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
2774,28559,TGF beta receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
28204,28559,TGF beta receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26861,28560,glutamate receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25992,28561,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25990,28561,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
15548,28561,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25994,28561,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
8327,28561,glutamate receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
2774,28562,TGF beta receptor inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
25885,28563,FAAH inhibitor|FAAH reuptake inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4449,28564,p38 MAPK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
28538,28565,leukotriene receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
26369,28566,CCK receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
11061,28567,glycine transporter inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7292,28568,androgen receptor modulator,MoA,Phase 2,Gene,Chemical_Compound
28538,28569,leukotriene receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
28086,28569,leukotriene receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
8554,28570,ribosomal protein inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7517,28571,CHK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7517,28572,CHK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
27818,28573,glucokinase activator,MoA,Phase 2,Gene,Chemical_Compound
7079,28574,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
11600,28575,JAK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
5775,28575,JAK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
10745,28576,MET inhibitor,MoA,Phase 2,Gene,Chemical_Compound
6908,28577,beta-secretase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
11699,28578,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5212,28579,FGFR antagonist,MoA,Phase 1,Gene,Chemical_Compound
25759,28579,FGFR antagonist,MoA,Phase 1,Gene,Chemical_Compound
25760,28579,FGFR antagonist,MoA,Phase 1,Gene,Chemical_Compound
26228,28579,FGFR antagonist,MoA,Phase 1,Gene,Chemical_Compound
25712,28579,FGFR antagonist,MoA,Phase 1,Gene,Chemical_Compound
26369,28580,CCK receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
6908,28581,beta-secretase inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
11481,28582,DNA dependent protein kinase inhibitor|mTOR inhibitor|phosphodiesterase inhibitor|PI3K inhibitor|PLK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7517,28582,DNA dependent protein kinase inhibitor|mTOR inhibitor|phosphodiesterase inhibitor|PI3K inhibitor|PLK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8086,28582,DNA dependent protein kinase inhibitor|mTOR inhibitor|phosphodiesterase inhibitor|PI3K inhibitor|PLK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26440,28582,DNA dependent protein kinase inhibitor|mTOR inhibitor|phosphodiesterase inhibitor|PI3K inhibitor|PLK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15365,28582,DNA dependent protein kinase inhibitor|mTOR inhibitor|phosphodiesterase inhibitor|PI3K inhibitor|PLK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25908,28582,DNA dependent protein kinase inhibitor|mTOR inhibitor|phosphodiesterase inhibitor|PI3K inhibitor|PLK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15947,28582,DNA dependent protein kinase inhibitor|mTOR inhibitor|phosphodiesterase inhibitor|PI3K inhibitor|PLK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4449,28582,DNA dependent protein kinase inhibitor|mTOR inhibitor|phosphodiesterase inhibitor|PI3K inhibitor|PLK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9097,28582,DNA dependent protein kinase inhibitor|mTOR inhibitor|phosphodiesterase inhibitor|PI3K inhibitor|PLK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7640,28582,DNA dependent protein kinase inhibitor|mTOR inhibitor|phosphodiesterase inhibitor|PI3K inhibitor|PLK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9637,28582,DNA dependent protein kinase inhibitor|mTOR inhibitor|phosphodiesterase inhibitor|PI3K inhibitor|PLK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6809,28582,DNA dependent protein kinase inhibitor|mTOR inhibitor|phosphodiesterase inhibitor|PI3K inhibitor|PLK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12097,28582,DNA dependent protein kinase inhibitor|mTOR inhibitor|phosphodiesterase inhibitor|PI3K inhibitor|PLK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25846,28582,DNA dependent protein kinase inhibitor|mTOR inhibitor|phosphodiesterase inhibitor|PI3K inhibitor|PLK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
2676,28582,DNA dependent protein kinase inhibitor|mTOR inhibitor|phosphodiesterase inhibitor|PI3K inhibitor|PLK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14636,28582,DNA dependent protein kinase inhibitor|mTOR inhibitor|phosphodiesterase inhibitor|PI3K inhibitor|PLK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7247,28582,DNA dependent protein kinase inhibitor|mTOR inhibitor|phosphodiesterase inhibitor|PI3K inhibitor|PLK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7453,28582,DNA dependent protein kinase inhibitor|mTOR inhibitor|phosphodiesterase inhibitor|PI3K inhibitor|PLK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13626,28582,DNA dependent protein kinase inhibitor|mTOR inhibitor|phosphodiesterase inhibitor|PI3K inhibitor|PLK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8554,28582,DNA dependent protein kinase inhibitor|mTOR inhibitor|phosphodiesterase inhibitor|PI3K inhibitor|PLK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4757,28582,DNA dependent protein kinase inhibitor|mTOR inhibitor|phosphodiesterase inhibitor|PI3K inhibitor|PLK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26425,28583,glutamate receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
5876,28584,cathepsin inhibitor,MoA,Phase 1,Gene,Chemical_Compound
9018,28585,RAF inhibitor,MoA,Phase 1,Gene,Chemical_Compound
5450,28585,RAF inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7640,28586,mTOR inhibitor|PI3K inhibitor,MoA,Phase 2,Gene,Chemical_Compound
5999,28587,casein kinase inhibitor|mTOR inhibitor|PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14000,28587,casein kinase inhibitor|mTOR inhibitor|PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15528,28587,casein kinase inhibitor|mTOR inhibitor|PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25553,28588,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25876,28589,cannabinoid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25551,28590,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25552,28590,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25553,28590,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25853,28590,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25854,28590,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25554,28590,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
7079,28590,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25555,28590,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25963,28590,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
2774,28591,p38 MAPK inhibitor|TGF beta receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25552,28592,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25553,28592,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25554,28592,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
7079,28592,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25992,28593,glutamate receptor positive allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
25990,28593,glutamate receptor positive allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
15548,28593,glutamate receptor positive allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
25994,28593,glutamate receptor positive allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
26996,28594,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25596,28595,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26192,28595,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
27138,28596,ATP-sensitive potassium channel antagonist,MoA,Phase 2,Gene,Chemical_Compound
26183,28597,smoothened receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
27034,28597,smoothened receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
10922,28597,smoothened receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
28598,28599,phospholipase activator,MoA,Preclinical,Gene,Chemical_Compound
14239,28599,phospholipase activator,MoA,Preclinical,Gene,Chemical_Compound
11575,28599,phospholipase activator,MoA,Preclinical,Gene,Chemical_Compound
6524,28599,phospholipase activator,MoA,Preclinical,Gene,Chemical_Compound
4602,28599,phospholipase activator,MoA,Preclinical,Gene,Chemical_Compound
11646,28600,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25598,28604,PPAR receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
10141,28604,PPAR receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25719,28610,cytomegalovirus inhibitor|protein kinase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26058,28611,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
28612,28611,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
28613,28611,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25684,28611,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26059,28611,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
3464,28611,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
28614,28611,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
6064,28611,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
15396,28611,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
3439,28611,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
3521,28611,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
28615,28611,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
13508,28611,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
28616,28611,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
6244,28611,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
27615,28611,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
28617,28611,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
28618,28611,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
13470,28611,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
11446,28611,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
28619,28611,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26305,28611,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25602,28611,matrix metalloprotease inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25872,28623,opioid receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25655,28624,glutamate receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
26045,28626,glucose dependent insulinotropic receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
28631,28632,NOD like receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26294,28633,nociceptin/orphanin FQ receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25551,28634,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25553,28634,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25853,28634,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25554,28634,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
7079,28634,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25555,28634,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25962,28634,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
9941,28635,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
28636,28637,NFkB pathway inhibitor,MoA,Phase 1,Gene,Chemical_Compound
10933,28638,dynamin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25554,28639,serotonin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
7079,28639,serotonin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25555,28639,serotonin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25729,28640,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25551,28641,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25551,28642,serotonin receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
5938,28643,PPAR receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
28647,28648,neurotensin receptor antagonist,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
28458,28648,neurotensin receptor antagonist,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
25849,28652,ATP citrase lyase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26456,28658,potassium channel blocker,MoA,Phase 2,Gene,Chemical_Compound
6599,28659,HMGCR inhibitor,MoA,Launched,Gene,Chemical_Compound
8551,28660,STAT inhibitor,MoA,Phase 3,Gene,Chemical_Compound
15643,28661,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7902,28670,hypoxia inducible factor inhibitor,MoA,Phase 1,Gene,Chemical_Compound
15155,28677,vitamin K,MoA,Phase 2,Gene,Chemical_Compound
3520,28677,vitamin K,MoA,Phase 2,Gene,Chemical_Compound
2720,28677,vitamin K,MoA,Phase 2,Gene,Chemical_Compound
10485,28679,MALT1 inhibitor (JH),MoA,Phase 2,Gene,Chemical_Compound
12989,28686,topoisomerase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
9570,28688,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9941,28688,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13152,28689,inosine monophosphate dehydrogenase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25554,28694,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
7079,28694,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25555,28694,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25596,28694,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
26192,28694,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25962,28694,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25963,28694,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
7829,28696,cyclooxygenase inhibitor|opioid receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
10758,28699,Bcr-Abl kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
5820,28699,Bcr-Abl kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25573,28700,adrenergic receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25751,28701,immunostimulant,MoA,Phase 2,Gene,Chemical_Compound
6859,28705,acetylcholinesterase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
13040,28707,histamine receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
7591,28712,angiotensin converting enzyme inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7896,28718,DNA repair enzyme inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25592,28726,acetylcholine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25571,28730,acetylcholine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25551,28737,anti-HCVE2,MoA,Preclinical,Gene,Chemical_Compound
25552,28737,anti-HCVE2,MoA,Preclinical,Gene,Chemical_Compound
25553,28737,anti-HCVE2,MoA,Preclinical,Gene,Chemical_Compound
25853,28737,anti-HCVE2,MoA,Preclinical,Gene,Chemical_Compound
25854,28737,anti-HCVE2,MoA,Preclinical,Gene,Chemical_Compound
25554,28737,anti-HCVE2,MoA,Preclinical,Gene,Chemical_Compound
7079,28737,anti-HCVE2,MoA,Preclinical,Gene,Chemical_Compound
25555,28737,anti-HCVE2,MoA,Preclinical,Gene,Chemical_Compound
25556,28737,anti-HCVE2,MoA,Preclinical,Gene,Chemical_Compound
25962,28737,anti-HCVE2,MoA,Preclinical,Gene,Chemical_Compound
25963,28737,anti-HCVE2,MoA,Preclinical,Gene,Chemical_Compound
7829,28743,cyclooxygenase inhibitor,MoA,Launched,Gene,Chemical_Compound
25665,28743,cyclooxygenase inhibitor,MoA,Launched,Gene,Chemical_Compound
6859,28744,acetylcholinesterase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
6599,28747,HMGCR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5938,28749,PARP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25940,28750,estrogen receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25832,28750,estrogen receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
8970,28751,proteasome inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25571,28752,acetylcholine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
4293,28753,VEGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10745,28753,VEGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12460,28754,PI4K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25992,28756,glutamate receptor modulator,MoA,Phase 2,Gene,Chemical_Compound
27380,28757,T-type calcium channel blocker,MoA,Withdrawn,Gene,Chemical_Compound
15539,28757,T-type calcium channel blocker,MoA,Withdrawn,Gene,Chemical_Compound
25971,28757,T-type calcium channel blocker,MoA,Withdrawn,Gene,Chemical_Compound
25972,28757,T-type calcium channel blocker,MoA,Withdrawn,Gene,Chemical_Compound
25617,28757,T-type calcium channel blocker,MoA,Withdrawn,Gene,Chemical_Compound
25619,28757,T-type calcium channel blocker,MoA,Withdrawn,Gene,Chemical_Compound
25620,28757,T-type calcium channel blocker,MoA,Withdrawn,Gene,Chemical_Compound
25973,28757,T-type calcium channel blocker,MoA,Withdrawn,Gene,Chemical_Compound
12340,28757,T-type calcium channel blocker,MoA,Withdrawn,Gene,Chemical_Compound
12318,28757,T-type calcium channel blocker,MoA,Withdrawn,Gene,Chemical_Compound
16027,28757,T-type calcium channel blocker,MoA,Withdrawn,Gene,Chemical_Compound
8733,28757,T-type calcium channel blocker,MoA,Withdrawn,Gene,Chemical_Compound
25858,28757,T-type calcium channel blocker,MoA,Withdrawn,Gene,Chemical_Compound
3489,28757,T-type calcium channel blocker,MoA,Withdrawn,Gene,Chemical_Compound
25860,28757,T-type calcium channel blocker,MoA,Withdrawn,Gene,Chemical_Compound
25861,28757,T-type calcium channel blocker,MoA,Withdrawn,Gene,Chemical_Compound
11142,28759,glutamate receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
4203,28759,glutamate receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
14160,28759,glutamate receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
14968,28759,glutamate receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
10141,28762,PPAR receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
7633,28765,monoamine oxidase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
4266,28769,DNA replication inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6708,28769,DNA replication inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26224,28769,DNA replication inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26082,28769,DNA replication inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6859,28770,serotonin reuptake inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25592,28770,serotonin reuptake inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25546,28770,serotonin reuptake inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25547,28770,serotonin reuptake inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25554,28770,serotonin reuptake inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
7079,28770,serotonin reuptake inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25555,28770,serotonin reuptake inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
7020,28770,serotonin reuptake inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25800,28770,serotonin reuptake inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
28774,28775,MRE11A exonuclease inhibitor,MoA,Preclinical,Gene,Chemical_Compound
28780,28781,antitumor agent,MoA,Phase 2,Gene,Chemical_Compound
25876,28787,cannabinoid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
15875,28788,niacin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25697,28788,niacin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
7292,28789,androgen receptor modulator,MoA,Phase 2,Gene,Chemical_Compound
26456,28790,CC chemokine receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
28385,28791,glucagon receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
5030,28792,WEE1 kinase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11481,28793,AKT inhibitor,MoA,Phase 2,Gene,Chemical_Compound
3613,28793,AKT inhibitor,MoA,Phase 2,Gene,Chemical_Compound
12367,28793,AKT inhibitor,MoA,Phase 2,Gene,Chemical_Compound
6190,28794,TRPV antagonist,MoA,Phase 2,Gene,Chemical_Compound
5212,28795,FGFR inhibitor|VEGFR inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
25759,28795,FGFR inhibitor|VEGFR inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
25760,28795,FGFR inhibitor|VEGFR inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
26178,28795,FGFR inhibitor|VEGFR inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
25632,28795,FGFR inhibitor|VEGFR inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
26179,28795,FGFR inhibitor|VEGFR inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
25712,28795,FGFR inhibitor|VEGFR inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
26477,28795,FGFR inhibitor|VEGFR inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
10745,28795,FGFR inhibitor|VEGFR inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
26478,28795,FGFR inhibitor|VEGFR inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
25966,28795,FGFR inhibitor|VEGFR inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
6074,28795,FGFR inhibitor|VEGFR inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
12302,28795,FGFR inhibitor|VEGFR inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
25862,28796,prostaglandin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26409,28797,calcitonin antagonist,MoA,Phase 2,Gene,Chemical_Compound
25711,28798,orexin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
28799,28800,bombesin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
27897,28800,bombesin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
28801,28800,bombesin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
13343,28802,Aurora kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
8285,28802,Aurora kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25916,28802,Aurora kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
14354,28803,leukotriene receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
26844,28803,leukotriene receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25709,28804,orexin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25711,28804,orexin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
10745,28805,c-Met inhibitor,MoA,Phase 1,Gene,Chemical_Compound
4180,28806,stearoyl-CoA desaturase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
13343,28807,Aurora kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6554,28808,MAP kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7640,28809,mTOR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
9637,28809,mTOR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
12097,28809,mTOR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25846,28809,mTOR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
9637,28810,PI3K inhibitor,MoA,Phase 2,Gene,Chemical_Compound
13343,28811,Aurora kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25596,28812,serotonin receptor partial agonist,MoA,Preclinical,Gene,Chemical_Compound
26192,28812,serotonin receptor partial agonist,MoA,Preclinical,Gene,Chemical_Compound
25855,28812,serotonin receptor partial agonist,MoA,Preclinical,Gene,Chemical_Compound
2512,28813,GTPase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4445,28814,CLK inhibitor|DYRK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13005,28814,CLK inhibitor|DYRK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
28815,28816,liver receptor homolog inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
25882,28817,G protein-coupled receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
9770,28818,transient receptor potential channel antagonist,MoA,Preclinical,Gene,Chemical_Compound
26792,28818,transient receptor potential channel antagonist,MoA,Preclinical,Gene,Chemical_Compound
26374,28819,potassium channel activator,MoA,Preclinical,Gene,Chemical_Compound
25617,28820,T-type calcium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
25619,28820,T-type calcium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
25620,28820,T-type calcium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
7902,28821,hypoxia inducible factor activator,MoA,Preclinical,Gene,Chemical_Compound
27138,28822,potassium channel activator,MoA,Preclinical,Gene,Chemical_Compound
3384,28823,serine/threonine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
28824,28825,inward rectifier potassium channel activator,MoA,Preclinical,Gene,Chemical_Compound
3540,28826,phospholipase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
28647,28827,neurotensin agonist,MoA,Preclinical,Gene,Chemical_Compound
13830,28828,ubiquitin specific protease inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8621,28829,histone lysine demethylase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25808,28830,MAP kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25908,28830,MAP kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15947,28830,MAP kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4449,28830,MAP kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12119,28831,ALK tyrosine kinase receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25733,28831,ALK tyrosine kinase receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
2805,28831,ALK tyrosine kinase receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14788,28832,lysophospholipase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8372,28833,potassium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
26016,28833,potassium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
9018,28834,RAF inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5450,28834,RAF inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7510,28835,myosin light chain kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6665,28836,retinoid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25551,28837,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
7800,28838,tankyrase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9570,28839,HDAC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26334,28839,HDAC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
9941,28839,HDAC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
5184,28839,HDAC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7020,28842,monoamine oxidase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7633,28842,monoamine oxidase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
13964,28844,hypoxia inducible factor inhibitor,MoA,Phase 3,Gene,Chemical_Compound
15188,28849,kinesin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25726,28853,cytochrome P450 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25625,28853,cytochrome P450 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4277,28853,cytochrome P450 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13264,28853,cytochrome P450 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
28442,28853,cytochrome P450 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6034,28854,other antibiotic,MoA,Launched,Gene,Chemical_Compound
26178,28856,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26179,28856,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25712,28856,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25633,28856,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
28123,28857,toll-like receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
26996,28861,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
27230,28861,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25655,28861,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
28862,28863,mitotic kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
28862,28864,monopolar spindle 1 kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
28862,28865,monopolar spindle 1 kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15890,28866,thromboxane synthase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25598,28867,GABA receptor inverse agonist,MoA,Phase 1,Gene,Chemical_Compound
25640,28867,GABA receptor inverse agonist,MoA,Phase 1,Gene,Chemical_Compound
25641,28867,GABA receptor inverse agonist,MoA,Phase 1,Gene,Chemical_Compound
25642,28867,GABA receptor inverse agonist,MoA,Phase 1,Gene,Chemical_Compound
7625,28868,gamma secretase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9810,28869,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25727,28869,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25727,28870,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
28871,28872,purinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
8041,28873,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25726,28873,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
9810,28873,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25727,28873,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25894,28874,CC chemokine receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
26425,28875,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26861,28875,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
12907,28876,protein tyrosine kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
13590,28876,protein tyrosine kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25598,28877,benzodiazepine receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25640,28877,benzodiazepine receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25641,28877,benzodiazepine receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25600,28877,benzodiazepine receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25642,28877,benzodiazepine receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25643,28877,benzodiazepine receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
27755,28877,benzodiazepine receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
27756,28877,benzodiazepine receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
27757,28877,benzodiazepine receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
11214,28878,phosphodiesterase inhibitor|platelet aggregation inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25846,28881,androgen receptor agonist|cytochrome P450 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26441,28882,PKC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7247,28882,PKC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26017,28883,transient receptor potential channel antagonist,MoA,Preclinical,Gene,Chemical_Compound
25961,28886,histamine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
4585,28887,ubiquitin ligase transport promoter,MoA,Preclinical,Gene,Chemical_Compound
15252,28889,free radical scavenger,MoA,Launched,Gene,Chemical_Compound
3984,28889,free radical scavenger,MoA,Launched,Gene,Chemical_Compound
4215,28889,free radical scavenger,MoA,Launched,Gene,Chemical_Compound
8154,28889,free radical scavenger,MoA,Launched,Gene,Chemical_Compound
3936,28889,free radical scavenger,MoA,Launched,Gene,Chemical_Compound
3311,28889,free radical scavenger,MoA,Launched,Gene,Chemical_Compound
15147,28889,free radical scavenger,MoA,Launched,Gene,Chemical_Compound
6599,28889,free radical scavenger,MoA,Launched,Gene,Chemical_Compound
3557,28889,free radical scavenger,MoA,Launched,Gene,Chemical_Compound
5503,28889,free radical scavenger,MoA,Launched,Gene,Chemical_Compound
11666,28889,free radical scavenger,MoA,Launched,Gene,Chemical_Compound
25658,28889,free radical scavenger,MoA,Launched,Gene,Chemical_Compound
25740,28889,free radical scavenger,MoA,Launched,Gene,Chemical_Compound
6943,28889,free radical scavenger,MoA,Launched,Gene,Chemical_Compound
26080,28889,free radical scavenger,MoA,Launched,Gene,Chemical_Compound
25547,28892,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25548,28892,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25551,28892,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25872,28901,opioid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25873,28901,opioid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25751,28903,opioid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25872,28903,opioid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25873,28903,opioid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25751,28904,opioid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25872,28904,opioid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25873,28904,opioid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25573,28905,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
13991,28905,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25575,28905,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25551,28905,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25854,28905,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
8551,28906,STAT inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25940,28910,aromatase inhibitor|TRPV antagonist,MoA,Phase 1,Gene,Chemical_Compound
3148,28910,aromatase inhibitor|TRPV antagonist,MoA,Phase 1,Gene,Chemical_Compound
25625,28910,aromatase inhibitor|TRPV antagonist,MoA,Phase 1,Gene,Chemical_Compound
6843,28910,aromatase inhibitor|TRPV antagonist,MoA,Phase 1,Gene,Chemical_Compound
3557,28910,aromatase inhibitor|TRPV antagonist,MoA,Phase 1,Gene,Chemical_Compound
28912,28913,cytochrome P450 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25552,28914,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26369,28915,CCK receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25826,28917,voltage-gated sodium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
28145,28918,CC chemokine receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
26229,28918,CC chemokine receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
5075,28919,BCL inhibitor,MoA,Phase 2,Gene,Chemical_Compound
16033,28919,BCL inhibitor,MoA,Phase 2,Gene,Chemical_Compound
13520,28919,BCL inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26034,28920,corticotropin releasing factor receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25905,28921,CC chemokine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25992,28922,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25990,28922,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
15548,28922,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25994,28922,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
8327,28922,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25652,28922,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
11142,28922,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
4203,28922,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
13139,28923,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25560,28923,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
13784,28923,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
7612,28924,complement antagonist,MoA,Preclinical,Gene,Chemical_Compound
14233,28925,sigma receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25592,28927,acetylcholine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
8041,28928,adenosine receptor agonist,MoA,Launched,Gene,Chemical_Compound
25726,28928,adenosine receptor agonist,MoA,Launched,Gene,Chemical_Compound
9810,28928,adenosine receptor agonist,MoA,Launched,Gene,Chemical_Compound
25727,28928,adenosine receptor agonist,MoA,Launched,Gene,Chemical_Compound
5513,28929,RIPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4774,28930,necroptosis inhibitor|RIPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25573,28933,adrenergic inhibitor|norepinephrine reuptake inhibitor|serotonin receptor antagonist|serotonin reuptake inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
13991,28933,adrenergic inhibitor|norepinephrine reuptake inhibitor|serotonin receptor antagonist|serotonin reuptake inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25541,28933,adrenergic inhibitor|norepinephrine reuptake inhibitor|serotonin receptor antagonist|serotonin reuptake inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25808,28933,adrenergic inhibitor|norepinephrine reuptake inhibitor|serotonin receptor antagonist|serotonin reuptake inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25551,28933,adrenergic inhibitor|norepinephrine reuptake inhibitor|serotonin receptor antagonist|serotonin reuptake inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25554,28933,adrenergic inhibitor|norepinephrine reuptake inhibitor|serotonin receptor antagonist|serotonin reuptake inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25555,28933,adrenergic inhibitor|norepinephrine reuptake inhibitor|serotonin receptor antagonist|serotonin reuptake inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25921,28933,adrenergic inhibitor|norepinephrine reuptake inhibitor|serotonin receptor antagonist|serotonin reuptake inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25958,28933,adrenergic inhibitor|norepinephrine reuptake inhibitor|serotonin receptor antagonist|serotonin reuptake inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25800,28933,adrenergic inhibitor|norepinephrine reuptake inhibitor|serotonin receptor antagonist|serotonin reuptake inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25592,28934,acetylcholine receptor agonist|benzodiazepine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
15946,28938,topoisomerase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
12989,28938,topoisomerase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
27307,28942,dopamine beta hydroxylase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
28946,28947,neural stem cell inducer,MoA,Preclinical,Gene,Chemical_Compound
9873,28947,neural stem cell inducer,MoA,Preclinical,Gene,Chemical_Compound
9570,28949,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15499,28949,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3844,28950,NFkB pathway inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26441,28951,nitric oxide synthase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25942,28951,nitric oxide synthase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
26138,28951,nitric oxide synthase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25548,28952,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25549,28953,dopamine receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
26034,28954,corticotropin releasing factor receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
9139,28955,lactate dehydrogenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14470,28956,bromodomain inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12654,28956,bromodomain inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11225,28956,bromodomain inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7628,28958,monoamine oxidase inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
7020,28958,monoamine oxidase inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
7633,28958,monoamine oxidase inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25876,28966,cannabinoid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25660,28968,adrenergic receptor antagonist,MoA,Launched,Gene,Chemical_Compound
25804,28968,adrenergic receptor antagonist,MoA,Launched,Gene,Chemical_Compound
25573,28973,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25921,28982,norepinephrine reuptake inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25958,28982,norepinephrine reuptake inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25800,28982,norepinephrine reuptake inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7628,28983,catechol O methyltransferase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25592,28985,cholinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
11871,28988,nuclear factor erythroid derived|like (NRF2) activator,MoA,Preclinical,Gene,Chemical_Compound
12009,28989,adenylyl cyclase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27469,28990,"indoleamine 2,3-dioxygenase inhibitor",MoA,Phase 1,Gene,Chemical_Compound
25652,28991,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
11142,28991,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
4203,28991,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
14160,28991,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
14968,28991,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25632,28992,PLK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
14636,28992,PLK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26406,28992,PLK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
15336,28992,PLK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11104,28993,ATPase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4689,28994,glucosidase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27947,28995,GABA uptake inhibitor|GAT inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25858,28996,T-type calcium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
3489,28996,T-type calcium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
25860,28996,T-type calcium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
25861,28996,T-type calcium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
26294,28997,opioid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
14233,28998,GABA uptake inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26816,28998,GABA uptake inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25665,28999,cyclooxygenase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
14717,29000,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27846,29001,tubulin polymerization inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14652,29002,thymidylate synthase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25547,29004,dopamine reuptake inhibitor|noradrenaline uptake inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25921,29004,dopamine reuptake inhibitor|noradrenaline uptake inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25958,29004,dopamine reuptake inhibitor|noradrenaline uptake inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25751,29006,opioid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25872,29006,opioid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25873,29006,opioid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
7079,29013,selective serotonin reuptake inhibitor (SSRI),MoA,Phase 1,Gene,Chemical_Compound
10141,29019,ICAM1 antagonist,MoA,Phase 2,Gene,Chemical_Compound
27380,29020,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
10885,29020,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
12435,29020,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
10608,29020,chloride channel blocker,MoA,Preclinical,Gene,Chemical_Compound
26611,29021,calcium receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26757,29022,neuropeptide receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
12018,29023,caspase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3105,29024,JAK inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
11600,29024,JAK inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
5775,29024,JAK inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
10662,29024,JAK inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
14707,29025,calcium-activated potassium channel activator,MoA,Preclinical,Gene,Chemical_Compound
25955,29026,voltage-gated potassium channel activator,MoA,Preclinical,Gene,Chemical_Compound
27134,29026,voltage-gated potassium channel activator,MoA,Preclinical,Gene,Chemical_Compound
14707,29026,voltage-gated potassium channel activator,MoA,Preclinical,Gene,Chemical_Compound
14707,29027,calcium-activated potassium channel activator,MoA,Preclinical,Gene,Chemical_Compound
26417,29028,calcium-activated potassium channel activator,MoA,Preclinical,Gene,Chemical_Compound
27175,29028,calcium-activated potassium channel activator,MoA,Preclinical,Gene,Chemical_Compound
27177,29028,calcium-activated potassium channel activator,MoA,Preclinical,Gene,Chemical_Compound
13006,29028,calcium-activated potassium channel activator,MoA,Preclinical,Gene,Chemical_Compound
25955,29029,voltage-gated potassium channel activator,MoA,Preclinical,Gene,Chemical_Compound
25582,29030,acetylcholine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
27084,29030,acetylcholine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
10082,29031,voltage-gated potassium channel activator,MoA,Preclinical,Gene,Chemical_Compound
14707,29032,potassium channel agonist,MoA,Phase 2,Gene,Chemical_Compound
26417,29033,calcium-activated potassium channel modulator,MoA,Preclinical,Gene,Chemical_Compound
27175,29033,calcium-activated potassium channel modulator,MoA,Preclinical,Gene,Chemical_Compound
27177,29033,calcium-activated potassium channel modulator,MoA,Preclinical,Gene,Chemical_Compound
25584,29034,acetylcholine receptor allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
9570,29035,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26058,29036,matrix metalloprotease inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25719,29037,ACAT inhibitor|sterol regulatory element binding protein (SREBP) inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25591,29038,CC chemokine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
8227,29039,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5659,29039,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8812,29040,ubiquitin specific protease inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13830,29040,ubiquitin specific protease inhibitor,MoA,Preclinical,Gene,Chemical_Compound
29041,29040,ubiquitin specific protease inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15642,29040,ubiquitin specific protease inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8621,29042,histone demethylase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4628,29042,histone demethylase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
29043,29044,CDC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3033,29044,CDC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
29045,29044,CDC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15410,29046,ubiquitin-conjugating enzyme inhibitor,MoA,Preclinical,Gene,Chemical_Compound
29043,29047,CDC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3033,29047,CDC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25584,29048,acetylcholine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25866,29048,acetylcholine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26757,29049,neuropeptide receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
28458,29050,neurotensin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
10141,29051,PPAR receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
11627,29052,IGF-1 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13754,29053,PARP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9645,29054,cyclin D inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8227,29054,cyclin D inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9645,29055,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8227,29055,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7453,29056,DNA dependent protein kinase inhibitor|mTOR inhibitor|PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7453,29057,DNA dependent protein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9986,29058,MDM inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8546,29058,MDM inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11627,29059,insulin growth factor receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11627,29060,IGF-1 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6218,29060,IGF-1 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4229,29061,HSP inhibitor,MoA,Phase 2,Gene,Chemical_Compound
4111,29061,HSP inhibitor,MoA,Phase 2,Gene,Chemical_Compound
15816,29062,mTOR inhibitor|PI3K inhibitor,MoA,Phase 3,Gene,Chemical_Compound
7640,29062,mTOR inhibitor|PI3K inhibitor,MoA,Phase 3,Gene,Chemical_Compound
9637,29062,mTOR inhibitor|PI3K inhibitor,MoA,Phase 3,Gene,Chemical_Compound
12097,29062,mTOR inhibitor|PI3K inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25846,29062,mTOR inhibitor|PI3K inhibitor,MoA,Phase 3,Gene,Chemical_Compound
5212,29063,FGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25759,29063,FGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25760,29063,FGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26228,29063,FGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25712,29063,FGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
6383,29064,ephrin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11600,29065,JAK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10745,29066,MET inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7351,29067,dipeptidyl peptidase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
4229,29068,HSP inhibitor,MoA,Phase 1,Gene,Chemical_Compound
4111,29068,HSP inhibitor,MoA,Phase 1,Gene,Chemical_Compound
9052,29069,protein tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11330,29070,ALK tyrosine kinase receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6218,29070,ALK tyrosine kinase receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11431,29071,tankyrase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3964,29072,ceramidase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7178,29073,p21 activated kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8041,29074,adenosine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25726,29074,adenosine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
9810,29074,adenosine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25727,29074,adenosine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
12154,29074,adenosine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
8835,29075,alcohol dehydrogenase inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
29077,29078,Oct activator,MoA,Preclinical,Gene,Chemical_Compound
5075,29079,BCL inhibitor,MoA,Phase 3,Gene,Chemical_Compound
8551,29082,STAT inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25598,29083,GABA receptor modulator,MoA,Phase 3,Gene,Chemical_Compound
25640,29083,GABA receptor modulator,MoA,Phase 3,Gene,Chemical_Compound
25641,29083,GABA receptor modulator,MoA,Phase 3,Gene,Chemical_Compound
25642,29083,GABA receptor modulator,MoA,Phase 3,Gene,Chemical_Compound
14011,29084,trace amine associated receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
27490,29084,trace amine associated receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26201,29089,CRTH receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
5877,29090,cathepsin inhibitor,MoA,Phase 3,Gene,Chemical_Compound
14710,29091,guanylyl cyclase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26311,29091,guanylyl cyclase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26313,29091,guanylyl cyclase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14470,29092,bromodomain inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9885,29093,histone lysine demethylase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12594,29094,WDR5/MLL interaction inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26045,29097,TRPV agonist,MoA,Preclinical,Gene,Chemical_Compound
25963,29098,cannabinoid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
27252,29098,cannabinoid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26396,29099,G protein-coupled receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25876,29100,cannabinoid receptor agonist|glucose dependent insulinotropic receptor agonist|potassium channel blocker|PPAR receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26045,29100,cannabinoid receptor agonist|glucose dependent insulinotropic receptor agonist|potassium channel blocker|PPAR receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25882,29100,cannabinoid receptor agonist|glucose dependent insulinotropic receptor agonist|potassium channel blocker|PPAR receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
8337,29100,cannabinoid receptor agonist|glucose dependent insulinotropic receptor agonist|potassium channel blocker|PPAR receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
5193,29101,estrogen receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
29102,29103,ATP synthase inhibitor|ATPase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15298,29107,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8227,29107,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6044,29107,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15365,29107,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14671,29114,nuclear factor erythroid derived|like (NRF2) activator,MoA,Phase 3,Gene,Chemical_Compound
25876,29115,TRPV agonist,MoA,Preclinical,Gene,Chemical_Compound
26045,29115,TRPV agonist,MoA,Preclinical,Gene,Chemical_Compound
6190,29115,TRPV agonist,MoA,Preclinical,Gene,Chemical_Compound
7591,29116,metalloproteinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15883,29116,metalloproteinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26045,29118,FAAH inhibitor,MoA,Preclinical,Gene,Chemical_Compound
29119,29120,cardiac myosin activator,MoA,Phase 3,Gene,Chemical_Compound
7087,29123,AKT inhibitor|MAP kinase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25862,29125,prostanoid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25636,29126,Bruton's tyrosine kinase (BTK) inhibitor,MoA,Phase 1,Gene,Chemical_Compound
26305,29127,matrix metalloprotease inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25790,29128,prostanoid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
5659,29129,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7533,29129,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12302,29129,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25590,29130,vasopressin receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
26153,29130,vasopressin receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
26154,29130,vasopressin receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
7628,29131,catechol O methyltransferase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
7628,29132,catechol O methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13343,29133,FGFR inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
8285,29133,FGFR inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
12907,29133,FGFR inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
5212,29133,FGFR inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25759,29133,FGFR inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25712,29133,FGFR inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
7392,29133,FGFR inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
12302,29133,FGFR inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
28500,29134,angiotensin converting enzyme inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
25554,29135,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
7079,29135,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25555,29135,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
7731,29136,glycine transporter inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26226,29136,glycine transporter inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25876,29137,cannabinoid receptor modulator,MoA,Preclinical,Gene,Chemical_Compound
25541,29138,adrenergic receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
5075,29139,BCL inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26223,29142,NFkB pathway modulator,MoA,Launched,Gene,Chemical_Compound
26294,29144,opioid receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25873,29144,opioid receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25610,29145,androgen biosynthesis inhibitor|androgen receptor antagonist|cytochrome P450 inhibitor,MoA,Phase 3,Gene,Chemical_Compound
9885,29146,histone lysine demethylase inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
25551,29149,serotonin receptor agonist,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
7640,29150,mTOR inhibitor,MoA,Phase 1,Gene,Chemical_Compound
12907,29151,EGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26178,29152,KIT inhibitor|VEGFR inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25712,29152,KIT inhibitor|VEGFR inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25633,29152,KIT inhibitor|VEGFR inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7292,29155,androgen receptor modulator,MoA,Phase 3,Gene,Chemical_Compound
25590,29156,oxytocin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26154,29156,oxytocin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
14011,29157,coagulation factor inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25592,29158,acetylcholine receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25593,29158,acetylcholine receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25594,29158,acetylcholine receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25595,29158,acetylcholine receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
9280,29158,acetylcholine receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
12500,29160,maternal embryonic leucine zipper kinase inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
5999,29161,bromodomain inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
14000,29161,bromodomain inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
15528,29161,bromodomain inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
13626,29163,rho associated kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9902,29163,rho associated kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15528,29167,bromodomain inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8215,29168,carnitine palmitoyltransferase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
29169,29168,carnitine palmitoyltransferase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25592,29171,acetylcholine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25593,29171,acetylcholine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25594,29171,acetylcholine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25595,29171,acetylcholine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25592,29172,cholinergic receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25593,29172,cholinergic receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25594,29172,cholinergic receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25595,29172,cholinergic receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25832,29179,xanthine oxidase inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
27071,29183,sphingosine 1-phosphate receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
29077,29184,Oct inducer,MoA,Preclinical,Gene,Chemical_Compound
4522,29185,O6-alkylguanine-DNA alkyltransferase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
9967,29186,retinoid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
12018,29187,caspase activator,MoA,Phase 1,Gene,Chemical_Compound
8365,29189,phospholipase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25632,29190,FLT3 inhibitor|JAK inhibitor,MoA,Phase 3,Gene,Chemical_Compound
3105,29190,FLT3 inhibitor|JAK inhibitor,MoA,Phase 3,Gene,Chemical_Compound
11600,29190,FLT3 inhibitor|JAK inhibitor,MoA,Phase 3,Gene,Chemical_Compound
5775,29190,FLT3 inhibitor|JAK inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25808,29193,dopamine synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25878,29194,cannabinoid receptor agonist,MoA,Launched,Gene,Chemical_Compound
26045,29194,cannabinoid receptor agonist,MoA,Launched,Gene,Chemical_Compound
25882,29194,cannabinoid receptor agonist,MoA,Launched,Gene,Chemical_Compound
7640,29195,AKT inhibitor|mTOR inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25634,29197,urotensin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
6665,29198,retinoid receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25547,29203,dopamine receptor modulator,MoA,Preclinical,Gene,Chemical_Compound
7762,29208,tubulin polymerization inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25547,29209,dopamine receptor agonist|serotonin receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25548,29209,dopamine receptor agonist|serotonin receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25549,29209,dopamine receptor agonist|serotonin receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25551,29209,dopamine receptor agonist|serotonin receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25963,29209,dopamine receptor agonist|serotonin receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
9570,29214,NFkB pathway inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8456,29215,NFkB pathway inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3844,29215,NFkB pathway inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25615,29220,platelet activating factor receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
9570,29221,HDAC inhibitor,MoA,Phase 3,Gene,Chemical_Compound
9941,29221,HDAC inhibitor,MoA,Phase 3,Gene,Chemical_Compound
5184,29221,HDAC inhibitor,MoA,Phase 3,Gene,Chemical_Compound
15499,29221,HDAC inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25636,29222,Bruton's tyrosine kinase (BTK) inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9570,29223,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26333,29223,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15499,29223,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11646,29223,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11455,29224,potassium channel activator,MoA,Phase 1,Gene,Chemical_Compound
14717,29225,MEK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25595,29226,acetylcholine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25955,29227,potassium channel activator,MoA,Preclinical,Gene,Chemical_Compound
26259,29228,angiotensin antagonist,MoA,Phase 1,Gene,Chemical_Compound
25547,29229,dopamine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25548,29229,dopamine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
12907,29230,EGFR inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25712,29230,EGFR inhibitor,MoA,Phase 1,Gene,Chemical_Compound
5173,29231,endothelin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
6150,29231,endothelin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
12907,29232,EGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27392,29233,neuropeptide receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
5212,29234,FGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12907,29235,SRC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5212,29235,SRC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12302,29235,SRC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14819,29235,SRC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15786,29235,SRC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5030,29235,SRC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26059,29236,collagenase inhibitor|metalloproteinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3521,29236,collagenase inhibitor|metalloproteinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11446,29236,collagenase inhibitor|metalloproteinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25547,29237,dopamine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
12907,29238,EGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13590,29238,EGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15786,29238,EGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25547,29239,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25549,29239,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
5212,29240,FGFR inhibitor|VEGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25759,29240,FGFR inhibitor|VEGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25760,29240,FGFR inhibitor|VEGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26228,29240,FGFR inhibitor|VEGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26178,29240,FGFR inhibitor|VEGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26179,29240,FGFR inhibitor|VEGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25712,29240,FGFR inhibitor|VEGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7392,29240,FGFR inhibitor|VEGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12302,29240,FGFR inhibitor|VEGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25778,29241,calcium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
14717,29242,MEK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
13225,29242,MEK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
4029,29242,MEK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
14717,29243,MAP kinase inhibitor|MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15643,29243,MAP kinase inhibitor|MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5030,29244,PKC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8041,29245,adenosine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
11481,29246,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7517,29246,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8086,29246,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26440,29246,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14717,29246,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15365,29246,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25908,29246,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15947,29246,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4449,29246,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9097,29246,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7247,29246,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5450,29246,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13626,29246,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8554,29246,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4757,29246,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26600,29247,phosphodiesterase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25885,29248,FAAH activator,MoA,Preclinical,Gene,Chemical_Compound
29249,29250,programmed death ligand inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25554,29253,serotonin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
12907,29254,EGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
2744,29264,aspartic protease inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6901,29264,aspartic protease inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4497,29264,aspartic protease inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25829,29264,aspartic protease inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9967,29265,retinoid receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25573,29266,dopamine receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
13991,29266,dopamine receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
25575,29266,dopamine receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
25541,29266,dopamine receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
25543,29266,dopamine receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
25544,29266,dopamine receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
25546,29266,dopamine receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
25547,29266,dopamine receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
25548,29266,dopamine receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
25549,29266,dopamine receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
25550,29266,dopamine receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
25551,29266,dopamine receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
25552,29266,dopamine receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
25553,29266,dopamine receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
25554,29266,dopamine receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
7079,29266,dopamine receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
25555,29266,dopamine receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
11481,29268,AKT inhibitor,MoA,Phase 3,Gene,Chemical_Compound
3325,29269,apoptosis stimulant|farnesyltransferase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7591,29271,angiotensin converting enzyme inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25652,29274,glutamate receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
11142,29274,glutamate receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
4203,29274,glutamate receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
12018,29275,caspase activator,MoA,Preclinical,Gene,Chemical_Compound
6963,29276,nedd activating enzyme inhibitor,MoA,Phase 3,Gene,Chemical_Compound
10149,29276,nedd activating enzyme inhibitor,MoA,Phase 3,Gene,Chemical_Compound
5185,29277,tyrosine kinase inhibitor,MoA,Launched,Gene,Chemical_Compound
25632,29277,tyrosine kinase inhibitor,MoA,Launched,Gene,Chemical_Compound
25633,29277,tyrosine kinase inhibitor,MoA,Launched,Gene,Chemical_Compound
4449,29278,MAP kinase inhibitor|TIE tyrosine kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
15295,29278,MAP kinase inhibitor|TIE tyrosine kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
26600,29279,phosphodiesterase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11214,29280,phosphodiesterase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
3944,29281,p21 activated kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
13343,29282,Aurora kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
8285,29282,Aurora kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
10745,29283,c-Met inhibitor,MoA,Phase 1,Gene,Chemical_Compound
9776,29284,prostaglandin inhibitor,MoA,Phase 1,Gene,Chemical_Compound
26607,29285,phosphodiesterase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25885,29286,FAAH inhibitor,MoA,Phase 2,Gene,Chemical_Compound
6399,29287,diacylglycerol O acyltransferase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7640,29288,mTOR inhibitor|PI3K inhibitor,MoA,Phase 2,Gene,Chemical_Compound
9637,29288,mTOR inhibitor|PI3K inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25578,29289,voltage-gated sodium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
27818,29290,glucokinase activator,MoA,Phase 2,Gene,Chemical_Compound
26012,29291,growth hormone secretagogue receptor inverse agonist,MoA,Phase 2,Gene,Chemical_Compound
7640,29292,mTOR inhibitor|PI3K inhibitor,MoA,Phase 2,Gene,Chemical_Compound
9637,29292,mTOR inhibitor|PI3K inhibitor,MoA,Phase 2,Gene,Chemical_Compound
4204,29293,serine/threonine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25590,29295,oxytocin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
26154,29295,oxytocin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25885,29296,FAAH inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10446,29297,SREBP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9052,29298,focal adhesion kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14351,29298,focal adhesion kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8554,29299,ribosomal protein inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7517,29300,CHK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
8332,29300,CHK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
10658,29301,casein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10045,29301,casein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25808,29302,cytochrome P450 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10922,29303,smoothened receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
9052,29304,focal adhesion kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
14351,29304,focal adhesion kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
15298,29305,focal adhesion kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8227,29305,focal adhesion kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5178,29305,focal adhesion kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8086,29305,focal adhesion kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8456,29305,focal adhesion kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10658,29306,casein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10045,29306,casein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25885,29307,FAAH inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15178,29308,autotaxin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7333,29309,11-beta hydroxysteroid dehydrogenase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
15528,29310,bromodomain inhibitor,MoA,Preclinical,Gene,Chemical_Compound
2612,29311,bromodomain inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5325,29311,bromodomain inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12654,29312,bromodomain inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4791,29313,phosphofructokinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
4791,29314,phosphofructokinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
13493,29315,JNK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
9097,29315,JNK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
3775,29315,JNK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25908,29316,p38 MAPK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
4449,29316,p38 MAPK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25571,29317,nicotinic receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
10745,29318,c-Met inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13343,29319,Aurora kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8285,29319,Aurora kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25916,29319,Aurora kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15298,29320,CDC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8554,29320,CDC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15298,29321,CDK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
8227,29321,CDK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
5659,29321,CDK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
6044,29321,CDK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
5178,29321,CDK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
11699,29321,CDK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
8227,29322,CDK inhibitor|growth factor receptor inhibitor,MoA,Phase 2,Gene,Chemical_Compound
5659,29322,CDK inhibitor|growth factor receptor inhibitor,MoA,Phase 2,Gene,Chemical_Compound
5178,29322,CDK inhibitor|growth factor receptor inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25966,29322,CDK inhibitor|growth factor receptor inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26996,29323,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
27230,29323,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
7829,29325,cyclooxygenase inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
14620,29329,anticancer agent,MoA,Phase 2,Gene,Chemical_Compound
11455,29330,AMPK activator,MoA,Withdrawn,Gene,Chemical_Compound
13924,29330,AMPK activator,MoA,Withdrawn,Gene,Chemical_Compound
28972,29335,indicator dye,MoA,Withdrawn,Gene,Chemical_Compound
6859,29338,acetylcholinesterase inhibitor|beta amyloid synthesis inhibitor,MoA,Phase 3,Gene,Chemical_Compound
7382,29338,acetylcholinesterase inhibitor|beta amyloid synthesis inhibitor,MoA,Phase 3,Gene,Chemical_Compound
6738,29340,cyclooxygenase inhibitor|prostanoid receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
7829,29340,cyclooxygenase inhibitor|prostanoid receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25665,29340,cyclooxygenase inhibitor|prostanoid receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
8546,29344,p53 stabilizing agent,MoA,Preclinical,Gene,Chemical_Compound
29345,29346,sodium/glucose cotransporter inhibitor,MoA,Launched,Gene,Chemical_Compound
7734,29346,sodium/glucose cotransporter inhibitor,MoA,Launched,Gene,Chemical_Compound
26124,29346,sodium/glucose cotransporter inhibitor,MoA,Launched,Gene,Chemical_Compound
26022,29347,sodium/glucose cotransporter inhibitor,MoA,Preclinical,Gene,Chemical_Compound
29348,29347,sodium/glucose cotransporter inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26620,29347,sodium/glucose cotransporter inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7994,29347,sodium/glucose cotransporter inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6024,29349,aryl hydrocarbon receptor ligand,MoA,Phase 1,Gene,Chemical_Compound
25598,29350,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25645,29350,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25648,29350,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
3613,29351,AKT inhibitor|pyruvate dehydrogenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5297,29351,AKT inhibitor|pyruvate dehydrogenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25625,29352,estrogen receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
7640,29355,mTOR inhibitor|PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9637,29355,mTOR inhibitor|PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6809,29355,mTOR inhibitor|PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12097,29355,mTOR inhibitor|PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25846,29355,mTOR inhibitor|PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7453,29355,mTOR inhibitor|PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7079,29356,serotonin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25855,29356,serotonin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
27233,29357,H+/K+-ATPase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
29102,29358,SYK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
29359,29358,SYK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
29360,29358,SYK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3947,29358,SYK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3004,29361,phosphodiesterase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11307,29361,phosphodiesterase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25558,29361,phosphodiesterase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7103,29361,phosphodiesterase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
6354,29363,GABA receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
3070,29363,GABA receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
26219,29363,GABA receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
7731,29363,GABA receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
6354,29364,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
3070,29364,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26219,29364,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
7731,29364,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25596,29364,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26192,29364,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
8546,29372,TP53 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8546,29373,TP53 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13141,29374,HSP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8546,29374,HSP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9637,29375,PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6809,29375,PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12097,29375,PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25846,29375,PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6809,29376,PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12097,29376,PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25846,29376,PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9637,29377,DNA protein kinase inhibitor|PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6809,29377,DNA protein kinase inhibitor|PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12097,29377,DNA protein kinase inhibitor|PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25846,29377,DNA protein kinase inhibitor|PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7453,29377,DNA protein kinase inhibitor|PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12460,29378,PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14372,29378,PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25846,29378,PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
2676,29381,Pim kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25551,29388,adrenergic receptor antagonist|serotonin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
3148,29389,cytochrome P450 inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7020,29396,monoamine oxidase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7633,29396,monoamine oxidase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
6190,29396,monoamine oxidase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25554,29401,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25963,29401,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25554,29406,dopamine receptor antagonist|serotonin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
8337,29407,PPAR receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
12418,29410,phosphodiesterase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25739,29411,purinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25614,29413,histamine receptor antagonist,MoA,Launched,Gene,Chemical_Compound
9570,29416,HDAC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
9941,29416,HDAC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
5184,29416,HDAC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11646,29416,HDAC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
10173,29419,PI4K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3595,29420,PARP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13754,29420,PARP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7715,29420,PARP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5938,29420,PARP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26016,29421,potassium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
9535,29422,benzodiazepine receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
7351,29423,dipeptidyl peptidase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12907,29424,EGFR inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7640,29425,mTOR inhibitor|PI3K inhibitor,MoA,Phase 1,Gene,Chemical_Compound
4180,29428,stearoyl-CoA desaturase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9018,29429,RAF inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25712,29429,RAF inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5185,29430,receptor tyrosine protein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25633,29430,receptor tyrosine protein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9018,29431,serine/threonine kinase inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
28349,29432,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25571,29433,acetylcholine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25553,29434,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25548,29435,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25554,29436,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
7079,29436,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25555,29436,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
7020,29436,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
7633,29436,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25571,29437,cholinergic receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
3188,29438,beta-catenin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15679,29438,beta-catenin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13139,29439,benzodiazepine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26272,29441,ICAM1 expression inhibitor,MoA,Phase 2,Gene,Chemical_Compound
8346,29442,immunostimulant,MoA,Preclinical,Gene,Chemical_Compound
11666,29442,immunostimulant,MoA,Preclinical,Gene,Chemical_Compound
25719,29442,immunostimulant,MoA,Preclinical,Gene,Chemical_Compound
27071,29445,sphingosine 1-phosphate receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25584,29448,acetylcholine receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25866,29448,acetylcholine receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
12907,29449,EGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
13590,29449,EGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11200,29449,EGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26494,29450,SRC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4171,29450,SRC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10758,29451,protein tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12907,29451,protein tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26494,29451,protein tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25712,29451,protein tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7640,29451,protein tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7392,29451,protein tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9637,29451,protein tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6809,29451,protein tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12097,29451,protein tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25846,29451,protein tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7453,29451,protein tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15786,29451,protein tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10758,29452,SRC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26440,29452,SRC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4774,29452,SRC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15786,29452,SRC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11393,29453,estrogen receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
10758,29454,Abl kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5820,29454,Abl kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7640,29455,mTOR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15284,29455,mTOR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11627,29456,IGF-1 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25660,29457,adrenergic receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
15539,29462,calcium channel blocker,MoA,Phase 2,Gene,Chemical_Compound
25876,29467,cyclooxygenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25878,29467,cyclooxygenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14233,29470,sigma receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25547,29471,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
14109,29475,glucocorticoid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25610,29479,GABA receptor negative allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
8041,29480,adenosine receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25726,29480,adenosine receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
9810,29480,adenosine receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25727,29480,adenosine receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
4277,29481,nitric oxide donor,MoA,Launched,Gene,Chemical_Compound
6859,29483,TP53 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25625,29485,estrogen receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
15076,29485,estrogen receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25778,29486,sodium channel blocker,MoA,Phase 3,Gene,Chemical_Compound
26441,29487,nitric oxide synthase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26091,29498,topical anesthetic,MoA,Phase 2,Gene,Chemical_Compound
26367,29501,CCK receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
26369,29501,CCK receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25804,29515,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25918,29515,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25660,29516,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25551,29516,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25556,29516,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
27061,29516,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
8584,29521,heme oxygenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25614,29523,histamine receptor modulator,MoA,Preclinical,Gene,Chemical_Compound
26317,29525,JAK inhibitor|SYK inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
27165,29526,SYK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
27791,29526,SYK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26317,29526,SYK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
29527,29528,polycomb repressive complex inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25554,29530,serotonin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25555,29530,serotonin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
7079,29531,serotonin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
29532,29533,NTPDase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8041,29534,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25726,29534,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25727,29534,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
8041,29535,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
9810,29535,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25727,29535,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
8041,29536,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25726,29536,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
9810,29536,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25727,29536,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
8041,29537,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25726,29537,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
9810,29537,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25727,29537,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26045,29538,glucose dependent insulinotropic receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25876,29539,cannabinoid receptor modulator,MoA,Preclinical,Gene,Chemical_Compound
7292,29541,androgen receptor modulator,MoA,Phase 1,Gene,Chemical_Compound
5130,29542,hypoxia inducible factor inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25665,29543,cyclooxygenase inhibitor|PPAR receptor agonist,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
4229,29544,HSP inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25596,29545,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25855,29545,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
10922,29546,smoothened receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26027,29547,protein synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26029,29547,protein synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8606,29547,protein synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3621,29547,protein synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8763,29547,protein synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3556,29547,protein synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14918,29547,protein synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9372,29547,protein synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4103,29547,protein synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9528,29547,protein synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3239,29547,protein synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9058,29547,protein synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9292,29547,protein synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15298,29548,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8227,29548,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5659,29548,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6044,29548,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14107,29548,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26403,29548,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15786,29548,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8227,29549,tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5659,29549,tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6044,29549,tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15365,29549,tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5719,29549,tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10260,29549,tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8955,29550,tissue transglutaminase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26077,29550,tissue transglutaminase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
15745,29550,tissue transglutaminase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25876,29551,thioredoxin inhibitor,MoA,Phase 2,Gene,Chemical_Compound
9075,29551,thioredoxin inhibitor,MoA,Phase 2,Gene,Chemical_Compound
13493,29553,JNK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9097,29553,JNK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
29554,29553,JNK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3775,29553,JNK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
28862,29553,JNK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15946,29555,topoisomerase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
12989,29555,topoisomerase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
9570,29560,HDAC inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7333,29561,NFkB pathway inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3844,29561,NFkB pathway inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15642,29563,ubiquitin specific protease inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15298,29564,CDK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
5659,29564,CDK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11699,29564,CDK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
15642,29565,ubiquitin specific protease inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13063,29566,NAMPT inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12418,29567,phosphodiesterase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
12939,29567,phosphodiesterase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25795,29570,leukotriene synthesis inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26005,29570,leukotriene synthesis inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25547,29574,dopamine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25548,29574,dopamine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25546,29579,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25547,29579,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25548,29579,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25549,29579,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25551,29579,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25554,29579,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
7079,29579,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25555,29579,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25551,29580,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25553,29580,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25554,29580,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
7079,29580,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25555,29580,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25596,29580,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26192,29580,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25962,29580,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25800,29580,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
5185,29581,FLT3 inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25632,29581,FLT3 inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25633,29581,FLT3 inhibitor,MoA,Phase 3,Gene,Chemical_Compound
7392,29581,FLT3 inhibitor,MoA,Phase 3,Gene,Chemical_Compound
12302,29581,FLT3 inhibitor,MoA,Phase 3,Gene,Chemical_Compound
4171,29581,FLT3 inhibitor,MoA,Phase 3,Gene,Chemical_Compound
4449,29582,sodium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
2774,29582,sodium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
25962,29583,serotonin receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
2774,29584,serine/threonine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4293,29585,AXL kinase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
12202,29586,diacylglycerol kinase inhibitor|protein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25554,29587,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
13139,29589,GABA receptor positive allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
25547,29591,dopamine receptor antagonist,MoA,Launched,Gene,Chemical_Compound
25548,29591,dopamine receptor antagonist,MoA,Launched,Gene,Chemical_Compound
25551,29591,dopamine receptor antagonist,MoA,Launched,Gene,Chemical_Compound
25958,29592,dopamine-norepinephrine reuptake inhibitor,MoA,Phase 2,Gene,Chemical_Compound
9018,29593,RAF inhibitor|VEGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
2742,29600,aldose reductase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25541,29604,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25543,29604,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25544,29604,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25552,29604,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25553,29604,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25853,29604,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
7079,29604,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
15365,29605,ERK1 and ERK2 phosphorylation inhibitor,MoA,Phase 1,Gene,Chemical_Compound
5719,29605,ERK1 and ERK2 phosphorylation inhibitor,MoA,Phase 1,Gene,Chemical_Compound
12161,29606,Ral GTPase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12295,29606,Ral GTPase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10758,29608,Bcr-Abl kinase inhibitor|TIE tyrosine kinase inhibitor|VEGFR inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
5820,29608,Bcr-Abl kinase inhibitor|TIE tyrosine kinase inhibitor|VEGFR inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
27165,29608,Bcr-Abl kinase inhibitor|TIE tyrosine kinase inhibitor|VEGFR inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
25632,29608,Bcr-Abl kinase inhibitor|TIE tyrosine kinase inhibitor|VEGFR inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
26494,29608,Bcr-Abl kinase inhibitor|TIE tyrosine kinase inhibitor|VEGFR inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
13780,29608,Bcr-Abl kinase inhibitor|TIE tyrosine kinase inhibitor|VEGFR inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
15786,29608,Bcr-Abl kinase inhibitor|TIE tyrosine kinase inhibitor|VEGFR inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
25573,29610,adrenergic receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
14717,29611,MEK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
15643,29611,MEK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25590,29614,vasopressin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
26152,29614,vasopressin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
26153,29614,vasopressin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
26154,29614,vasopressin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25652,29615,glutamate receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
13139,29616,benzodiazepine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
10339,29617,transferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25547,29618,dopamine receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25548,29618,dopamine receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25549,29618,dopamine receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25554,29618,dopamine receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
14233,29618,dopamine receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
28145,29620,CC chemokine receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
26229,29620,CC chemokine receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
2774,29621,TGF beta receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14448,29622,toll-like receptor inhibitor,MoA,Phase 3,Gene,Chemical_Compound
27321,29624,toll-like receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
28123,29624,toll-like receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
9570,29625,HDAC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
5184,29625,HDAC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
15499,29625,HDAC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11646,29625,HDAC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11536,29627,cytochrome P450 inhibitor|SIRT activator,MoA,Launched,Gene,Chemical_Compound
15168,29627,cytochrome P450 inhibitor|SIRT activator,MoA,Launched,Gene,Chemical_Compound
7829,29627,cytochrome P450 inhibitor|SIRT activator,MoA,Launched,Gene,Chemical_Compound
25665,29627,cytochrome P450 inhibitor|SIRT activator,MoA,Launched,Gene,Chemical_Compound
4229,29628,HSP inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25795,29635,leukotriene receptor antagonist|lipoxygenase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
10012,29637,MRP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8285,29638,Aurora kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
29639,29638,Aurora kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14717,29638,Aurora kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15298,29640,CDK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
8227,29640,CDK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
14263,29640,CDK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
5659,29640,CDK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
6044,29640,CDK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
3305,29640,CDK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
5178,29640,CDK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
11699,29640,CDK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25632,29640,CDK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
8086,29640,CDK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
11600,29640,CDK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
8949,29640,CDK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
3775,29640,CDK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
5184,29641,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14831,29642,DNA methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11040,29642,DNA methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5212,29643,FGFR inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25759,29643,FGFR inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 1,Gene,Chemical_Compound
9570,29644,HDAC inhibitor,MoA,Phase 1,Gene,Chemical_Compound
5184,29644,HDAC inhibitor,MoA,Phase 1,Gene,Chemical_Compound
8514,29645,gamma secretase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
9986,29646,MDM inhibitor,MoA,Phase 1,Gene,Chemical_Compound
13076,29647,triacylglycerol lipase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5539,29647,triacylglycerol lipase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4909,29649,protein tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7320,29658,prostanoid receptor agonist,MoA,Launched,Gene,Chemical_Compound
14636,29662,cell cycle inhibitor|PLK inhibitor,MoA,Phase 3,Gene,Chemical_Compound
14233,29667,sigma receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
26409,29668,calcitonin antagonist,MoA,Launched,Gene,Chemical_Compound
25876,29670,cannabinoid receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25882,29670,cannabinoid receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25598,29673,benzodiazepine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
9986,29676,MDM inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25573,29677,serotonin receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
13991,29677,serotonin receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25575,29677,serotonin receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25551,29677,serotonin receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25552,29677,serotonin receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25553,29677,serotonin receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25554,29677,serotonin receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
7079,29677,serotonin receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25555,29677,serotonin receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25556,29677,serotonin receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25962,29677,serotonin receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25963,29677,serotonin receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25584,29679,acetylcholine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25866,29679,acetylcholine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
26662,29679,acetylcholine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
12642,29683,rho associated kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10506,29683,rho associated kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
2722,29683,rho associated kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6322,29683,rho associated kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7178,29683,rho associated kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9446,29683,rho associated kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13626,29683,rho associated kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9902,29683,rho associated kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9885,29684,histone demethylase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6139,29685,TRPV antagonist,MoA,Preclinical,Gene,Chemical_Compound
6139,29686,TRPV agonist,MoA,Preclinical,Gene,Chemical_Compound
4203,29687,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
7324,29688,NGF binding inhibitor,MoA,Preclinical,Gene,Chemical_Compound
28509,29688,NGF binding inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25549,29689,dopamine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
9852,29690,prostanoid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25598,29691,GABA benzodiazepine site receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
25640,29691,GABA benzodiazepine site receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
25641,29691,GABA benzodiazepine site receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
25600,29691,GABA benzodiazepine site receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
25642,29691,GABA benzodiazepine site receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
25643,29691,GABA benzodiazepine site receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
25645,29691,GABA benzodiazepine site receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
25648,29691,GABA benzodiazepine site receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
25598,29692,GABA benzodiazepine site receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
25640,29692,GABA benzodiazepine site receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
25641,29692,GABA benzodiazepine site receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
25642,29692,GABA benzodiazepine site receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
12418,29693,phosphodiesterase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3004,29693,phosphodiesterase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11307,29693,phosphodiesterase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25558,29693,phosphodiesterase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7103,29693,phosphodiesterase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4203,29694,glutamate receptor antagonist|monamine transporter modulator,MoA,Preclinical,Gene,Chemical_Compound
27818,29695,glucokinase activator,MoA,Preclinical,Gene,Chemical_Compound
25565,29696,purinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
15298,29697,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9869,29698,oxidosqualene cyclase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14717,29699,MEK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
9018,29700,MEK inhibitor|RAF inhibitor,MoA,Phase 1,Gene,Chemical_Compound
14717,29700,MEK inhibitor|RAF inhibitor,MoA,Phase 1,Gene,Chemical_Compound
15643,29700,MEK inhibitor|RAF inhibitor,MoA,Phase 1,Gene,Chemical_Compound
5450,29700,MEK inhibitor|RAF inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25554,29701,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
7079,29701,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25555,29701,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
29702,29703,kynurenine 3-monooxygenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26996,29704,glutamate receptor positive allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
7625,29705,beta amyloid protein neurotoxicity inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25551,29706,serotonin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
12907,29707,EGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
6626,29709,cyclooxygenase inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25665,29709,cyclooxygenase inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
8227,29714,CDK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11699,29714,CDK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25849,29715,insulin sensitizer|PPAR receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
10141,29715,insulin sensitizer|PPAR receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
26792,29715,insulin sensitizer|PPAR receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
9069,29715,insulin sensitizer|PPAR receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
13264,29716,GABA transaminase inhibitor,MoA,Launched,Gene,Chemical_Compound
26082,29716,GABA transaminase inhibitor,MoA,Launched,Gene,Chemical_Compound
10693,29717,ATPase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
27071,29723,sphingosine 1-phosphate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26017,29724,transient receptor potential channel antagonist,MoA,Preclinical,Gene,Chemical_Compound
13973,29725,glucose 6-phosphate dehydrogenase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25573,29726,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25575,29726,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25554,29727,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
7079,29727,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25555,29727,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26456,29728,CCR antagonist,MoA,Preclinical,Gene,Chemical_Compound
25554,29729,serotonin receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
7079,29729,serotonin receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25555,29729,serotonin receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25573,29730,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25575,29730,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25855,29731,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25855,29732,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
4266,29733,CC chemokine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26456,29733,CC chemokine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25596,29734,serotonin receptor partial agonist,MoA,Preclinical,Gene,Chemical_Compound
25855,29735,serotonin receptor partial agonist,MoA,Preclinical,Gene,Chemical_Compound
25855,29736,serotonin receptor partial agonist,MoA,Preclinical,Gene,Chemical_Compound
25541,29737,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
11871,29738,nitric oxide production inhibitor,MoA,Phase 2,Gene,Chemical_Compound
8680,29739,hedgehog pathway inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25551,29740,serotonin receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25552,29740,serotonin receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25553,29740,serotonin receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25554,29740,serotonin receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
7079,29740,serotonin receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25555,29740,serotonin receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25556,29740,serotonin receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25962,29740,serotonin receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
12016,29741,cytochrome P450 inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25804,29742,adrenergic receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
7292,29743,androgen receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
15946,29744,topoisomerase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
13754,29745,PARP inhibitor,MoA,Phase 3,Gene,Chemical_Compound
9999,29745,PARP inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26082,29746,tyrosinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25665,29749,cyclooxygenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3105,29752,JAK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11600,29752,JAK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27321,29753,toll-like receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
26272,29754,integrin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4449,29755,MAP kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25665,29755,MAP kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
8227,29756,CDK inhibitor|DNA synthesis inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
14831,29756,CDK inhibitor|DNA synthesis inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
25573,29757,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
13991,29757,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25575,29757,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25541,29757,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25543,29757,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25544,29757,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
8227,29758,histone lysine methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5659,29758,histone lysine methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26317,29759,SYK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
4171,29760,SYK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
26317,29760,SYK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
15298,29761,CDK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
8227,29761,CDK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
5659,29761,CDK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
5178,29761,CDK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
26138,29762,nitric oxide synthase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4909,29764,nitric oxide stimulant,MoA,Phase 1,Gene,Chemical_Compound
26852,29765,CAR antagonist,MoA,Preclinical,Gene,Chemical_Compound
13754,29766,PARP inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25551,29767,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25885,29768,FAAH inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10748,29769,DNA polymerase inhibitor,MoA,Launched,Gene,Chemical_Compound
7555,29769,DNA polymerase inhibitor,MoA,Launched,Gene,Chemical_Compound
25676,29769,DNA polymerase inhibitor,MoA,Launched,Gene,Chemical_Compound
26682,29769,DNA polymerase inhibitor,MoA,Launched,Gene,Chemical_Compound
13139,29770,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25560,29770,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
10388,29770,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
2657,29770,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26281,29770,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
9069,29773,PKC inhibitor,MoA,Phase 1,Gene,Chemical_Compound
13139,29774,benzodiazepine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
10922,29775,smoothened receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
7510,29775,smoothened receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
7625,29777,beta amyloid protein neurotoxicity inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10608,29778,mTOR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
9267,29780,eukaryotic translation initiation factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25602,29781,EGFR inhibitor|metalloproteinase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25751,29782,opioid receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25872,29782,opioid receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25873,29782,opioid receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
4968,29783,eukaryotic translation initiation factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12018,29784,apoptosis stimulant,MoA,Phase 1,Gene,Chemical_Compound
29785,29786,smoothened receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
10922,29786,smoothened receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
29785,29787,smoothened receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
10922,29787,smoothened receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
7640,29790,PI3K inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
25846,29790,PI3K inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
10758,29791,SRC inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
26440,29791,SRC inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
15786,29791,SRC inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
6491,29791,SRC inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
11061,29792,glycine transporter inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26179,29795,VEGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14372,29796,PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9986,29797,MDM inhibitor,MoA,Phase 1,Gene,Chemical_Compound
13626,29798,rho associated kinase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
10745,29800,c-Met inhibitor,MoA,Phase 3,Gene,Chemical_Compound
7079,29802,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25555,29802,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
11481,29803,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25795,29803,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7517,29803,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8086,29803,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26440,29803,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15365,29803,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25908,29803,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15947,29803,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4449,29803,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9097,29803,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7247,29803,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13626,29803,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8554,29803,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4757,29803,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25855,29804,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
11481,29805,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25795,29805,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7517,29805,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26848,29805,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25808,29805,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8817,29805,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8086,29805,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26440,29805,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15365,29805,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13493,29805,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25908,29805,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15947,29805,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4449,29805,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9097,29805,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3775,29805,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7247,29805,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5450,29805,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4774,29805,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13626,29805,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8554,29805,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4757,29805,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15786,29805,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25998,29805,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25641,29806,GABA receptor modulator,MoA,Preclinical,Gene,Chemical_Compound
25642,29806,GABA receptor modulator,MoA,Preclinical,Gene,Chemical_Compound
25643,29806,GABA receptor modulator,MoA,Preclinical,Gene,Chemical_Compound
25554,29807,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
7079,29807,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25555,29807,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25551,29808,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25552,29808,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25553,29808,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25554,29808,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
7079,29808,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25555,29808,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
9645,29809,glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8227,29809,glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6999,29809,glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8086,29809,glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7517,29810,CHK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
29811,29812,tachykinin antagonist,MoA,Preclinical,Gene,Chemical_Compound
25554,29813,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
7079,29813,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25555,29813,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
29811,29814,tachykinin antagonist,MoA,Preclinical,Gene,Chemical_Compound
26229,29815,CC chemokine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25554,29816,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
7079,29816,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25555,29816,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
7640,29817,mTOR inhibitor|PI3K inhibitor,MoA,Phase 1,Gene,Chemical_Compound
9637,29817,mTOR inhibitor|PI3K inhibitor,MoA,Phase 1,Gene,Chemical_Compound
6809,29817,mTOR inhibitor|PI3K inhibitor,MoA,Phase 1,Gene,Chemical_Compound
12097,29817,mTOR inhibitor|PI3K inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25846,29817,mTOR inhibitor|PI3K inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25908,29818,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4449,29818,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25665,29818,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13453,29819,p38 MAPK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
4449,29819,p38 MAPK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25554,29820,serotonin receptor inverse agonist,MoA,Phase 1,Gene,Chemical_Compound
7079,29820,serotonin receptor inverse agonist,MoA,Phase 1,Gene,Chemical_Compound
25555,29820,serotonin receptor inverse agonist,MoA,Phase 1,Gene,Chemical_Compound
25962,29820,serotonin receptor inverse agonist,MoA,Phase 1,Gene,Chemical_Compound
25962,29821,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26409,29822,calcitonin antagonist,MoA,Preclinical,Gene,Chemical_Compound
25963,29823,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25962,29824,serotonin receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
29825,29826,CC chemokine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25709,29827,orexin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25711,29827,orexin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
6190,29828,TRPV antagonist,MoA,Preclinical,Gene,Chemical_Compound
25962,29829,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25709,29830,orexin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25711,29830,orexin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
6999,29831,glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8086,29831,glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8554,29831,glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15553,29832,TGF beta receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
2774,29832,TGF beta receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6190,29833,TRPV antagonist,MoA,Preclinical,Gene,Chemical_Compound
2774,29834,ALK tyrosine kinase receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
2774,29835,TGF beta receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9018,29836,RAF inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26294,29837,nociceptin/orphanin FQ receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25634,29838,urotensin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
12477,29839,integrin antagonist,MoA,Phase 1,Gene,Chemical_Compound
6567,29839,integrin antagonist,MoA,Phase 1,Gene,Chemical_Compound
15105,29839,integrin antagonist,MoA,Phase 1,Gene,Chemical_Compound
29840,29839,integrin antagonist,MoA,Phase 1,Gene,Chemical_Compound
6190,29841,TRPV antagonist,MoA,Phase 2,Gene,Chemical_Compound
25634,29842,urotensin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25962,29843,serotonin receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
15188,29844,kinesin-like spindle protein inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
11481,29845,kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12367,29845,kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13626,29845,kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10642,29845,kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8554,29845,kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26396,29846,G protein-coupled receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
13626,29847,rho associated kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9902,29847,rho associated kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9570,29848,HDAC inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26333,29848,HDAC inhibitor,MoA,Phase 3,Gene,Chemical_Compound
9941,29848,HDAC inhibitor,MoA,Phase 3,Gene,Chemical_Compound
5184,29848,HDAC inhibitor,MoA,Phase 3,Gene,Chemical_Compound
11348,29848,HDAC inhibitor,MoA,Phase 3,Gene,Chemical_Compound
11002,29848,HDAC inhibitor,MoA,Phase 3,Gene,Chemical_Compound
15499,29848,HDAC inhibitor,MoA,Phase 3,Gene,Chemical_Compound
3799,29848,HDAC inhibitor,MoA,Phase 3,Gene,Chemical_Compound
14636,29849,PLK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9570,29850,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5184,29850,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7247,29851,protein kinase activator,MoA,Preclinical,Gene,Chemical_Compound
29852,29853,dihydroorotate dehydrogenase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25790,29854,prostanoid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25665,29855,cyclooxygenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25790,29856,prostanoid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
7829,29857,cyclooxygenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7247,29858,protein tyrosine kinase activator,MoA,Preclinical,Gene,Chemical_Compound
25592,29859,G protein-coupled receptor modulator,MoA,Preclinical,Gene,Chemical_Compound
25593,29859,G protein-coupled receptor modulator,MoA,Preclinical,Gene,Chemical_Compound
25546,29859,G protein-coupled receptor modulator,MoA,Preclinical,Gene,Chemical_Compound
25547,29859,G protein-coupled receptor modulator,MoA,Preclinical,Gene,Chemical_Compound
26294,29860,nociceptin/orphanin FQ receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25546,29861,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25550,29861,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25555,29861,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26077,29861,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
29862,29861,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
27233,29863,ATPase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
12683,29864,MTH1 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8041,29865,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25726,29865,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
9810,29865,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25727,29865,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
8227,29866,CHK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7517,29866,CHK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
15816,29867,antioxidant,MoA,Preclinical,Gene,Chemical_Compound
25592,29871,acetylcholine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25593,29871,acetylcholine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25594,29871,acetylcholine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25595,29871,acetylcholine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
9570,29872,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9941,29872,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5184,29872,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11348,29872,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11002,29872,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15499,29872,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26335,29872,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11646,29872,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3799,29872,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4449,29873,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
2774,29874,TGF beta receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26058,29875,matrix metalloprotease inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26059,29875,matrix metalloprotease inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3521,29875,matrix metalloprotease inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25751,29876,opioid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
12473,29877,tachykinin antagonist,MoA,Phase 1,Gene,Chemical_Compound
25554,29878,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
7079,29878,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25555,29878,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
8041,29879,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25596,29880,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26192,29880,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25551,29881,adrenergic receptor antagonist|serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25552,29881,adrenergic receptor antagonist|serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25652,29882,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25652,29883,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25598,29885,GABA receptor antagonist|TP53 activator,MoA,Preclinical,Gene,Chemical_Compound
25835,29886,progesterone receptor agonist,MoA,Launched,Gene,Chemical_Compound
11142,29889,glutamate receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
4203,29889,glutamate receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
14160,29889,glutamate receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
14968,29889,glutamate receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
14717,29891,MEK inhibitor,MoA,Phase 3,Gene,Chemical_Compound
8514,29892,gamma secretase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
4449,29893,cytokine production inhibitor|p38 MAPK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
5212,29894,VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26178,29894,VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25712,29894,VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25633,29894,VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
7392,29894,VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
12302,29894,VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
4171,29894,VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
7625,29895,beta amyloid inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13006,29896,intermediate conductance potassium channel blocker,MoA,Phase 3,Gene,Chemical_Compound
6126,29897,vitamin D receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
26361,29898,D-amino acid oxidase Inhibitor,MoA,Phase 1,Gene,Chemical_Compound
9986,29900,MDM inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25573,29902,dopamine receptor antagonist|serotonin receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
13991,29902,dopamine receptor antagonist|serotonin receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25575,29902,dopamine receptor antagonist|serotonin receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25547,29902,dopamine receptor antagonist|serotonin receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25548,29902,dopamine receptor antagonist|serotonin receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25549,29902,dopamine receptor antagonist|serotonin receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
13040,29902,dopamine receptor antagonist|serotonin receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25551,29902,dopamine receptor antagonist|serotonin receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25552,29902,dopamine receptor antagonist|serotonin receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25553,29902,dopamine receptor antagonist|serotonin receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25853,29902,dopamine receptor antagonist|serotonin receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25854,29902,dopamine receptor antagonist|serotonin receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25554,29902,dopamine receptor antagonist|serotonin receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25555,29902,dopamine receptor antagonist|serotonin receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25962,29902,dopamine receptor antagonist|serotonin receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25955,29902,dopamine receptor antagonist|serotonin receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
26201,29904,prostaglandin inhibitor,MoA,Phase 3,Gene,Chemical_Compound
27071,29907,lysophospholipid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
29908,29909,neuropeptide receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
27077,29909,neuropeptide receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
12752,29910,bromodomain inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9531,29910,bromodomain inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5241,29911,protein arginine N-methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14831,29912,DNA methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8047,29912,DNA methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11040,29912,DNA methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25632,29913,Pim kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
2676,29913,Pim kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
26197,29913,Pim kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
3068,29913,Pim kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
13139,29914,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25560,29914,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
10745,29915,hepatocyte growth factor receptor inhibitor,MoA,Phase 1,Gene,Chemical_Compound
29916,29917,neuropeptide receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
6921,29918,protein tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27084,29919,acetylcholine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25655,29920,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
27230,29921,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25655,29921,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
29922,29923,steroidogenic factor antagonist,MoA,Preclinical,Gene,Chemical_Compound
12418,29924,phosphodiesterase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
11964,29930,DNA methyltransferase inhibitor|RNA synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25971,29931,voltage-gated sodium channel blocker,MoA,Phase 2,Gene,Chemical_Compound
25578,29931,voltage-gated sodium channel blocker,MoA,Phase 2,Gene,Chemical_Compound
25821,29931,voltage-gated sodium channel blocker,MoA,Phase 2,Gene,Chemical_Compound
25823,29931,voltage-gated sodium channel blocker,MoA,Phase 2,Gene,Chemical_Compound
25824,29931,voltage-gated sodium channel blocker,MoA,Phase 2,Gene,Chemical_Compound
25662,29931,voltage-gated sodium channel blocker,MoA,Phase 2,Gene,Chemical_Compound
25826,29931,voltage-gated sodium channel blocker,MoA,Phase 2,Gene,Chemical_Compound
25573,29933,sigma receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
13991,29933,sigma receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25575,29933,sigma receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
14923,29935,SIRT inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10315,29936,SIRT inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14923,29936,SIRT inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7559,29937,serine/threonine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
2774,29937,serine/threonine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5173,29939,endothelin receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
6150,29939,endothelin receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
13355,29941,MDM inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14233,29942,sigma receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
13006,29943,potassium channel activator,MoA,Preclinical,Gene,Chemical_Compound
4449,29944,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25545,29945,dopamine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25546,29945,dopamine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25550,29945,dopamine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25546,29946,dopamine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25546,29947,dopamine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25550,29947,dopamine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25546,29948,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25550,29948,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25795,29949,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4449,29949,p38 MAPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26816,29950,GABA uptake inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8064,29951,histamine N-methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25808,29952,calcium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
8834,29952,calcium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
9917,29952,calcium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
28272,29952,calcium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
9770,29952,calcium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
26792,29952,calcium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
6706,29952,calcium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
14020,29953,sphingosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25712,29954,VEGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25876,29955,cannabinoid receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25547,29955,cannabinoid receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25551,29955,cannabinoid receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
8041,29956,adenosine receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25726,29956,adenosine receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
9810,29956,adenosine receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25727,29956,adenosine receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
4198,29957,XIAP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26234,29957,XIAP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8344,29957,XIAP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13208,29958,sigma receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
29959,29960,autophagy inducer,MoA,Preclinical,Gene,Chemical_Compound
2676,29961,Pim kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
29908,29962,transient receptor potential channel agonist,MoA,Preclinical,Gene,Chemical_Compound
4909,29964,nitric oxide donor,MoA,Phase 2,Gene,Chemical_Compound
25573,29965,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
13991,29965,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25575,29965,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25541,29965,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25543,29965,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25544,29965,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
15539,29965,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25971,29965,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
11393,29968,selective estrogen receptor modulator (SERM),MoA,Preclinical,Gene,Chemical_Compound
13343,29969,Aurora kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
8285,29969,Aurora kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25916,29969,Aurora kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
4229,29970,HSP inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
4111,29970,HSP inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
7584,29971,thyroid hormone receptor agonist,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
9625,29971,thyroid hormone receptor agonist,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
7382,29972,HDAC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
27092,29972,HDAC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
27093,29972,HDAC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
9570,29972,HDAC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
9941,29972,HDAC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
5184,29972,HDAC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11646,29972,HDAC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
3105,29979,JAK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
2742,29985,aldose reductase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26022,29986,sodium/glucose cotransporter inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26620,29986,sodium/glucose cotransporter inhibitor,MoA,Phase 3,Gene,Chemical_Compound
7247,29988,PKC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26752,29988,PKC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
15425,29988,PKC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25765,29988,PKC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
12513,29988,PKC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25766,29988,PKC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
10073,29989,NFkB pathway inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13922,29989,NFkB pathway inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9986,29990,ubiquitin ligase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12989,29992,bacterial DNA gyrase inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25676,29993,aspartate carbamoyltransferase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25677,29993,aspartate carbamoyltransferase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
2944,29994,deubiquitinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6813,29994,deubiquitinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26077,29995,glutamate receptor modulator,MoA,Preclinical,Gene,Chemical_Compound
8235,29995,glutamate receptor modulator,MoA,Preclinical,Gene,Chemical_Compound
29997,29998,gene expression stimulant,MoA,Preclinical,Gene,Chemical_Compound
25872,30000,opioid receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25573,30003,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
13991,30003,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25575,30003,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25541,30003,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25543,30003,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25544,30003,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25551,30003,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
7079,30003,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
10315,30004,SIRT inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5173,30005,endothelin receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
4171,30006,receptor tyrosine protein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11239,30007,bacterial cell wall synthesis inhibitor,MoA,Phase 3,Gene,Chemical_Compound
4467,30008,adenylyl cyclase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15412,30009,retinoid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
30010,30009,retinoid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
12473,30011,neurokinin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
10141,30012,PPAR receptor ligand,MoA,Preclinical,Gene,Chemical_Compound
30010,30013,retinoid receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
26844,30014,leukotriene receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
26367,30015,CCK receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
13493,30016,JNK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9097,30016,JNK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3775,30016,JNK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13493,30017,JNK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9902,30018,rho associated kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25596,30019,serotonin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25660,30020,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25804,30020,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25918,30020,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25592,30021,acetylcholine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
4588,30022,SRC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26440,30022,SRC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4774,30022,SRC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3272,30023,serine arginine protein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10260,30023,serine arginine protein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10315,30024,SIRT activator,MoA,Preclinical,Gene,Chemical_Compound
10315,30025,SIRT activator,MoA,Phase 2,Gene,Chemical_Compound
25571,30026,acetylcholine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
12125,30027,myeloid differentiation primary response inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26066,30028,interleukin synthesis inhibitor,MoA,Phase 2,Gene,Chemical_Compound
8551,30029,STAT inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6024,30030,aryl hydrocarbon receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
6202,30031,serine/threonine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13063,30032,NAMPT inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13063,30033,NAMPT inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14676,30033,NAMPT inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25573,30035,adrenergic receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25592,30037,acetylcholine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25593,30037,acetylcholine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25594,30037,acetylcholine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25595,30037,acetylcholine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
9280,30037,acetylcholine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26782,30037,acetylcholine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
27761,30037,acetylcholine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
6354,30037,acetylcholine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
3070,30037,acetylcholine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26219,30037,acetylcholine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
7731,30037,acetylcholine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
12473,30038,neurokinin receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25597,30038,neurokinin receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
29811,30038,neurokinin receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
30045,30046,antioxidant,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
10895,30049,dihydrofolate reductase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11871,30057,anticancer agent|aryl hydrocarbon receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25676,30060,carbonic anhydrase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25547,30061,dopamine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
30063,30064,calcitonin agonist,MoA,Preclinical,Gene,Chemical_Compound
5212,30065,fibroblast growth factor mimetic,MoA,Preclinical,Gene,Chemical_Compound
7829,30067,cyclooxygenase inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25665,30067,cyclooxygenase inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
13139,30070,GABA receptor inverse agonist,MoA,Phase 2,Gene,Chemical_Compound
25712,30071,PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
10745,30072,hepatocyte growth factor receptor inhibitor|tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12302,30073,PDGFR tyrosine kinase receptor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9097,30074,JNK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25712,30075,PDGFR tyrosine kinase receptor inhibitor|tyrosine kinase inhibitor|VEGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12302,30075,PDGFR tyrosine kinase receptor inhibitor|tyrosine kinase inhibitor|VEGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15298,30076,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8227,30076,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5659,30076,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6044,30076,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9932,30077,alpha mannosidase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
4449,30078,MAP kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8327,30079,kainate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
11784,30079,kainate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
28266,30079,kainate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
28267,30079,kainate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
28268,30079,kainate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26872,30079,kainate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25992,30080,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25990,30080,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
15548,30080,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25994,30080,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
27071,30082,sphingosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25992,30083,glutamate receptor modulator,MoA,Phase 2,Gene,Chemical_Compound
25990,30083,glutamate receptor modulator,MoA,Phase 2,Gene,Chemical_Compound
15548,30083,glutamate receptor modulator,MoA,Phase 2,Gene,Chemical_Compound
25994,30083,glutamate receptor modulator,MoA,Phase 2,Gene,Chemical_Compound
10141,30084,PPAR receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
7555,30085,carbonic anhydrase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26682,30085,carbonic anhydrase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10141,30086,PPAR receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
11214,30087,phosphodiesterase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15076,30088,LXR agonist,MoA,Preclinical,Gene,Chemical_Compound
13677,30088,LXR agonist,MoA,Preclinical,Gene,Chemical_Compound
9476,30088,LXR agonist,MoA,Preclinical,Gene,Chemical_Compound
11708,30088,LXR agonist,MoA,Preclinical,Gene,Chemical_Compound
26919,30088,LXR agonist,MoA,Preclinical,Gene,Chemical_Compound
14857,30088,LXR agonist,MoA,Preclinical,Gene,Chemical_Compound
10073,30089,AP inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7284,30090,LIM kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25726,30091,adenosine receptor modulator,MoA,Phase 2,Gene,Chemical_Compound
10658,30092,casein kinase inhibitor|MAP kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10045,30092,casein kinase inhibitor|MAP kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4449,30092,casein kinase inhibitor|MAP kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26012,30093,growth hormone secretagogue receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
9570,30095,HDAC inhibitor,MoA,Phase 3,Gene,Chemical_Compound
12212,30102,phosphorylase inhibitor,MoA,Launched,Gene,Chemical_Compound
26600,30103,phosphodiesterase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25720,30104,CC chemokine receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
13590,30105,EGFR inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7392,30106,VEGFR inhibitor,MoA,Phase 1,Gene,Chemical_Compound
9018,30107,RAF inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4449,30108,p38 MAPK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
14717,30109,MEK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25849,30110,insulin secretagogue,MoA,Phase 3,Gene,Chemical_Compound
8285,30111,Aurora kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
14636,30112,PLK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7351,30113,dipeptidyl peptidase inhibitor|fibroblast activation protein inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26183,30114,smoothened receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
27034,30114,smoothened receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
10922,30114,smoothened receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25992,30115,glutamate receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25990,30115,glutamate receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
15548,30115,glutamate receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25994,30115,glutamate receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
28478,30116,cytochrome P450 inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26020,30120,p38 MAPK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25908,30120,p38 MAPK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
4449,30120,p38 MAPK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
3680,30120,p38 MAPK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25998,30120,p38 MAPK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25597,30121,tachykinin antagonist,MoA,Phase 2,Gene,Chemical_Compound
29811,30121,tachykinin antagonist,MoA,Phase 2,Gene,Chemical_Compound
25921,30123,adrenergic inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25835,30128,progesterone receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
5185,30130,FLT3 inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25632,30130,FLT3 inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25633,30130,FLT3 inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor,MoA,Phase 2,Gene,Chemical_Compound
3848,30130,FLT3 inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor,MoA,Phase 2,Gene,Chemical_Compound
12302,30130,FLT3 inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor,MoA,Phase 2,Gene,Chemical_Compound
4229,30131,HSP inhibitor,MoA,Phase 3,Gene,Chemical_Compound
29112,30133,AP inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26020,30134,anti-inflammatory agent|interleukin inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
26919,30134,anti-inflammatory agent|interleukin inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
25998,30134,anti-inflammatory agent|interleukin inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
9776,30135,prostaglandin receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25594,30136,acetylcholine receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25876,30137,cannabinoid receptor inverse agonist,MoA,Phase 3,Gene,Chemical_Compound
26138,30138,nitric oxide synthase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25731,30139,P glycoprotein inhibitor,MoA,Phase 3,Gene,Chemical_Compound
15946,30140,topoisomerase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
9637,30141,PI3K inhibitor,MoA,Phase 3,Gene,Chemical_Compound
11348,30143,angiogenesis inhibitor|S100A9 inhibitor,MoA,Phase 3,Gene,Chemical_Compound
30144,30145,G protein-coupled receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
26803,30145,G protein-coupled receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
29490,30145,G protein-coupled receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
13395,30146,opioid receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
11100,30148,histone lysine methyltransferase inhibitor,MoA,Launched,Gene,Chemical_Compound
3815,30149,excitatory amino acid transporter inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26872,30149,excitatory amino acid transporter inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6594,30149,excitatory amino acid transporter inhibitor,MoA,Preclinical,Gene,Chemical_Compound
28359,30149,excitatory amino acid transporter inhibitor,MoA,Preclinical,Gene,Chemical_Compound
28360,30149,excitatory amino acid transporter inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13343,30150,Aurora kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4997,30151,MAP kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14472,30151,MAP kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12416,30152,histone demethylase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8621,30152,histone demethylase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7816,30152,histone demethylase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12722,30152,histone demethylase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27890,30152,histone demethylase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15241,30152,histone demethylase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11184,30152,histone demethylase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7625,30153,gamma secretase modulator,MoA,Preclinical,Gene,Chemical_Compound
25885,30154,FAAH inhibitor,MoA,Preclinical,Gene,Chemical_Compound
30155,30156,formyl peptide receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25541,30157,adrenergic receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25543,30157,adrenergic receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25544,30157,adrenergic receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25726,30158,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26396,30159,G protein-coupled receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
5432,30160,G protein-coupled receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
9570,30161,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9941,30161,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5184,30161,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11646,30161,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15694,30162,integrin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15105,30162,integrin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26017,30163,transient receptor potential channel antagonist,MoA,Preclinical,Gene,Chemical_Compound
26017,30164,transient receptor potential channel antagonist,MoA,Preclinical,Gene,Chemical_Compound
30165,30166,lysophosphatidic acid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
28862,30167,monopolar spindle 1 kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25826,30168,sodium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
28647,30169,neurotensin agonist,MoA,Preclinical,Gene,Chemical_Compound
28240,30170,G protein-coupled receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25590,30171,oxytocin receptor agonist|vasopressin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
30172,30171,oxytocin receptor agonist|vasopressin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26440,30173,SRC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8328,30174,DYRK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13005,30174,DYRK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26406,30175,PLK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13234,30176,MAP kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5130,30177,hypoxia inducible factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27071,30178,sphingosine 1-phosphate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
11142,30179,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
27230,30180,glutamate receptor positive allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
15499,30181,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25711,30182,orexin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
2676,30183,Pim kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8086,30184,glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5775,30185,JAK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12477,30186,integrin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15105,30186,integrin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26551,30187,G protein-coupled receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25632,30188,FLT3 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10608,30189,transient receptor potential channel antagonist,MoA,Preclinical,Gene,Chemical_Compound
6908,30190,beta-secretase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25584,30191,acetylcholine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
8041,30193,adenosine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
26611,30194,calcium-sensing receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25955,30195,histamine receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25554,30196,serotonin receptor partial agonist,MoA,Withdrawn,Gene,Chemical_Compound
7079,30196,serotonin receptor partial agonist,MoA,Withdrawn,Gene,Chemical_Compound
25555,30196,serotonin receptor partial agonist,MoA,Withdrawn,Gene,Chemical_Compound
25855,30196,serotonin receptor partial agonist,MoA,Withdrawn,Gene,Chemical_Compound
26456,30197,CC chemokine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25712,30199,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
3725,30200,calcitonin antagonist,MoA,Phase 3,Gene,Chemical_Compound
15447,30200,calcitonin antagonist,MoA,Phase 3,Gene,Chemical_Compound
25592,30201,acetylcholine receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
27469,30209,ATPase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26077,30211,cyclooxygenase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
7829,30211,cyclooxygenase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
10315,30214,SIRT inhibitor|TP53 activator,MoA,Preclinical,Gene,Chemical_Compound
10315,30215,SIRT inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14923,30215,SIRT inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4184,30215,SIRT inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14456,30218,pyruvate kinase isozyme activator,MoA,Preclinical,Gene,Chemical_Compound
30219,30220,lipoxygenase inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
15298,30220,lipoxygenase inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
13040,30224,histamine receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
5402,30224,histamine receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25955,30224,histamine receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25636,30228,Bruton's tyrosine kinase (BTK) inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26913,30229,prostanoid receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
8337,30230,insulin sensitizer|PPAR receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
10141,30230,insulin sensitizer|PPAR receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
7103,30231,phosphodiesterase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7992,30234,superoxide dismutase inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
16048,30234,superoxide dismutase inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
30236,30237,cytidine deaminase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25958,30239,calcium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
25652,30240,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
11142,30240,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
4203,30240,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
14160,30240,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
14968,30240,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
7020,30241,monoamine oxidase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
27846,30242,prostaglandin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3181,30243,CLK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4445,30243,CLK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8328,30243,CLK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13005,30243,CLK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15298,30244,CDK inhibitor|FLT3 inhibitor|JAK inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
8227,30244,CDK inhibitor|FLT3 inhibitor|JAK inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
5178,30244,CDK inhibitor|FLT3 inhibitor|JAK inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
11699,30244,CDK inhibitor|FLT3 inhibitor|JAK inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
25632,30244,CDK inhibitor|FLT3 inhibitor|JAK inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
11600,30244,CDK inhibitor|FLT3 inhibitor|JAK inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
25712,30245,SRC inhibitor|VEGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15786,30245,SRC inhibitor|VEGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4588,30246,SRC inhibitor|VEGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
5212,30246,SRC inhibitor|VEGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26178,30246,SRC inhibitor|VEGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26179,30246,SRC inhibitor|VEGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25712,30246,SRC inhibitor|VEGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
15786,30246,SRC inhibitor|VEGFR inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11600,30247,JAK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5775,30247,JAK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6809,30248,PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12097,30248,PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9637,30249,PI3K inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
6809,30249,PI3K inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
12097,30249,PI3K inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
25846,30249,PI3K inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
12683,30250,MTH1 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8041,30252,phosphodiesterase inhibitor,MoA,Launched,Gene,Chemical_Compound
25726,30252,phosphodiesterase inhibitor,MoA,Launched,Gene,Chemical_Compound
11307,30252,phosphodiesterase inhibitor,MoA,Launched,Gene,Chemical_Compound
30253,30254,GLCNAC phosphotransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25614,30263,histamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25961,30263,histamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25546,30265,dopamine receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25547,30265,dopamine receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25548,30265,dopamine receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25549,30265,dopamine receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25550,30265,dopamine receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
13040,30265,dopamine receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25551,30265,dopamine receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25554,30265,dopamine receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25555,30265,dopamine receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25962,30265,dopamine receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25963,30265,dopamine receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
15883,30266,membrane metalloendopeptidase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
5178,30272,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5178,30273,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5178,30274,CDK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11481,30282,AKT inhibitor|TRAIL modulator,MoA,Phase 2,Gene,Chemical_Compound
15365,30282,AKT inhibitor|TRAIL modulator,MoA,Phase 2,Gene,Chemical_Compound
8086,30283,glycogen synthase kinase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
27055,30284,cytochrome P450 inhibitor|sodium/potassium/chloride transporter inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
5054,30284,cytochrome P450 inhibitor|sodium/potassium/chloride transporter inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25712,30285,TIE tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4449,30285,TIE tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25679,30286,ATP-sensitive potassium channel agonist,MoA,Phase 1,Gene,Chemical_Compound
25683,30286,ATP-sensitive potassium channel agonist,MoA,Phase 1,Gene,Chemical_Compound
7449,30288,cholesterol inhibitor|lipase clearing factor inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25613,30290,histamine receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25676,30292,carbonic anhydrase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3325,30293,farnesyltransferase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
9265,30293,farnesyltransferase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
4768,30294,plasminogen activator inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25660,30295,adrenergic receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25804,30295,adrenergic receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25918,30295,adrenergic receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25662,30296,sodium channel blocker,MoA,Withdrawn,Gene,Chemical_Compound
10745,30299,tyrosine kinase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
14905,30302,cyclophilin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11461,30303,methionine aminopeptidase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25660,30309,adrenergic receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25804,30309,adrenergic receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25918,30309,adrenergic receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
7628,30313,catechol O methyltransferase inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
13780,30314,SRC activator,MoA,Phase 2,Gene,Chemical_Compound
15786,30314,SRC activator,MoA,Phase 2,Gene,Chemical_Compound
25541,30316,adrenergic receptor antagonist,MoA,Launched,Gene,Chemical_Compound
3984,30319,aldose reductase inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
2742,30319,aldose reductase inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
30320,30319,aldose reductase inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
26844,30323,leukotriene receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
26008,30328,cholesteryl ester transfer protein inhibitor,MoA,Phase 3,Gene,Chemical_Compound
14769,30329,DNA polymerase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
10014,30329,DNA polymerase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7640,30331,mTOR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7640,30332,mTOR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9311,30333,peptidase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
14765,30333,peptidase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
15620,30333,peptidase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
6202,30334,serine/threonine kinase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25726,30335,adenosine receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
13343,30336,Aurora kinase inhibitor|Bcr-Abl kinase inhibitor|FLT3 inhibitor|JAK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
8285,30336,Aurora kinase inhibitor|Bcr-Abl kinase inhibitor|FLT3 inhibitor|JAK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25916,30336,Aurora kinase inhibitor|Bcr-Abl kinase inhibitor|FLT3 inhibitor|JAK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26440,30336,Aurora kinase inhibitor|Bcr-Abl kinase inhibitor|FLT3 inhibitor|JAK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25598,30337,GABA receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
25640,30337,GABA receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
25641,30337,GABA receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
25642,30337,GABA receptor inverse agonist,MoA,Preclinical,Gene,Chemical_Compound
4293,30338,AXL kinase inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
8456,30339,IKK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25598,30340,GABA receptor modulator,MoA,Phase 2,Gene,Chemical_Compound
13006,30341,potassium channel antagonist,MoA,Preclinical,Gene,Chemical_Compound
13006,30342,calcium-activated potassium channel activator,MoA,Preclinical,Gene,Chemical_Compound
7625,30344,beta amyloid protein neurotoxicity inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26294,30349,nociceptin/orphanin FQ receptor antagonist|opioid receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
4203,30352,glutamate receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
11214,30357,phosphodiesterase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
15168,30358,DNA replication inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7850,30364,ribonucleotide reductase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26886,30364,ribonucleotide reductase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
9570,30366,HDAC inhibitor,MoA,Phase 1,Gene,Chemical_Compound
26333,30366,HDAC inhibitor,MoA,Phase 1,Gene,Chemical_Compound
9941,30366,HDAC inhibitor,MoA,Phase 1,Gene,Chemical_Compound
5184,30366,HDAC inhibitor,MoA,Phase 1,Gene,Chemical_Compound
11348,30366,HDAC inhibitor,MoA,Phase 1,Gene,Chemical_Compound
11002,30366,HDAC inhibitor,MoA,Phase 1,Gene,Chemical_Compound
15499,30366,HDAC inhibitor,MoA,Phase 1,Gene,Chemical_Compound
26335,30366,HDAC inhibitor,MoA,Phase 1,Gene,Chemical_Compound
11646,30366,HDAC inhibitor,MoA,Phase 1,Gene,Chemical_Compound
3799,30366,HDAC inhibitor,MoA,Phase 1,Gene,Chemical_Compound
11481,30367,AKT inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
3613,30367,AKT inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
12367,30367,AKT inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
10895,30382,dihydrofolate reductase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25552,30386,serotonin receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
25553,30386,serotonin receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
3844,30387,RNA polymerase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
29112,30389,cytokine production inhibitor,MoA,Phase 2,Gene,Chemical_Compound
6026,30389,cytokine production inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25998,30389,cytokine production inhibitor,MoA,Phase 2,Gene,Chemical_Compound
27054,30390,insulin sensitizer|PPAR receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
10141,30390,insulin sensitizer|PPAR receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
9069,30390,insulin sensitizer|PPAR receptor agonist,MoA,Withdrawn,Gene,Chemical_Compound
25596,30392,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26192,30392,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
7829,30393,cyclooxygenase inhibitor,MoA,Launched,Gene,Chemical_Compound
25665,30393,cyclooxygenase inhibitor,MoA,Launched,Gene,Chemical_Compound
12989,30397,bacterial DNA gyrase inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25873,30398,opioid receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
27469,30399,cyclooxygenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6481,30401,retinoid receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
14201,30401,retinoid receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
6665,30401,retinoid receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
11536,30402,casein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15499,30403,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13590,30406,EGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25849,30407,free fatty acid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25785,30408,free fatty acid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
5075,30410,BCL inhibitor,MoA,Preclinical,Gene,Chemical_Compound
16033,30410,BCL inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13264,30410,BCL inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8086,30411,glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10073,30411,glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5216,30411,glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12316,30412,sphingosine 1-phosphate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25632,30413,FLT3 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12907,30414,EGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4449,30414,EGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12907,30415,EGFR inhibitor|tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12907,30416,EGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13590,30417,protein tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12907,30418,protein tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13590,30419,tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25712,30419,tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25966,30419,tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12907,30420,tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11481,30421,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7517,30421,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8086,30421,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26440,30421,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14717,30421,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15643,30421,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15781,30421,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15365,30421,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25908,30421,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15947,30421,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4449,30421,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9097,30421,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7247,30421,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5450,30421,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13626,30421,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8554,30421,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4757,30421,MEK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7628,30422,catechol O methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10748,30423,carbonic anhydrase inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
7555,30423,carbonic anhydrase inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
25676,30423,carbonic anhydrase inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
26682,30423,carbonic anhydrase inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
25872,30424,opioid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25872,30425,opioid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26012,30426,growth hormone releasing factor agonist,MoA,Phase 1,Gene,Chemical_Compound
25548,30427,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
7351,30428,dipeptidyl peptidase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3360,30428,dipeptidyl peptidase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25582,30429,acetylcholine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25584,30429,acetylcholine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25866,30429,acetylcholine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
8327,30431,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
8327,30432,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
8327,30433,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
28268,30433,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
8344,30434,XIAP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9570,30435,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9941,30435,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5184,30435,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11646,30435,HDAC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25547,30437,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25548,30437,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25549,30437,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25551,30437,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26059,30438,metalloproteinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3464,30438,metalloproteinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3521,30438,metalloproteinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11446,30438,metalloproteinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25602,30438,metalloproteinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11792,30439,procollagen C-endopeptidase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7323,30440,monocarboxylate transporter inhibitor,MoA,Preclinical,Gene,Chemical_Compound
2788,30443,histone lysine methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5189,30443,histone lysine methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5189,30444,histone lysine methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5189,30445,histone lysine methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
2788,30446,histone lysine methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5189,30446,histone lysine methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
2788,30447,histone lysine methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5189,30447,histone lysine methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5189,30448,histone lysine methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
2788,30449,histone lysine methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5189,30449,histone lysine methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8956,30450,L3MBTL antagonist,MoA,Preclinical,Gene,Chemical_Compound
11100,30451,histone lysine methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25632,30452,FLT3 inhibitor|MER tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26477,30452,FLT3 inhibitor|MER tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26477,30453,MER tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5241,30454,protein arginine N-methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6722,30455,phosphatidyl-inositol activator,MoA,Preclinical,Gene,Chemical_Compound
15068,30456,L3MBTL antagonist,MoA,Preclinical,Gene,Chemical_Compound
15068,30457,MBT inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9999,30458,PARP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11481,30459,AKT inhibitor,MoA,Phase 2,Gene,Chemical_Compound
3613,30459,AKT inhibitor,MoA,Phase 2,Gene,Chemical_Compound
12367,30459,AKT inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25885,30462,FAAH inhibitor,MoA,Phase 1,Gene,Chemical_Compound
30463,30462,FAAH inhibitor,MoA,Phase 1,Gene,Chemical_Compound
10608,30462,FAAH inhibitor,MoA,Phase 1,Gene,Chemical_Compound
14897,30467,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
12092,30467,dopamine receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25740,30468,purinergic receptor activator,MoA,Launched,Gene,Chemical_Compound
25742,30468,purinergic receptor activator,MoA,Launched,Gene,Chemical_Compound
25743,30468,purinergic receptor activator,MoA,Launched,Gene,Chemical_Compound
28871,30468,purinergic receptor activator,MoA,Launched,Gene,Chemical_Compound
5392,30468,purinergic receptor activator,MoA,Launched,Gene,Chemical_Compound
30469,30470,mixed lineage kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3594,30470,mixed lineage kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25632,30470,mixed lineage kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4204,30470,mixed lineage kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7973,30470,mixed lineage kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6110,30470,mixed lineage kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4029,30470,mixed lineage kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27791,30470,mixed lineage kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10260,30470,mixed lineage kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7333,30472,ATPase inhibitor|NFkB pathway inhibitor|STAT inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
26804,30472,ATPase inhibitor|NFkB pathway inhibitor|STAT inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
4909,30472,ATPase inhibitor|NFkB pathway inhibitor|STAT inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
25719,30472,ATPase inhibitor|NFkB pathway inhibitor|STAT inhibitor,MoA,Phase 2/Phase 3,Gene,Chemical_Compound
4909,30473,MAP kinase activator,MoA,Preclinical,Gene,Chemical_Compound
7555,30474,cyclooxygenase inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25665,30474,cyclooxygenase inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
25731,30483,P glycoprotein inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25958,30495,dopamine reuptake inhibitor,MoA,Phase 3,Gene,Chemical_Compound
27252,30498,secretory phospholipase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
12907,30500,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26178,30500,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26179,30500,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25712,30500,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
12302,30500,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
2744,30501,cathepsin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4497,30501,cathepsin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5876,30501,cathepsin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15816,30502,ATR kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12946,30503,ATR kinase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
15816,30503,ATR kinase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7640,30503,ATR kinase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25846,30503,ATR kinase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26005,30506,leukotriene synthesis inhibitor,MoA,Phase 3,Gene,Chemical_Compound
13754,30507,PARP inhibitor,MoA,Phase 3,Gene,Chemical_Compound
9999,30507,PARP inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26757,30508,neuropeptide receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
13141,30512,HSP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4229,30513,HSP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
30515,30516,CC chemokine receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
28442,30517,urate transporter inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7762,30519,tubulin polymerization inhibitor,MoA,Phase 2,Gene,Chemical_Compound
30520,30521,acetylcholinesterase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14448,30523,tumor necrosis factor receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25720,30524,CC chemokine receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25592,30533,adrenergic receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25593,30533,adrenergic receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25594,30533,adrenergic receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
25595,30533,adrenergic receptor antagonist,MoA,Withdrawn,Gene,Chemical_Compound
8041,30538,adenosine receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25726,30538,adenosine receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
9810,30538,adenosine receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25727,30538,adenosine receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25795,30540,LDL oxidation inhibitor|PKC inhibitor,MoA,Launched,Gene,Chemical_Compound
12202,30540,LDL oxidation inhibitor|PKC inhibitor,MoA,Launched,Gene,Chemical_Compound
26919,30540,LDL oxidation inhibitor|PKC inhibitor,MoA,Launched,Gene,Chemical_Compound
9934,30540,LDL oxidation inhibitor|PKC inhibitor,MoA,Launched,Gene,Chemical_Compound
6055,30540,LDL oxidation inhibitor|PKC inhibitor,MoA,Launched,Gene,Chemical_Compound
7247,30540,LDL oxidation inhibitor|PKC inhibitor,MoA,Launched,Gene,Chemical_Compound
26752,30540,LDL oxidation inhibitor|PKC inhibitor,MoA,Launched,Gene,Chemical_Compound
6266,30540,LDL oxidation inhibitor|PKC inhibitor,MoA,Launched,Gene,Chemical_Compound
30541,30540,LDL oxidation inhibitor|PKC inhibitor,MoA,Launched,Gene,Chemical_Compound
30542,30540,LDL oxidation inhibitor|PKC inhibitor,MoA,Launched,Gene,Chemical_Compound
8546,30543,antitumor agent|ubiquitin C-terminal hydrolase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
8301,30543,antitumor agent|ubiquitin C-terminal hydrolase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
14636,30545,PLK inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25554,30546,serotonin receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
7079,30546,serotonin receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25555,30546,serotonin receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25955,30546,serotonin receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
12989,30549,topoisomerase inhibitor,MoA,Phase 3,Gene,Chemical_Compound
7640,30553,mTOR inhibitor|PI3K inhibitor,MoA,Phase 2,Gene,Chemical_Compound
9637,30553,mTOR inhibitor|PI3K inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25949,30554,beta amyloid antagonist,MoA,Phase 1,Gene,Chemical_Compound
8124,30554,beta amyloid antagonist,MoA,Phase 1,Gene,Chemical_Compound
25610,30555,cytochrome P450 inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25829,30556,renin inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25596,30557,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26192,30557,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25961,30558,histamine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
5446,30559,CC chemokine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
8093,30560,phospholipase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9280,30561,acetylcholine receptor allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
26552,30562,potassium/chloride cotransporter inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25655,30563,glutamate receptor positive allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
25655,30564,glutamate receptor positive allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
27230,30565,glutamate receptor positive allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
27230,30566,glutamate receptor positive allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
3540,30567,phospholipase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27230,30568,glutamate receptor positive allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
26861,30569,glutamate receptor positive allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
25595,30570,acetylcholine receptor allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
25595,30571,acetylcholine receptor allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
25655,30572,glutamate receptor positive allosteric modulator,MoA,Preclinical,Gene,Chemical_Compound
25655,30573,glutamate receptor potentiator,MoA,Preclinical,Gene,Chemical_Compound
25681,30574,potassium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
15365,30575,MAP kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26020,30576,p38 MAPK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
6026,30576,p38 MAPK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25908,30576,p38 MAPK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
15947,30576,p38 MAPK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
4449,30576,p38 MAPK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25998,30576,p38 MAPK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25908,30577,p38 MAPK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
15947,30577,p38 MAPK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
4449,30577,p38 MAPK inhibitor,MoA,Phase 2,Gene,Chemical_Compound
4815,30578,caspase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7612,30579,anaphylatoxin chemotactic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25551,30581,serotonin receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25555,30582,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26059,30583,metalloproteinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13590,30584,estrogen receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26246,30584,estrogen receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
11200,30584,estrogen receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25625,30584,estrogen receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25604,30585,gonadotropin releasing factor hormone receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25613,30585,gonadotropin releasing factor hormone receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25597,30585,gonadotropin releasing factor hormone receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25547,30586,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25554,30586,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25555,30586,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25962,30586,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25963,30586,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26872,30587,glutamate inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12497,30588,secreted frizzled related protein inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26768,30589,FXR agonist,MoA,Phase 1,Gene,Chemical_Compound
7640,30590,mTOR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25555,30591,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25573,30592,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
13991,30592,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25575,30592,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25541,30592,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25543,30592,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25544,30592,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25551,30592,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
12594,30593,histone lysine methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26440,30594,SRC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15786,30594,SRC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12907,30595,JAK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3105,30595,JAK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11600,30595,JAK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5775,30595,JAK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11431,30596,tankyrase inhibitor|WNT pathway inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7552,30597,aldehyde dehydrogenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6161,30598,bradykinin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
5205,30599,actin related protein inhibitor|neural Wiskott-Aldrich syndrome protein inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4919,30600,porcupine inhibitor,MoA,Preclinical,Gene,Chemical_Compound
30601,30602,PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12460,30602,PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9637,30602,PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12097,30602,PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25846,30602,PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5177,30602,PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14636,30602,PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7453,30602,PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8551,30603,STAT inhibitor,MoA,Phase 1,Gene,Chemical_Compound
11600,30604,deubiquitinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3127,30604,deubiquitinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8301,30604,deubiquitinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11055,30604,deubiquitinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
30606,30607,carboxylesterase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9915,30608,monoacylglycerol lipase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7640,30609,mTOR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7640,30610,mTOR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7640,30611,mTOR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12907,30612,EGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12907,30613,EGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13590,30613,EGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7533,30614,AMPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15278,30614,AMPK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12907,30615,EGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25894,30616,CC chemokine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25551,30617,serotonin receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25660,30618,adrenergic receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25592,30619,acetylcholine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25593,30619,acetylcholine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25594,30619,acetylcholine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25595,30619,acetylcholine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
9280,30619,acetylcholine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25551,30619,acetylcholine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25552,30619,acetylcholine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25553,30619,acetylcholine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25853,30619,acetylcholine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25854,30619,acetylcholine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25554,30619,acetylcholine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
7079,30619,acetylcholine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25555,30619,acetylcholine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25962,30619,acetylcholine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25963,30619,acetylcholine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
7800,30620,tankyrase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11431,30620,tankyrase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9535,30621,benzodiazepine receptor ligand,MoA,Phase 2,Gene,Chemical_Compound
5999,30622,bromodomain inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14000,30622,bromodomain inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15528,30622,bromodomain inhibitor,MoA,Preclinical,Gene,Chemical_Compound
28245,30622,bromodomain inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27138,30623,potassium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
25965,30623,potassium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
2757,30623,potassium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
26374,30623,potassium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
5524,30623,potassium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
3105,30625,JAK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
11600,30625,JAK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
5775,30625,JAK inhibitor,MoA,Phase 1,Gene,Chemical_Compound
9637,30626,PI3K inhibitor,MoA,Phase 2,Gene,Chemical_Compound
12097,30626,PI3K inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25846,30626,PI3K inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11627,30627,Abl kinase inhibitor|insulin growth factor receptor inhibitor|SRC inhibitor,MoA,Phase 1,Gene,Chemical_Compound
15786,30627,Abl kinase inhibitor|insulin growth factor receptor inhibitor|SRC inhibitor,MoA,Phase 1,Gene,Chemical_Compound
7640,30628,mTOR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
12907,30629,EGFR inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
6383,30629,EGFR inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
13590,30629,EGFR inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
26179,30629,EGFR inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25712,30629,EGFR inhibitor|VEGFR inhibitor,MoA,Phase 3,Gene,Chemical_Compound
15491,30630,MAP kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8849,30631,MAP kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15491,30631,MAP kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26180,30631,MAP kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
30632,30631,MAP kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9052,30635,focal adhesion kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11393,30636,estrogen receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25625,30636,estrogen receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
11455,30637,potassium channel activator,MoA,Phase 1,Gene,Chemical_Compound
11455,30638,potassium channel activator,MoA,Phase 1,Gene,Chemical_Compound
12916,30639,rho associated kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14999,30639,rho associated kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5770,30639,rho associated kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25765,30639,rho associated kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13626,30639,rho associated kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9902,30639,rho associated kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7432,30640,prolyl endopeptidase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
29852,30641,interleukin inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13626,30642,rho associated kinase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
9902,30642,rho associated kinase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
14710,30643,guanylyl cyclase activator,MoA,Preclinical,Gene,Chemical_Compound
26311,30643,guanylyl cyclase activator,MoA,Preclinical,Gene,Chemical_Compound
26313,30643,guanylyl cyclase activator,MoA,Preclinical,Gene,Chemical_Compound
7902,30643,guanylyl cyclase activator,MoA,Preclinical,Gene,Chemical_Compound
26012,30644,ghrelin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
30645,30646,apoptosis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3421,30646,apoptosis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26369,30647,CCK receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
30219,30648,survivin inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26996,30649,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26996,30650,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25940,30651,aromatase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
28272,30652,calcium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
26792,30652,calcium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
10825,30652,calcium channel blocker,MoA,Preclinical,Gene,Chemical_Compound
8363,30653,ACAT inhibitor,MoA,Phase 1,Gene,Chemical_Compound
30654,30655,IL5 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
30656,30655,IL5 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3004,30657,phosphodiesterase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
10994,30658,piezo channel activator,MoA,Preclinical,Gene,Chemical_Compound
10043,30660,phosphofructokinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4791,30660,phosphofructokinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7710,30661,rho associated kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25596,30662,serotonin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
26192,30662,serotonin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25855,30662,serotonin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25556,30662,serotonin receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
8517,30664,calmodulin antagonist,MoA,Phase 3,Gene,Chemical_Compound
25613,30665,histamine receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
25594,30666,acetylcholine receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
26551,30668,phosphodiesterase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
12646,30668,phosphodiesterase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7103,30668,phosphodiesterase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11214,30668,phosphodiesterase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26607,30668,phosphodiesterase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7103,30669,phosphodiesterase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
28212,30670,HCN channel blocker,MoA,Phase 3,Gene,Chemical_Compound
30671,30670,HCN channel blocker,MoA,Phase 3,Gene,Chemical_Compound
28214,30670,HCN channel blocker,MoA,Phase 3,Gene,Chemical_Compound
28215,30670,HCN channel blocker,MoA,Phase 3,Gene,Chemical_Compound
2512,30672,CDC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25918,30673,adrenergic receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
25918,30674,adrenergic receptor agonist,MoA,Phase 1,Gene,Chemical_Compound
5948,30675,angiotensin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
28212,30676,HCN channel blocker,MoA,Phase 2,Gene,Chemical_Compound
30671,30676,HCN channel blocker,MoA,Phase 2,Gene,Chemical_Compound
28214,30676,HCN channel blocker,MoA,Phase 2,Gene,Chemical_Compound
28215,30676,HCN channel blocker,MoA,Phase 2,Gene,Chemical_Compound
30236,30677,DNA methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14831,30677,DNA methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5173,30678,endothelin receptor antagonist,MoA,Phase 3,Gene,Chemical_Compound
7020,30682,selective serotonin reuptake inhibitor (SSRI),MoA,Withdrawn,Gene,Chemical_Compound
7633,30682,selective serotonin reuptake inhibitor (SSRI),MoA,Withdrawn,Gene,Chemical_Compound
25800,30682,selective serotonin reuptake inhibitor (SSRI),MoA,Withdrawn,Gene,Chemical_Compound
11393,30684,estrogen receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25625,30684,estrogen receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25591,30685,CC chemokine receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
25598,30686,benzodiazepine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25640,30686,benzodiazepine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25641,30686,benzodiazepine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25642,30686,benzodiazepine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25645,30686,benzodiazepine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25648,30686,benzodiazepine receptor agonist,MoA,Phase 3,Gene,Chemical_Compound
25598,30687,benzodiazepine receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25640,30687,benzodiazepine receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25641,30687,benzodiazepine receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25642,30687,benzodiazepine receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
13924,30688,AMPK activator,MoA,Preclinical,Gene,Chemical_Compound
7535,30688,AMPK activator,MoA,Preclinical,Gene,Chemical_Compound
13398,30688,AMPK activator,MoA,Preclinical,Gene,Chemical_Compound
8041,30689,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25726,30689,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
9810,30689,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25727,30689,adenosine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
12907,30690,Abl kinase inhibitor|SRC inhibitor|VEGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26178,30690,Abl kinase inhibitor|SRC inhibitor|VEGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26179,30690,Abl kinase inhibitor|SRC inhibitor|VEGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25712,30690,Abl kinase inhibitor|SRC inhibitor|VEGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25712,30691,VEGFR inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9018,30692,RAF inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26440,30692,RAF inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4449,30692,RAF inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5450,30692,RAF inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3105,30693,JAK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
5775,30693,JAK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13343,30694,Aurora kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8285,30694,Aurora kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26201,30698,prostaglandin synthesis inhibitor,MoA,Withdrawn,Gene,Chemical_Compound
11988,30699,sodium/hydrogen exchanger inhibitor,MoA,Phase 3,Gene,Chemical_Compound
25731,30705,P glycoprotein inhibitor,MoA,Phase 3,Gene,Chemical_Compound
30706,30705,P glycoprotein inhibitor,MoA,Phase 3,Gene,Chemical_Compound
6809,30709,PI3K inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
12097,30709,PI3K inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
25846,30709,PI3K inhibitor,MoA,Phase 1/Phase 2,Gene,Chemical_Compound
7440,30711,N-type calcium channel blocker,MoA,Phase 2,Gene,Chemical_Compound
11600,30712,JAK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3823,30713,benzodiazepine receptor agonist|gamma hydroxybutyric acid agonist,MoA,Phase 1,Gene,Chemical_Compound
27252,30713,benzodiazepine receptor agonist|gamma hydroxybutyric acid agonist,MoA,Phase 1,Gene,Chemical_Compound
25949,30713,benzodiazepine receptor agonist|gamma hydroxybutyric acid agonist,MoA,Phase 1,Gene,Chemical_Compound
8870,30714,glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15298,30714,glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6044,30714,glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8086,30714,glycogen synthase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9932,30715,alpha mannosidase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26417,30716,potassium channel activator,MoA,Preclinical,Gene,Chemical_Compound
27175,30716,potassium channel activator,MoA,Preclinical,Gene,Chemical_Compound
27177,30716,potassium channel activator,MoA,Preclinical,Gene,Chemical_Compound
13006,30716,potassium channel activator,MoA,Preclinical,Gene,Chemical_Compound
14586,30717,sphingosine 1-phosphate receptor substrate,MoA,Preclinical,Gene,Chemical_Compound
27232,30717,sphingosine 1-phosphate receptor substrate,MoA,Preclinical,Gene,Chemical_Compound
15786,30718,SRC inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25596,30720,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26192,30720,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
2676,30721,AKT inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15946,30722,topoisomerase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
10555,30723,PKC activator,MoA,Phase 2,Gene,Chemical_Compound
6139,30723,PKC activator,MoA,Phase 2,Gene,Chemical_Compound
26441,30724,nitric oxide synthase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25942,30724,nitric oxide synthase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26138,30724,nitric oxide synthase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26951,30725,prostanoid receptor agonist,MoA,Phase 2,Gene,Chemical_Compound
8041,30727,adenosine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
16033,30728,BCL-XL downregulator,MoA,Preclinical,Gene,Chemical_Compound
9075,30729,thioredoxin inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7625,30730,ATP synthase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27303,30731,hemoglobin modulator,MoA,Phase 2,Gene,Chemical_Compound
28349,30732,glutamate carboxypeptidase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25855,30733,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
7555,30734,carbonic anhydrase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25675,30734,carbonic anhydrase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25676,30734,carbonic anhydrase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26681,30734,carbonic anhydrase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26682,30734,carbonic anhydrase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9917,30735,"1,4,5-trisphosphate inhibitor",MoA,Preclinical,Gene,Chemical_Compound
28272,30735,"1,4,5-trisphosphate inhibitor",MoA,Preclinical,Gene,Chemical_Compound
9770,30735,"1,4,5-trisphosphate inhibitor",MoA,Preclinical,Gene,Chemical_Compound
26792,30735,"1,4,5-trisphosphate inhibitor",MoA,Preclinical,Gene,Chemical_Compound
7510,30735,"1,4,5-trisphosphate inhibitor",MoA,Preclinical,Gene,Chemical_Compound
25933,30735,"1,4,5-trisphosphate inhibitor",MoA,Preclinical,Gene,Chemical_Compound
26080,30735,"1,4,5-trisphosphate inhibitor",MoA,Preclinical,Gene,Chemical_Compound
9069,30735,"1,4,5-trisphosphate inhibitor",MoA,Preclinical,Gene,Chemical_Compound
30736,30735,"1,4,5-trisphosphate inhibitor",MoA,Preclinical,Gene,Chemical_Compound
6190,30735,"1,4,5-trisphosphate inhibitor",MoA,Preclinical,Gene,Chemical_Compound
30737,30735,"1,4,5-trisphosphate inhibitor",MoA,Preclinical,Gene,Chemical_Compound
25541,30738,imidazoline receptor ligand,MoA,Preclinical,Gene,Chemical_Compound
25543,30738,imidazoline receptor ligand,MoA,Preclinical,Gene,Chemical_Compound
25544,30738,imidazoline receptor ligand,MoA,Preclinical,Gene,Chemical_Compound
7020,30738,imidazoline receptor ligand,MoA,Preclinical,Gene,Chemical_Compound
7633,30738,imidazoline receptor ligand,MoA,Preclinical,Gene,Chemical_Compound
8041,30739,adenosine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25726,30739,adenosine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
9810,30739,adenosine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25727,30739,adenosine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
8041,30740,adenosine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25726,30740,adenosine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
9810,30740,adenosine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25547,30741,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25549,30741,dopamine receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
14676,30742,glycolysis inhibitor,MoA,Phase 2,Gene,Chemical_Compound
30743,30742,glycolysis inhibitor,MoA,Phase 2,Gene,Chemical_Compound
30744,30742,glycolysis inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11730,30742,glycolysis inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7292,30746,androgen receptor antagonist,MoA,Phase 2,Gene,Chemical_Compound
13139,30747,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25560,30747,GABA receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26441,30748,nitric oxide synthase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25942,30748,nitric oxide synthase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25783,30749,melatonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25784,30749,melatonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
15168,30749,melatonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
7628,30750,hypoxia inducible factor inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25940,30750,hypoxia inducible factor inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26344,30750,hypoxia inducible factor inhibitor,MoA,Phase 2,Gene,Chemical_Compound
3148,30750,hypoxia inducible factor inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7902,30750,hypoxia inducible factor inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7762,30750,hypoxia inducible factor inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25552,30751,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25553,30751,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25853,30751,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25854,30751,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25596,30751,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26192,30751,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25962,30751,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26045,30752,glucose dependent insulinotropic receptor ligand,MoA,Phase 1,Gene,Chemical_Compound
2925,30755,pyruvate dehydrogenase kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25783,30756,melatonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25784,30756,melatonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25573,30757,adrenergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
13040,30758,histamine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
13722,30759,lipoxygenase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25547,30760,dopamine receptor ligand,MoA,Preclinical,Gene,Chemical_Compound
25655,30761,glutamate receptor modulator,MoA,Preclinical,Gene,Chemical_Compound
7292,30762,"CHK inhibitor|cytochrome P450 activator|indoleamine 2,3-dioxygenase inhibitor",MoA,Phase 3,Gene,Chemical_Compound
7902,30762,"CHK inhibitor|cytochrome P450 activator|indoleamine 2,3-dioxygenase inhibitor",MoA,Phase 3,Gene,Chemical_Compound
29112,30762,"CHK inhibitor|cytochrome P450 activator|indoleamine 2,3-dioxygenase inhibitor",MoA,Phase 3,Gene,Chemical_Compound
30763,30762,"CHK inhibitor|cytochrome P450 activator|indoleamine 2,3-dioxygenase inhibitor",MoA,Phase 3,Gene,Chemical_Compound
26863,30764,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26863,30765,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
15786,30766,SRC inhibitor|SYK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26317,30766,SRC inhibitor|SYK inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26996,30767,glutamate receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25592,30768,dopamine uptake inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25921,30768,dopamine uptake inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25958,30768,dopamine uptake inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25800,30768,dopamine uptake inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13754,30771,PARP inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25596,30772,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
26441,30773,nitric oxide synthase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25942,30773,nitric oxide synthase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26138,30773,nitric oxide synthase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
3157,30774,hexokinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25652,30775,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
11142,30775,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
4203,30775,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
14160,30775,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26996,30776,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25655,30776,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
15252,30777,adenosylhomocysteinase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
11100,30778,histone lysine methyltransferase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26996,30782,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
2925,30783,GABA aminotransferase activator,MoA,Preclinical,Gene,Chemical_Compound
30763,30784,PI3K inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25573,30785,adrenergic receptor ligand,MoA,Preclinical,Gene,Chemical_Compound
4791,30786,phosphofructokinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11481,30787,casein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7517,30787,casein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
11536,30787,casein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8086,30787,casein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26440,30787,casein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14717,30787,casein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15365,30787,casein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25908,30787,casein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
15947,30787,casein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4449,30787,casein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9097,30787,casein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7247,30787,casein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
13626,30787,casein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8554,30787,casein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4757,30787,casein kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25554,30788,serotonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26996,30790,glutamate receptor agonist|glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26996,30791,glutamate receptor agonist|glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
26425,30791,glutamate receptor agonist|glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
12347,30792,urokinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27092,30793,free fatty acid receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25592,30794,cholinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25593,30794,cholinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25594,30794,cholinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25595,30794,cholinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
9280,30794,cholinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
13754,30795,PARP inhibitor,MoA,Preclinical,Gene,Chemical_Compound
14233,30796,sigma receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
10043,30798,macrophage migration inhibiting factor inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25940,30799,protein tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
2833,30799,protein tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
27114,30799,protein tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25764,30799,protein tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
4277,30799,protein tyrosine kinase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25961,30800,histamine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
6202,30801,IRE1 inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25783,30802,melatonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25784,30802,melatonin receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
14233,30803,sigma receptor ligand,MoA,Preclinical,Gene,Chemical_Compound
25571,30804,nicotinic receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
6821,30805,protein synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
6821,30806,protein synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
7720,30806,protein synthesis inhibitor,MoA,Preclinical,Gene,Chemical_Compound
9570,30807,HDAC inhibitor,MoA,Phase 1,Gene,Chemical_Compound
8041,30808,adenosine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
3070,30809,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25652,30809,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
11142,30809,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
4203,30809,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
14160,30809,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
14968,30809,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
9226,30812,purinergic receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25551,30813,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25552,30813,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25553,30813,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25853,30813,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25854,30813,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25554,30813,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
7079,30813,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25555,30813,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25556,30813,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25962,30813,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25963,30813,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
14652,30815,thymidylate synthase inhibitor,MoA,Phase 1,Gene,Chemical_Compound
25594,30816,acetylcholine receptor antagonist,MoA,Phase 1,Gene,Chemical_Compound
25592,30819,acetylcholine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25593,30819,acetylcholine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25594,30819,acetylcholine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25595,30819,acetylcholine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25783,30820,melatonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25784,30820,melatonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
6190,30821,TRPV antagonist,MoA,Preclinical,Gene,Chemical_Compound
25652,30822,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
11142,30822,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
4203,30822,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
14160,30822,glutamate receptor antagonist,MoA,Preclinical,Gene,Chemical_Compound
25547,30823,dopamine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25548,30823,dopamine receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25548,30824,dopamine receptor ligand,MoA,Preclinical,Gene,Chemical_Compound
15298,30825,CDK inhibitor|CHK inhibitor|PKC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7517,30825,CDK inhibitor|CHK inhibitor|PKC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
8332,30825,CDK inhibitor|CHK inhibitor|PKC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
8086,30825,CDK inhibitor|CHK inhibitor|PKC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26440,30825,CDK inhibitor|CHK inhibitor|PKC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
4449,30825,CDK inhibitor|CHK inhibitor|PKC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
10696,30825,CDK inhibitor|CHK inhibitor|PKC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
4583,30825,CDK inhibitor|CHK inhibitor|PKC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
5297,30825,CDK inhibitor|CHK inhibitor|PKC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
7247,30825,CDK inhibitor|CHK inhibitor|PKC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26752,30825,CDK inhibitor|CHK inhibitor|PKC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
15425,30825,CDK inhibitor|CHK inhibitor|PKC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
25765,30825,CDK inhibitor|CHK inhibitor|PKC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
27466,30825,CDK inhibitor|CHK inhibitor|PKC inhibitor,MoA,Phase 2,Gene,Chemical_Compound
6859,30826,acetylcholinesterase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
26441,30827,nitric oxide synthase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
25942,30827,nitric oxide synthase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
26138,30827,nitric oxide synthase inhibitor,MoA,Preclinical,Gene,Chemical_Compound
8196,30828,PKA activator,MoA,Preclinical,Gene,Chemical_Compound
25556,30829,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25963,30829,serotonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25547,30830,dopamine receptor ligand,MoA,Preclinical,Gene,Chemical_Compound
25548,30830,dopamine receptor ligand,MoA,Preclinical,Gene,Chemical_Compound
25783,30831,melatonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
25784,30831,melatonin receptor agonist,MoA,Preclinical,Gene,Chemical_Compound
15946,30832,topoisomerase inhibitor,MoA,Phase 2,Gene,Chemical_Compound
